activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	1410290	CHEMBL832926	Inhibition of ATR kinase using rabbit polyclonal antisera; No inhibition observed at 100 uM	B	CC1CN(c2cc(=O)c3ccc4ccccc4c3o2)CCO1		CHEMBL435507	>	IC50	nM	100000.0	CHEMBL5024	Homo sapiens	IC50	uM	100.0
	1410290	CHEMBL832926	Inhibition of ATR kinase using rabbit polyclonal antisera; No inhibition observed at 100 uM	B	CC1CN(c2cc(=O)c3ccc4ccccc4c3o2)CCO1		CHEMBL435507	>	IC50	nM	100000.0	CHEMBL5024	Homo sapiens	IC50	uM	100.0
	1412180	CHEMBL874431	Inhibition of ATR kinase using rabbit polyclonal antisera	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	>	IC50	nM	100000.0	CHEMBL5024	Homo sapiens	IC50	uM	100.0
	1412287	CHEMBL832926	Inhibition of ATR kinase using rabbit polyclonal antisera; No inhibition observed at 100 uM	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	>	IC50	nM	100000.0	CHEMBL5024	Homo sapiens	IC50	uM	100.0
	1412302	CHEMBL832926	Inhibition of ATR kinase using rabbit polyclonal antisera; No inhibition observed at 100 uM	B	O=c1cc(N2CCOCC2)nc2c3ccccc3ccn12		CHEMBL179242	>	IC50	nM	100000.0	CHEMBL5024	Homo sapiens	IC50	uM	100.0
	1459737	CHEMBL827225	Inhibition of Ataxia telangiectasia related protein ATR kinase	B	O=c1cc(N2CCOCC2)oc2c(-c3cccc4c3sc3ccccc34)cccc12		CHEMBL188678	>	IC50	nM	100000.0	CHEMBL5024	Homo sapiens	IC50	uM	100.0
	1459743	CHEMBL827225	Inhibition of Ataxia telangiectasia related protein ATR kinase	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	>	IC50	nM	100000.0	CHEMBL5024	Homo sapiens	IC50	uM	100.0
	1459748	CHEMBL827225	Inhibition of Ataxia telangiectasia related protein ATR kinase	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	>	IC50	nM	100000.0	CHEMBL5024	Homo sapiens	IC50	uM	100.0
Not Active	1658675	CHEMBL860293	Inhibitory activity against ATR protein kinase receptor at 100 uM	B	O=c1cc(N2CCOCC2)oc2c(-c3cccc4c3sc3ccccc34)cccc12		CHEMBL188678		Activity			CHEMBL5024	Homo sapiens	Activity		
Not Determined	1728703	CHEMBL860293	Inhibitory activity against ATR protein kinase receptor at 100 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccco3)ccc12		CHEMBL196964		Activity			CHEMBL5024	Homo sapiens	Activity		
Not Determined	1728746	CHEMBL860293	Inhibitory activity against ATR protein kinase receptor at 100 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc(F)cc3)ccc12		CHEMBL197439		Activity			CHEMBL5024	Homo sapiens	Activity		
Not Determined	1728789	CHEMBL860293	Inhibitory activity against ATR protein kinase receptor at 100 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccsc3)ccc12		CHEMBL196764		Activity			CHEMBL5024	Homo sapiens	Activity		
Not Determined	1728832	CHEMBL860293	Inhibitory activity against ATR protein kinase receptor at 100 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4c3oc3ccccc34)ccc12		CHEMBL196759		Activity			CHEMBL5024	Homo sapiens	Activity		
Not Determined	1728875	CHEMBL860293	Inhibitory activity against ATR protein kinase receptor at 100 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cc4ccccc4s3)ccc12		CHEMBL381025		Activity			CHEMBL5024	Homo sapiens	Activity		
Not Determined	1728928	CHEMBL860293	Inhibitory activity against ATR protein kinase receptor at 100 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4c3Sc3ccccc3S4)ccc12		CHEMBL199216		Activity			CHEMBL5024	Homo sapiens	Activity		
Not Determined	1728971	CHEMBL860293	Inhibitory activity against ATR protein kinase receptor at 100 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)ccc12		CHEMBL436767		Activity			CHEMBL5024	Homo sapiens	Activity		
Not Determined	1729014	CHEMBL860293	Inhibitory activity against ATR protein kinase receptor at 100 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4ccccc34)ccc12		CHEMBL199050		Activity			CHEMBL5024	Homo sapiens	Activity		
Not Determined	1729057	CHEMBL860293	Inhibitory activity against ATR protein kinase receptor at 100 uM	B	O=c1cc(N2CCOCC2)oc2cc(/C=C/c3ccc(Cl)cc3)ccc12		CHEMBL199051		Activity			CHEMBL5024	Homo sapiens	Activity		
Not Determined	1729100	CHEMBL860293	Inhibitory activity against ATR protein kinase receptor at 100 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc4[nH]ccc4c3)ccc12		CHEMBL369969		Activity			CHEMBL5024	Homo sapiens	Activity		
Not Determined	1729143	CHEMBL860293	Inhibitory activity against ATR protein kinase receptor at 100 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc4ncccc4c3)ccc12		CHEMBL198740		Activity			CHEMBL5024	Homo sapiens	Activity		
Not Determined	1729186	CHEMBL860293	Inhibitory activity against ATR protein kinase receptor at 100 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4c3Oc3ccccc3S4)ccc12		CHEMBL197239		Activity			CHEMBL5024	Homo sapiens	Activity		
Not Determined	1729229	CHEMBL860293	Inhibitory activity against ATR protein kinase receptor at 100 uM	B	Nc1cc(C(=O)O)cc(-c2ccc3c(=O)cc(N4CCOCC4)oc3c2)c1		CHEMBL370108		Activity			CHEMBL5024	Homo sapiens	Activity		
Not Determined	1729272	CHEMBL860293	Inhibitory activity against ATR protein kinase receptor at 100 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4c3sc3ccccc34)ccc12		CHEMBL198801		Activity			CHEMBL5024	Homo sapiens	Activity		
Not Determined	1729318	CHEMBL860293	Inhibitory activity against ATR protein kinase receptor at 100 uM	B	O=C1c2ccccc2C(=O)N1Cc1cccc(-c2ccc3c(=O)cc(N4CCOCC4)oc3c2)c1		CHEMBL197219		Activity			CHEMBL5024	Homo sapiens	Activity		
Not Determined	1729361	CHEMBL860293	Inhibitory activity against ATR protein kinase receptor at 100 uM	B	O=C1c2ccccc2C(=O)N1Cc1ccc(-c2ccc3c(=O)cc(N4CCOCC4)oc3c2)cc1		CHEMBL197227		Activity			CHEMBL5024	Homo sapiens	Activity		
Not Determined	1729404	CHEMBL860293	Inhibitory activity against ATR protein kinase receptor at 100 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccs3)ccc12		CHEMBL371968		Activity			CHEMBL5024	Homo sapiens	Activity		
Not Determined	1729447	CHEMBL860293	Inhibitory activity against ATR protein kinase receptor at 100 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc4ccccc4c3)ccc12		CHEMBL200299		Activity			CHEMBL5024	Homo sapiens	Activity		
Not Determined	1729490	CHEMBL860293	Inhibitory activity against ATR protein kinase receptor at 100 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3csc4ccccc34)ccc12		CHEMBL199416		Activity			CHEMBL5024	Homo sapiens	Activity		
Not Determined	1729533	CHEMBL860293	Inhibitory activity against ATR protein kinase receptor at 100 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc(OCc4ccccc4)cc3)ccc12		CHEMBL382501		Activity			CHEMBL5024	Homo sapiens	Activity		
Not Determined	1729591	CHEMBL860293	Inhibitory activity against ATR protein kinase receptor at 100 uM	B	Cc1ccc(-c2ccc3c(=O)cc(N4CCOCC4)oc3c2)c2ccccc12		CHEMBL200275		Activity			CHEMBL5024	Homo sapiens	Activity		
Not Determined	1729634	CHEMBL860293	Inhibitory activity against ATR protein kinase receptor at 100 uM	B	COC(=O)/C=C/c1ccccc1-c1ccc2c(=O)cc(N3CCOCC3)oc2c1		CHEMBL199424		Activity			CHEMBL5024	Homo sapiens	Activity		
	2137163	CHEMBL937044	Inhibition of ATR	B	NC(N)=S		CHEMBL260876	=	IC50	nM	200.0	CHEMBL5024	Homo sapiens	IC50	nM	200.0
	2137236	CHEMBL937044	Inhibition of ATR	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	>	IC50	nM	100000.0	CHEMBL5024	Homo sapiens	IC50	nM	100000.0
	3227661	CHEMBL1107748	Inhibition of ATR	B	COc1ccc(-c2ccc3c(N4CCOCC4)nc(N4C[C@H](C)O[C@H](C)C4)nc3n2)cc1CO		CHEMBL1078983	>	IC50	nM	10000.0	CHEMBL5024	Homo sapiens	IC50	uM	10.0
	3264392	CHEMBL1104618	Inhibition of ATR by DELFIA assay	B	CC(C)(C)OC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(N)cc4)nc32)CC1		CHEMBL1095627	=	IC50	nM	11400.0	CHEMBL5024	Homo sapiens	IC50	uM	11.4
	3264393	CHEMBL1104618	Inhibition of ATR by DELFIA assay	B	COC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(N)cc4)nc32)CC1		CHEMBL1095626	>	IC50	nM	50000.0	CHEMBL5024	Homo sapiens	IC50	uM	50.0
	3271227	CHEMBL1104618	Inhibition of ATR by DELFIA assay	B	CNC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(C(=O)OC)CC4)c3n2)cc1		CHEMBL563985	=	IC50	nM	4800.0	CHEMBL5024	Homo sapiens	IC50	nM	4800.0
	3271228	CHEMBL1104618	Inhibition of ATR by DELFIA assay	B	CNC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(C(=O)OC(C)C)CC4)c3n2)cc1		CHEMBL1095932	=	IC50	nM	7700.0	CHEMBL5024	Homo sapiens	IC50	nM	7700.0
	3271230	CHEMBL1104618	Inhibition of ATR by DELFIA assay	B	CNC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(C(=O)OC(C)(C)C)CC4)c3n2)cc1		CHEMBL1095933	=	IC50	nM	11700.0	CHEMBL5024	Homo sapiens	IC50	nM	11700.0
	3271231	CHEMBL1104618	Inhibition of ATR by DELFIA assay	B	COC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(NC(=O)NC5CC5)cc4)nc32)CC1		CHEMBL562999	=	IC50	nM	26200.0	CHEMBL5024	Homo sapiens	IC50	nM	26200.0
	3271232	CHEMBL1104618	Inhibition of ATR by DELFIA assay	B	COC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(NC(=O)NCCF)cc4)nc32)CC1		CHEMBL561907	=	IC50	nM	41500.0	CHEMBL5024	Homo sapiens	IC50	nM	41500.0
	3271246	CHEMBL1104618	Inhibition of ATR by DELFIA assay	B	CC(C)OC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(NC(=O)NCCF)cc4)nc32)CC1		CHEMBL1094981	>	IC50	nM	50000.0	CHEMBL5024	Homo sapiens	IC50	nM	50000.0
	3271247	CHEMBL1104618	Inhibition of ATR by DELFIA assay	B	CC(C)(C)OC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(NC(=O)NCCF)cc4)nc32)CC1		CHEMBL1098242	>	IC50	nM	50000.0	CHEMBL5024	Homo sapiens	IC50	nM	50000.0
	3271248	CHEMBL1104618	Inhibition of ATR by DELFIA assay	B	CC(C)OC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(NC(=O)NC5CC5)cc4)nc32)CC1		CHEMBL1097942	>	IC50	nM	50000.0	CHEMBL5024	Homo sapiens	IC50	nM	50000.0
	3271249	CHEMBL1104618	Inhibition of ATR by DELFIA assay	B	CC(C)(C)OC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(NC(=O)NC5CC5)cc4)nc32)CC1		CHEMBL1098243	>	IC50	nM	50000.0	CHEMBL5024	Homo sapiens	IC50	nM	50000.0
	3418823	CHEMBL1226705	Inhibition of Rad3-related (ATR) protein-mediated p53 phosphorylation	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	IC50	nM	200.0	CHEMBL5024	Homo sapiens	IC50	nM	200.0
	6172233	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	>	IC50	nM	100000.0	CHEMBL5024	Homo sapiens	IC50	uM	100.0
	6172237	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	>	IC50	nM	100000.0	CHEMBL5024	Homo sapiens	IC50	uM	100.0
	6172241	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	Cn1c(=O)c2c(ncn2C)n(C)c1=O	Outside typical range	CHEMBL113	=	IC50	nM	1100000.0	CHEMBL5024	Homo sapiens	IC50	uM	1100.0
	6172245	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	COc1cc2c(c(OC)c1OC)-c1c(cc3c(c1OC)OCO3)CC(C)C(C)C2		CHEMBL479488	=	IC50	nM	7200.0	CHEMBL5024	Homo sapiens	IC50	uM	7.2
	6172248	CHEMBL1767685	Inhibition of ATR in human HT-29 cells assessed as hydroxyurea-induced phosphorylation of H2AX by immunofluorescence microscopy	B	Nc1ncc(-c2ccccc2)nc1C(=O)Nc1ccccc1		CHEMBL1766759	>	IC50	nM	2500.0	CHEMBL5024	Homo sapiens	IC50	uM	2.5
	6172253	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	Nc1ncc(-c2ccccc2)nc1C(=O)Nc1ccccc1		CHEMBL1766759	=	IC50	nM	620.0	CHEMBL5024	Homo sapiens	IC50	uM	0.62
	6172254	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	Nc1nccnc1C(=O)Nc1ccccc1		CHEMBL1766760	=	IC50	nM	7100.0	CHEMBL5024	Homo sapiens	IC50	uM	7.1
	6172255	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	Nc1ncc(Br)nc1C(=O)Nc1ccccc1		CHEMBL1766761	=	IC50	nM	5200.0	CHEMBL5024	Homo sapiens	IC50	uM	5.2
	6172256	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	Nc1ncc(C2CCCCC2)nc1C(=O)Nc1ccccc1		CHEMBL1766762	=	IC50	nM	3000.0	CHEMBL5024	Homo sapiens	IC50	uM	3.0
	6172257	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	Nc1ncc(C2=CCCCC2)nc1C(=O)Nc1ccccc1		CHEMBL1766763	=	IC50	nM	2100.0	CHEMBL5024	Homo sapiens	IC50	uM	2.1
	6172258	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	Nc1ncc(-c2cccnc2)nc1C(=O)Nc1ccccc1		CHEMBL1765107	=	IC50	nM	180.0	CHEMBL5024	Homo sapiens	IC50	uM	0.18
	6172259	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	Nc1ncc(-c2ccncc2)nc1C(=O)Nc1ccccc1		CHEMBL1766764	=	IC50	nM	640.0	CHEMBL5024	Homo sapiens	IC50	uM	0.64
	6172260	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	N#Cc1ccccc1-c1cnc(N)c(C(=O)Nc2ccccc2)n1		CHEMBL1766765	=	IC50	nM	24.0	CHEMBL5024	Homo sapiens	IC50	uM	0.024
	6172261	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	C[S+]([O-])c1ccccc1-c1cnc(N)c(C(=O)Nc2ccccc2)n1		CHEMBL1766766	=	IC50	nM	130.0	CHEMBL5024	Homo sapiens	IC50	uM	0.13
	6172262	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	CS(=O)(=O)c1ccccc1-c1cnc(N)c(C(=O)Nc2ccccc2)n1		CHEMBL1766767	=	IC50	nM	1300.0	CHEMBL5024	Homo sapiens	IC50	uM	1.3
	6172263	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	Nc1ncc(-c2ccccc2O)nc1C(=O)Nc1ccccc1		CHEMBL1766768	=	IC50	nM	2400.0	CHEMBL5024	Homo sapiens	IC50	uM	2.4
	6172264	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	COc1ccccc1-c1cnc(N)c(C(=O)Nc2ccccc2)n1		CHEMBL1766769	=	IC50	nM	740.0	CHEMBL5024	Homo sapiens	IC50	uM	0.74
	6172265	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	Nc1ncc(-c2ccccc2Cl)nc1C(=O)Nc1ccccc1		CHEMBL1766770	=	IC50	nM	700.0	CHEMBL5024	Homo sapiens	IC50	uM	0.7
	6172266	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	Cc1ccccc1-c1cnc(N)c(C(=O)Nc2ccccc2)n1		CHEMBL1766771	=	IC50	nM	1400.0	CHEMBL5024	Homo sapiens	IC50	uM	1.4
	6172267	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	N#Cc1cccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)c1		CHEMBL1766772	=	IC50	nM	400.0	CHEMBL5024	Homo sapiens	IC50	uM	0.4
	6172268	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	CS(=O)(=O)c1cccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)c1		CHEMBL1766773	=	IC50	nM	340.0	CHEMBL5024	Homo sapiens	IC50	uM	0.34
	6172269	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	Nc1ncc(-c2cccc(O)c2)nc1C(=O)Nc1ccccc1		CHEMBL1766774	=	IC50	nM	540.0	CHEMBL5024	Homo sapiens	IC50	uM	0.54
	6172270	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	COc1cccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)c1		CHEMBL1766775	=	IC50	nM	2200.0	CHEMBL5024	Homo sapiens	IC50	uM	2.2
	6172271	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	Nc1ncc(-c2cccc(Cl)c2)nc1C(=O)Nc1ccccc1		CHEMBL1766776	=	IC50	nM	1600.0	CHEMBL5024	Homo sapiens	IC50	uM	1.6
	6172272	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	Cc1cccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)c1		CHEMBL1766777	=	IC50	nM	560.0	CHEMBL5024	Homo sapiens	IC50	uM	0.56
	6172273	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	N#Cc1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL1766778	=	IC50	nM	180.0	CHEMBL5024	Homo sapiens	IC50	uM	0.18
	6172274	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	CS(=O)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL1766779	=	IC50	nM	26.0	CHEMBL5024	Homo sapiens	IC50	uM	0.026
	6172275	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	Nc1ncc(-c2ccc(O)cc2)nc1C(=O)Nc1ccccc1		CHEMBL1766780	=	IC50	nM	320.0	CHEMBL5024	Homo sapiens	IC50	uM	0.32
	6172276	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	COc1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL1766781	=	IC50	nM	1500.0	CHEMBL5024	Homo sapiens	IC50	uM	1.5
	6172277	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	Nc1ncc(-c2ccc(Cl)cc2)nc1C(=O)Nc1ccccc1		CHEMBL1766782	=	IC50	nM	2400.0	CHEMBL5024	Homo sapiens	IC50	uM	2.4
	6172278	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	Cc1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL1766783	=	IC50	nM	1700.0	CHEMBL5024	Homo sapiens	IC50	uM	1.7
	6172279	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	NC(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL1766784	=	IC50	nM	110.0	CHEMBL5024	Homo sapiens	IC50	uM	0.11
	6172280	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	CNC(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL1766785	=	IC50	nM	180.0	CHEMBL5024	Homo sapiens	IC50	uM	0.18
	6172281	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	Nc1ncc(-c2ccc(C(=O)N3CCC3)cc2)nc1C(=O)Nc1ccccc1		CHEMBL1766786	=	IC50	nM	100.0	CHEMBL5024	Homo sapiens	IC50	uM	0.1
	6172282	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	CN(C)C(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL1766787	=	IC50	nM	54.0	CHEMBL5024	Homo sapiens	IC50	uM	0.054
	6172283	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	Nc1ncc(-c2ccc(C(=O)N3CCCC3)cc2)nc1C(=O)Nc1ccccc1		CHEMBL1766788	=	IC50	nM	54.0	CHEMBL5024	Homo sapiens	IC50	uM	0.054
	6172284	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	Nc1ncc(-c2ccc(C(=O)N3CCCCC3)cc2)nc1C(=O)Nc1ccccc1		CHEMBL1766789	=	IC50	nM	26.0	CHEMBL5024	Homo sapiens	IC50	uM	0.026
	6172285	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	CN(C)C(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1Cl		CHEMBL1766790	=	IC50	nM	48.0	CHEMBL5024	Homo sapiens	IC50	uM	0.048
	6172286	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	C[S+]([O-])c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL1766791	=	IC50	nM	56.0	CHEMBL5024	Homo sapiens	IC50	uM	0.056
	6172287	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	CCS(=O)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL1766792	=	IC50	nM	12.0	CHEMBL5024	Homo sapiens	IC50	uM	0.012
	6172288	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL1766793	=	IC50	nM	8.0	CHEMBL5024	Homo sapiens	IC50	uM	0.008
	6172289	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	CCCS(=O)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL1766794	=	IC50	nM	14.0	CHEMBL5024	Homo sapiens	IC50	uM	0.014
	6172290	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	CCC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL1766795	=	IC50	nM	10.0	CHEMBL5024	Homo sapiens	IC50	uM	0.01
	6172291	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	CC(C)(C)S(=O)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL1766796	=	IC50	nM	6.0	CHEMBL5024	Homo sapiens	IC50	uM	0.006
	6172292	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	CC(CN(C)C)S(=O)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL1766797	=	IC50	nM	12.0	CHEMBL5024	Homo sapiens	IC50	uM	0.012
	6172293	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	CC(CCO)S(=O)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL1766798	=	IC50	nM	8.0	CHEMBL5024	Homo sapiens	IC50	uM	0.008
	6172294	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	Nc1ncc(-c2ccc(S(=O)(=O)[C@@H]3CCOC3)cc2)nc1C(=O)Nc1ccccc1		CHEMBL1766799	=	IC50	nM	10.0	CHEMBL5024	Homo sapiens	IC50	uM	0.01
	6172295	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	CS(=O)(=O)c1ccc(-c2cnc(N)c(C(=O)NC3CCCCC3)n2)cc1		CHEMBL1766800	=	IC50	nM	3560.0	CHEMBL5024	Homo sapiens	IC50	uM	3.56
	6172296	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	CS(=O)(=O)c1ccc(-c2cnc(N)c(-c3nc4ccccc4[nH]3)n2)cc1		CHEMBL1766801	=	IC50	nM	30.0	CHEMBL5024	Homo sapiens	IC50	uM	0.03
	6172297	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	CS(=O)(=O)c1ccc(-c2cnc(N)c(-c3nc4ccccc4o3)n2)cc1		CHEMBL1766802	=	IC50	nM	36.0	CHEMBL5024	Homo sapiens	IC50	uM	0.036
	6172298	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	CS(=O)(=O)c1ccc(-c2cnc(N)c(-c3nc4ccccc4s3)n2)cc1		CHEMBL1766803	=	IC50	nM	22.0	CHEMBL5024	Homo sapiens	IC50	uM	0.022
	6172299	CHEMBL1767585	Inhibition of full length recombinant ATR after 24 hrs by radiometric phosphate incorporation assay	B	CS(=O)(=O)c1ccc(-c2cnc(N)c(-c3cc4ccccc4[nH]3)n2)cc1		CHEMBL1766804	=	IC50	nM	23.0	CHEMBL5024	Homo sapiens	IC50	uM	0.023
	6172394	CHEMBL1767685	Inhibition of ATR in human HT-29 cells assessed as hydroxyurea-induced phosphorylation of H2AX by immunofluorescence microscopy	B	CC(CN(C)C)S(=O)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL1766797	=	IC50	nM	420.0	CHEMBL5024	Homo sapiens	IC50	uM	0.42
	6172395	CHEMBL1767685	Inhibition of ATR in human HT-29 cells assessed as hydroxyurea-induced phosphorylation of H2AX by immunofluorescence microscopy	B	CCCS(=O)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL1766794	=	IC50	nM	2000.0	CHEMBL5024	Homo sapiens	IC50	uM	2.0
Not Determined	6172396	CHEMBL1767685	Inhibition of ATR in human HT-29 cells assessed as hydroxyurea-induced phosphorylation of H2AX by immunofluorescence microscopy	B	NC(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL1766784		IC50			CHEMBL5024	Homo sapiens	IC50		
Not Determined	6172397	CHEMBL1767685	Inhibition of ATR in human HT-29 cells assessed as hydroxyurea-induced phosphorylation of H2AX by immunofluorescence microscopy	B	CNC(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL1766785		IC50			CHEMBL5024	Homo sapiens	IC50		
	6172398	CHEMBL1767685	Inhibition of ATR in human HT-29 cells assessed as hydroxyurea-induced phosphorylation of H2AX by immunofluorescence microscopy	B	Nc1ncc(-c2ccc(C(=O)N3CCC3)cc2)nc1C(=O)Nc1ccccc1		CHEMBL1766786	=	IC50	nM	1000.0	CHEMBL5024	Homo sapiens	IC50	uM	1.0
	6172399	CHEMBL1767685	Inhibition of ATR in human HT-29 cells assessed as hydroxyurea-induced phosphorylation of H2AX by immunofluorescence microscopy	B	CN(C)C(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL1766787	=	IC50	nM	2000.0	CHEMBL5024	Homo sapiens	IC50	uM	2.0
	6172400	CHEMBL1767685	Inhibition of ATR in human HT-29 cells assessed as hydroxyurea-induced phosphorylation of H2AX by immunofluorescence microscopy	B	Nc1ncc(-c2ccc(C(=O)N3CCCC3)cc2)nc1C(=O)Nc1ccccc1		CHEMBL1766788	=	IC50	nM	1400.0	CHEMBL5024	Homo sapiens	IC50	uM	1.4
	6172401	CHEMBL1767685	Inhibition of ATR in human HT-29 cells assessed as hydroxyurea-induced phosphorylation of H2AX by immunofluorescence microscopy	B	Nc1ncc(-c2ccc(C(=O)N3CCCCC3)cc2)nc1C(=O)Nc1ccccc1		CHEMBL1766789	=	IC50	nM	6500.0	CHEMBL5024	Homo sapiens	IC50	uM	6.5
	6172402	CHEMBL1767685	Inhibition of ATR in human HT-29 cells assessed as hydroxyurea-induced phosphorylation of H2AX by immunofluorescence microscopy	B	CN(C)C(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1Cl		CHEMBL1766790	=	IC50	nM	12000.0	CHEMBL5024	Homo sapiens	IC50	uM	12.0
	6172403	CHEMBL1767685	Inhibition of ATR in human HT-29 cells assessed as hydroxyurea-induced phosphorylation of H2AX by immunofluorescence microscopy	B	C[S+]([O-])c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL1766791	=	IC50	nM	5400.0	CHEMBL5024	Homo sapiens	IC50	uM	5.4
	6172404	CHEMBL1767685	Inhibition of ATR in human HT-29 cells assessed as hydroxyurea-induced phosphorylation of H2AX by immunofluorescence microscopy	B	CCS(=O)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL1766792	=	IC50	nM	1500.0	CHEMBL5024	Homo sapiens	IC50	uM	1.5
	6172405	CHEMBL1767685	Inhibition of ATR in human HT-29 cells assessed as hydroxyurea-induced phosphorylation of H2AX by immunofluorescence microscopy	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL1766793	=	IC50	nM	1000.0	CHEMBL5024	Homo sapiens	IC50	uM	1.0
	6172406	CHEMBL1767685	Inhibition of ATR in human HT-29 cells assessed as hydroxyurea-induced phosphorylation of H2AX by immunofluorescence microscopy	B	CCC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL1766795	=	IC50	nM	1600.0	CHEMBL5024	Homo sapiens	IC50	uM	1.6
	6172407	CHEMBL1767685	Inhibition of ATR in human HT-29 cells assessed as hydroxyurea-induced phosphorylation of H2AX by immunofluorescence microscopy	B	CC(C)(C)S(=O)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL1766796	=	IC50	nM	1000.0	CHEMBL5024	Homo sapiens	IC50	uM	1.0
	6172408	CHEMBL1767685	Inhibition of ATR in human HT-29 cells assessed as hydroxyurea-induced phosphorylation of H2AX by immunofluorescence microscopy	B	CC(CCO)S(=O)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL1766798	=	IC50	nM	380.0	CHEMBL5024	Homo sapiens	IC50	uM	0.38
	6172409	CHEMBL1767685	Inhibition of ATR in human HT-29 cells assessed as hydroxyurea-induced phosphorylation of H2AX by immunofluorescence microscopy	B	Nc1ncc(-c2ccc(S(=O)(=O)[C@@H]3CCOC3)cc2)nc1C(=O)Nc1ccccc1		CHEMBL1766799	=	IC50	nM	460.0	CHEMBL5024	Homo sapiens	IC50	uM	0.46
	6172412	CHEMBL1767695	Competitive inhibition of full length recombinant ATR Morrison equation analysis	B	CC(CN(C)C)S(=O)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL1766797	=	Ki	nM	6.0	CHEMBL5024	Homo sapiens	Ki	nM	6.0
	8003484	CHEMBL1942461	Inhibition of human ATR in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940980	<	Inhibition	%	35.0	CHEMBL5024	Homo sapiens	INH	%	35.0
	8003485	CHEMBL1942461	Inhibition of human ATR in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940981	<	Inhibition	%	35.0	CHEMBL5024	Homo sapiens	INH	%	35.0
	8003486	CHEMBL1942461	Inhibition of human ATR in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940987	<	Inhibition	%	35.0	CHEMBL5024	Homo sapiens	INH	%	35.0
	8003487	CHEMBL1942461	Inhibition of human ATR in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940990	<	Inhibition	%	35.0	CHEMBL5024	Homo sapiens	INH	%	35.0
	12159934	CHEMBL2183413	Inhibition of flag-tagged ATR expressed in HEK293T cells using PHAS-1 as substrate after 20 mins by autoradiography	B	COc1cc2c(c(OC)c1OC)-c1c(cc3c(c1OC)OCO3)CC(C)C(C)C2		CHEMBL479488	=	IC50	nM	7300.0	CHEMBL5024	Homo sapiens	IC50	uM	7.3
	12159935	CHEMBL2183425	Inhibition of ATR autophosphorylation in irradiated human MCF7 cells compound treated for 2 hr before and 1 hr after irradiation by Western blot method	B	Nc1nc(N)c(N=O)c(OCC2CCCCC2)n1		CHEMBL303958	=	IC50	nM	6700.0	CHEMBL5024	Homo sapiens	IC50	uM	6.7
	12183792	CHEMBL2216371	Inhibition of ATR	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	5888.44	CHEMBL5024	Homo sapiens	pIC50		5.23
	12660557	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	CS(=O)(=O)C1(c2cc(N3CC4CCC(C3)O4)nc(-c3cccc4[nH]ccc34)n2)CC1		CHEMBL2325699	=	IC50	nM	350.0	CHEMBL5024	Homo sapiens	IC50	uM	0.35
	12660558	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	CC[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-c2cccc3[nH]ccc23)n1		CHEMBL2325698	=	IC50	nM	4400.0	CHEMBL5024	Homo sapiens	IC50	uM	4.4
	12660559	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	C[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-c2cccc3[nH]ccc23)n1		CHEMBL2325697	=	IC50	nM	50.0	CHEMBL5024	Homo sapiens	IC50	uM	0.05
	12660560	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	C[C@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-c2cccc3[nH]ccc23)n1		CHEMBL2325696	=	IC50	nM	3700.0	CHEMBL5024	Homo sapiens	IC50	uM	3.7
	12660561	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	COc1cc(-c2nc(N3CCOCC3)cc(C3(S(C)(=O)=O)CC3)n2)c2cc[nH]c2c1		CHEMBL2325695	=	IC50	nM	800.0	CHEMBL5024	Homo sapiens	IC50	uM	0.8
	12660562	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cc(Cl)cc4[nH]ccc34)n2)CC1		CHEMBL2325440	=	IC50	nM	720.0	CHEMBL5024	Homo sapiens	IC50	uM	0.72
	12660563	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cc(F)cc4[nH]ccc34)n2)CC1		CHEMBL2325439	=	IC50	nM	440.0	CHEMBL5024	Homo sapiens	IC50	uM	0.44
	12660564	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cc(C(N)=O)cc4[nH]ccc34)n2)CC1		CHEMBL2325438	=	IC50	nM	9200.0	CHEMBL5024	Homo sapiens	IC50	uM	9.2
	12660565	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	CNC(=O)c1cc(-c2nc(N3CCOCC3)cc(C3(S(C)(=O)=O)CC3)n2)c2cc[nH]c2c1		CHEMBL2325726	=	IC50	nM	15000.0	CHEMBL5024	Homo sapiens	IC50	uM	15.0
	12660566	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	CN(C)C(=O)c1cc(-c2nc(N3CCOCC3)cc(C3(S(C)(=O)=O)CC3)n2)c2cc[nH]c2c1		CHEMBL2325725	=	IC50	nM	24000.0	CHEMBL5024	Homo sapiens	IC50	uM	24.0
	12660567	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cc(C#N)cc4[nH]ccc34)n2)CC1		CHEMBL2325724	=	IC50	nM	1500.0	CHEMBL5024	Homo sapiens	IC50	uM	1.5
	12660568	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cccc4[nH]c(C#N)cc34)n2)CC1		CHEMBL2325723	=	IC50	nM	7200.0	CHEMBL5024	Homo sapiens	IC50	uM	7.2
	12660569	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cccc4[nH]c(C(N)=O)cc34)n2)CC1		CHEMBL2325722	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	12660570	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	Cc1ccc(-c2nc(N3CCOCC3)cc(C3(S(C)(=O)=O)CC3)n2)c2cc[nH]c12		CHEMBL2325721	=	IC50	nM	6300.0	CHEMBL5024	Homo sapiens	IC50	uM	6.3
	12660571	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	Cc1cc(-c2nc(N3CCOCC3)cc(C3(S(C)(=O)=O)CC3)n2)c2cc[nH]c2c1		CHEMBL2325720	=	IC50	nM	490.0	CHEMBL5024	Homo sapiens	IC50	uM	0.49
	12660572	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	Cc1ccc2[nH]ccc2c1-c1nc(N2CCOCC2)cc(C2(S(C)(=O)=O)CC2)n1		CHEMBL2325719	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	12660573	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	Cc1c[nH]c2cccc(-c3nc(N4CCOCC4)cc(C4(S(C)(=O)=O)CC4)n3)c12		CHEMBL2321916	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	12660574	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	Cc1cc2c(-c3nc(N4CCOCC4)cc(C4(S(C)(=O)=O)CC4)n3)cccc2[nH]1		CHEMBL2325718	=	IC50	nM	2500.0	CHEMBL5024	Homo sapiens	IC50	uM	2.5
	12660575	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cccc4[nH]cnc34)n2)CC1		CHEMBL2325717	=	IC50	nM	8900.0	CHEMBL5024	Homo sapiens	IC50	uM	8.9
	12660576	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cccc4[nH]ncc34)n2)CC1		CHEMBL2325716	=	IC50	nM	13000.0	CHEMBL5024	Homo sapiens	IC50	uM	13.0
	12660577	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cccc4c3CC(=O)N4)n2)CC1		CHEMBL2325715	=	IC50	nM	16000.0	CHEMBL5024	Homo sapiens	IC50	uM	16.0
	12660578	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cccc(N)c3)n2)CC1		CHEMBL2325714	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	12660579	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3ccccc3)n2)CC1		CHEMBL2325713	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	12660580	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	O=S(=O)(c1ccccn1)C1(c2cc(N3CCOCC3)nc(-c3cccc4[nH]ccc34)n2)CC1		CHEMBL2325712	=	IC50	nM	2000.0	CHEMBL5024	Homo sapiens	IC50	uM	2.0
	12660581	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	O=S(=O)(c1ccccc1)C1(c2cc(N3CCOCC3)nc(-c3cccc4[nH]ccc34)n2)CC1		CHEMBL2325711	=	IC50	nM	590.0	CHEMBL5024	Homo sapiens	IC50	uM	0.59
	12660582	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	O=S(=O)(C1CCNCC1)C1(c2cc(N3CCOCC3)nc(-c3cccc4[nH]ccc34)n2)CC1		CHEMBL2325710	=	IC50	nM	2900.0	CHEMBL5024	Homo sapiens	IC50	uM	2.9
	12660583	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	O=S(=O)(C1CCOCC1)C1(c2cc(N3CCOCC3)nc(-c3cccc4[nH]ccc34)n2)CC1		CHEMBL2325709	=	IC50	nM	2800.0	CHEMBL5024	Homo sapiens	IC50	uM	2.8
	12660584	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	CC(C)S(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cccc4[nH]ccc34)n2)CC1		CHEMBL2325708	=	IC50	nM	770.0	CHEMBL5024	Homo sapiens	IC50	uM	0.77
	12660585	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	CN1CCC(c2cc(N3CCOCC3)nc(-c3cccc4[nH]ccc34)n2)(S(C)(=O)=O)CC1		CHEMBL2325707	=	IC50	nM	3700.0	CHEMBL5024	Homo sapiens	IC50	uM	3.7
	12660586	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cccc4[nH]ccc34)n2)CCNCC1		CHEMBL2325706	=	IC50	nM	420.0	CHEMBL5024	Homo sapiens	IC50	uM	0.42
	12660587	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cccc4[nH]ccc34)n2)CCOCC1		CHEMBL2325705	=	IC50	nM	180.0	CHEMBL5024	Homo sapiens	IC50	uM	0.18
	12660588	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cccc4[nH]ccc34)n2)CC1		CHEMBL2325704	=	IC50	nM	360.0	CHEMBL5024	Homo sapiens	IC50	uM	0.36
	12660589	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	CC(C)(c1cc(N2CCOCC2)nc(-c2cccc3[nH]ccc23)n1)S(C)(=O)=O		CHEMBL2325703	=	IC50	nM	280.0	CHEMBL5024	Homo sapiens	IC50	uM	0.28
	12660590	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	Cn1ccc2c(-c3nc(CS(C)(=O)=O)cc(N4CCOCC4)n3)cccc21		CHEMBL2325702	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	12660591	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	CS(=O)(=O)Cc1cc(N2CCOCC2)nc(-c2cccc3cc[nH]c23)n1		CHEMBL2325701	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	12660592	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	CS(=O)(=O)Cc1cc(N2CCOCC2)nc(-c2ccc3cc[nH]c3c2)n1		CHEMBL2325700	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	12660593	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	CS(=O)(=O)Cc1cc(N2CCOCC2)nc(-c2ccc3[nH]ccc3c2)n1		CHEMBL2030436	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	12660594	CHEMBL2330631	Inhibition of ATR-mediated CHK1 phosphorylation at serine 345 in human HT29 cells after 1 hr in presence of 4-nitroquinoline 1-oxide	B	CS(=O)(=O)Cc1cc(N2CCOCC2)nc(-c2cccc3[nH]ccc23)n1		CHEMBL2030442	=	IC50	nM	1100.0	CHEMBL5024	Homo sapiens	IC50	uM	1.1
	12660608	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	CS(=O)(=O)C1(c2cc(N3CC4CCC(C3)O4)nc(-c3cccc4[nH]ccc34)n2)CC1		CHEMBL2325699	=	IC50	nM	7.0	CHEMBL5024	Homo sapiens	IC50	uM	0.007
	12660609	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	CC[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-c2cccc3[nH]ccc23)n1		CHEMBL2325698	=	IC50	nM	170.0	CHEMBL5024	Homo sapiens	IC50	uM	0.17
	12660610	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	C[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-c2cccc3[nH]ccc23)n1		CHEMBL2325697	=	IC50	nM	5.0	CHEMBL5024	Homo sapiens	IC50	uM	0.005
	12660611	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	C[C@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-c2cccc3[nH]ccc23)n1		CHEMBL2325696	=	IC50	nM	34.0	CHEMBL5024	Homo sapiens	IC50	uM	0.034
	12660612	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	COc1cc(-c2nc(N3CCOCC3)cc(C3(S(C)(=O)=O)CC3)n2)c2cc[nH]c2c1		CHEMBL2325695	=	IC50	nM	23.0	CHEMBL5024	Homo sapiens	IC50	uM	0.023
	12660613	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cc(Cl)cc4[nH]ccc34)n2)CC1		CHEMBL2325440	=	IC50	nM	16.0	CHEMBL5024	Homo sapiens	IC50	uM	0.016
	12660614	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cc(F)cc4[nH]ccc34)n2)CC1		CHEMBL2325439	=	IC50	nM	15.0	CHEMBL5024	Homo sapiens	IC50	uM	0.015
	12660615	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cc(C(N)=O)cc4[nH]ccc34)n2)CC1		CHEMBL2325438	=	IC50	nM	41.0	CHEMBL5024	Homo sapiens	IC50	uM	0.041
	12660616	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	CNC(=O)c1cc(-c2nc(N3CCOCC3)cc(C3(S(C)(=O)=O)CC3)n2)c2cc[nH]c2c1		CHEMBL2325726	=	IC50	nM	140.0	CHEMBL5024	Homo sapiens	IC50	uM	0.14
	12660617	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	CN(C)C(=O)c1cc(-c2nc(N3CCOCC3)cc(C3(S(C)(=O)=O)CC3)n2)c2cc[nH]c2c1		CHEMBL2325725	=	IC50	nM	720.0	CHEMBL5024	Homo sapiens	IC50	uM	0.72
	12660618	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cc(C#N)cc4[nH]ccc34)n2)CC1		CHEMBL2325724	=	IC50	nM	66.0	CHEMBL5024	Homo sapiens	IC50	uM	0.066
	12660619	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cccc4[nH]c(C#N)cc34)n2)CC1		CHEMBL2325723	=	IC50	nM	300.0	CHEMBL5024	Homo sapiens	IC50	uM	0.3
	12660620	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cccc4[nH]c(C(N)=O)cc34)n2)CC1		CHEMBL2325722	=	IC50	nM	1100.0	CHEMBL5024	Homo sapiens	IC50	uM	1.1
	12660621	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	Cc1ccc(-c2nc(N3CCOCC3)cc(C3(S(C)(=O)=O)CC3)n2)c2cc[nH]c12		CHEMBL2325721	=	IC50	nM	220.0	CHEMBL5024	Homo sapiens	IC50	uM	0.22
	12660622	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	Cc1cc(-c2nc(N3CCOCC3)cc(C3(S(C)(=O)=O)CC3)n2)c2cc[nH]c2c1		CHEMBL2325720	=	IC50	nM	8.0	CHEMBL5024	Homo sapiens	IC50	uM	0.008
Not Determined	12660623	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	Cc1ccc2[nH]ccc2c1-c1nc(N2CCOCC2)cc(C2(S(C)(=O)=O)CC2)n1		CHEMBL2325719		IC50			CHEMBL5024	Homo sapiens	IC50		
	12660624	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	Cc1c[nH]c2cccc(-c3nc(N4CCOCC4)cc(C4(S(C)(=O)=O)CC4)n3)c12		CHEMBL2321916	=	IC50	nM	14000.0	CHEMBL5024	Homo sapiens	IC50	uM	14.0
	12660625	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	Cc1cc2c(-c3nc(N4CCOCC4)cc(C4(S(C)(=O)=O)CC4)n3)cccc2[nH]1		CHEMBL2325718	=	IC50	nM	28.0	CHEMBL5024	Homo sapiens	IC50	uM	0.028
	12660626	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cccc4[nH]cnc34)n2)CC1		CHEMBL2325717	=	IC50	nM	180.0	CHEMBL5024	Homo sapiens	IC50	uM	0.18
	12660627	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cccc4[nH]ncc34)n2)CC1		CHEMBL2325716	=	IC50	nM	130.0	CHEMBL5024	Homo sapiens	IC50	uM	0.13
	12660628	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cccc4c3CC(=O)N4)n2)CC1		CHEMBL2325715	=	IC50	nM	120.0	CHEMBL5024	Homo sapiens	IC50	uM	0.12
	12660629	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cccc(N)c3)n2)CC1		CHEMBL2325714	=	IC50	nM	1200.0	CHEMBL5024	Homo sapiens	IC50	uM	1.2
	12660630	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3ccccc3)n2)CC1		CHEMBL2325713	=	IC50	nM	360.0	CHEMBL5024	Homo sapiens	IC50	uM	0.36
	12660631	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	O=S(=O)(c1ccccn1)C1(c2cc(N3CCOCC3)nc(-c3cccc4[nH]ccc34)n2)CC1		CHEMBL2325712	=	IC50	nM	33.0	CHEMBL5024	Homo sapiens	IC50	uM	0.033
	12660632	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	O=S(=O)(c1ccccc1)C1(c2cc(N3CCOCC3)nc(-c3cccc4[nH]ccc34)n2)CC1		CHEMBL2325711	=	IC50	nM	5.0	CHEMBL5024	Homo sapiens	IC50	uM	0.005
	12660633	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	O=S(=O)(C1CCNCC1)C1(c2cc(N3CCOCC3)nc(-c3cccc4[nH]ccc34)n2)CC1		CHEMBL2325710	=	IC50	nM	46.0	CHEMBL5024	Homo sapiens	IC50	uM	0.046
	12660634	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	O=S(=O)(C1CCOCC1)C1(c2cc(N3CCOCC3)nc(-c3cccc4[nH]ccc34)n2)CC1		CHEMBL2325709	=	IC50	nM	33.0	CHEMBL5024	Homo sapiens	IC50	uM	0.033
	12660635	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	CC(C)S(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cccc4[nH]ccc34)n2)CC1		CHEMBL2325708	=	IC50	nM	13.0	CHEMBL5024	Homo sapiens	IC50	uM	0.013
	12660636	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	CN1CCC(c2cc(N3CCOCC3)nc(-c3cccc4[nH]ccc34)n2)(S(C)(=O)=O)CC1		CHEMBL2325707	=	IC50	nM	61.0	CHEMBL5024	Homo sapiens	IC50	uM	0.061
	12660637	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cccc4[nH]ccc34)n2)CCNCC1		CHEMBL2325706	=	IC50	nM	9.0	CHEMBL5024	Homo sapiens	IC50	uM	0.009
	12660638	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cccc4[nH]ccc34)n2)CCOCC1		CHEMBL2325705	=	IC50	nM	4.0	CHEMBL5024	Homo sapiens	IC50	uM	0.004
	12660639	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cccc4[nH]ccc34)n2)CC1		CHEMBL2325704	=	IC50	nM	8.0	CHEMBL5024	Homo sapiens	IC50	uM	0.008
	12660640	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	CC(C)(c1cc(N2CCOCC2)nc(-c2cccc3[nH]ccc23)n1)S(C)(=O)=O		CHEMBL2325703	=	IC50	nM	3.0	CHEMBL5024	Homo sapiens	IC50	uM	0.003
	12660641	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	Cn1ccc2c(-c3nc(CS(C)(=O)=O)cc(N4CCOCC4)n3)cccc21		CHEMBL2325702	=	IC50	nM	3300.0	CHEMBL5024	Homo sapiens	IC50	uM	3.3
	12660642	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	CS(=O)(=O)Cc1cc(N2CCOCC2)nc(-c2cccc3cc[nH]c23)n1		CHEMBL2325701	=	IC50	nM	180.0	CHEMBL5024	Homo sapiens	IC50	uM	0.18
	12660643	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	CS(=O)(=O)Cc1cc(N2CCOCC2)nc(-c2ccc3cc[nH]c3c2)n1		CHEMBL2325700	=	IC50	nM	1500.0	CHEMBL5024	Homo sapiens	IC50	uM	1.5
	12660644	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	CS(=O)(=O)Cc1cc(N2CCOCC2)nc(-c2ccc3[nH]ccc3c2)n1		CHEMBL2030436	=	IC50	nM	1700.0	CHEMBL5024	Homo sapiens	IC50	uM	1.7
	12660645	CHEMBL2330635	Inhibition of ATR in human HeLa cell nuclear extracts using glutathione S-transferase-p53N66 and ATP as substrate incubated for 10 mins prior to ATP addition measured after 1 hr by ELISA	B	CS(=O)(=O)Cc1cc(N2CCOCC2)nc(-c2cccc3[nH]ccc23)n1		CHEMBL2030442	=	IC50	nM	30.0	CHEMBL5024	Homo sapiens	IC50	uM	0.03
	13350661	CHEMBL2400706	Inhibition of ATR (unknown origin)	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	IC50	nM	9100.0	CHEMBL5024	Homo sapiens	IC50	uM	9.1
	13380419	CHEMBL2412508	Inhibition of ATR (unknown origin)	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(C3CC(c4ccccc4)=NO3)n2)cc1		CHEMBL2409216	=	Ki	nM	90.0	CHEMBL5024	Homo sapiens	Ki	nM	90.0
	13380420	CHEMBL2412508	Inhibition of ATR (unknown origin)	B	CNCc1ccc(C2=NOC(c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)C2)cc1		CHEMBL2409217	=	Ki	nM	16.0	CHEMBL5024	Homo sapiens	Ki	nM	16.0
	13424282	CHEMBL2423429	Inhibition of ATR (unknown origin)	B	CCN1CCN(CC(=O)Nc2ccc(-c3cccc4c(=O)cc(N5CCOCC5)oc34)c3sc4ccccc4c23)CC1		CHEMBL1086377	>	IC50	nM	10000.0	CHEMBL5024	Homo sapiens	IC50	uM	10.0
	13424283	CHEMBL2423429	Inhibition of ATR (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3cccc4c3sc3ccccc34)cccc12		CHEMBL188678	>	IC50	nM	10000.0	CHEMBL5024	Homo sapiens	IC50	uM	10.0
	13424284	CHEMBL2423429	Inhibition of ATR (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	>	IC50	nM	10000.0	CHEMBL5024	Homo sapiens	IC50	uM	10.0
	13438212	CHEMBL2422450	Inhibition of ATR in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(Cc2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420551	<	Inhibition	%	35.0	CHEMBL5024	Homo sapiens	INH	%	35.0
	13438213	CHEMBL2422450	Inhibition of ATR in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420555	<	Inhibition	%	35.0	CHEMBL5024	Homo sapiens	INH	%	35.0
	13438214	CHEMBL2422450	Inhibition of ATR in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CCC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420573	<	Inhibition	%	35.0	CHEMBL5024	Homo sapiens	INH	%	35.0
	13438215	CHEMBL2422450	Inhibition of ATR in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420572	<	Inhibition	%	35.0	CHEMBL5024	Homo sapiens	INH	%	35.0
	13438216	CHEMBL2422450	Inhibition of ATR in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC(C)(NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420570	<	Inhibition	%	35.0	CHEMBL5024	Homo sapiens	INH	%	35.0
	13438217	CHEMBL2422450	Inhibition of ATR in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CCC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420565	<	Inhibition	%	35.0	CHEMBL5024	Homo sapiens	INH	%	35.0
	13438218	CHEMBL2422450	Inhibition of ATR in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(N[C@H](CO)c1ccccc1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420564	<	Inhibition	%	35.0	CHEMBL5024	Homo sapiens	INH	%	35.0
	13438219	CHEMBL2422450	Inhibition of ATR in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420562	<	Inhibition	%	35.0	CHEMBL5024	Homo sapiens	INH	%	35.0
	13438220	CHEMBL2422450	Inhibition of ATR in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420560	<	Inhibition	%	35.0	CHEMBL5024	Homo sapiens	INH	%	35.0
	13438221	CHEMBL2422450	Inhibition of ATR in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420556	<	Inhibition	%	35.0	CHEMBL5024	Homo sapiens	INH	%	35.0
	13438222	CHEMBL2422450	Inhibition of ATR in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420587	<	Inhibition	%	35.0	CHEMBL5024	Homo sapiens	INH	%	35.0
	13438223	CHEMBL2422450	Inhibition of ATR in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420585	<	Inhibition	%	35.0	CHEMBL5024	Homo sapiens	INH	%	35.0
	14979275	CHEMBL3379628	Inhibition of ATR (unknown origin) using Avi-tagged protein substrate by alphascreen assay	B	COc1ccc(-c2ccc3ncc(-c4ccc(C(N)=O)cc4)n3n2)cc1OC		CHEMBL3355068	=	IC50	nM	26.0	CHEMBL5024	Homo sapiens	IC50	uM	0.026
	14979276	CHEMBL3379628	Inhibition of ATR (unknown origin) using Avi-tagged protein substrate by alphascreen assay	B	CN(C)S(=O)(=O)c1ccc(-c2cnc3ccc(-c4ccnc5[nH]ccc45)nn23)cc1		CHEMBL3355069	=	IC50	nM	0.5	CHEMBL5024	Homo sapiens	IC50	uM	0.0005
	14979277	CHEMBL3379628	Inhibition of ATR (unknown origin) using Avi-tagged protein substrate by alphascreen assay	B	CN(C)S(=O)(=O)c1ccc(-c2cnn3c2CN(c2ccnc4[nH]ccc24)CC3)cc1		CHEMBL3355070	=	IC50	nM	1.0	CHEMBL5024	Homo sapiens	IC50	uM	0.001
	14979278	CHEMBL3379628	Inhibition of ATR (unknown origin) using Avi-tagged protein substrate by alphascreen assay	B	C[C@@H]1Cn2ncc(-c3ccc(S(=O)(=O)N(C)C)cc3)c2CN1c1ccnc2[nH]ccc12		CHEMBL3355071	=	IC50	nM	0.5	CHEMBL5024	Homo sapiens	IC50	uM	0.0005
	14979279	CHEMBL3379628	Inhibition of ATR (unknown origin) using Avi-tagged protein substrate by alphascreen assay	B	C[C@@H]1Cn2ncc(-c3ccc(S(C)(=O)=O)cc3)c2CN1c1ccnc2[nH]ccc12		CHEMBL3355072	=	IC50	nM	0.3	CHEMBL5024	Homo sapiens	IC50	uM	0.0003
	14979280	CHEMBL3379628	Inhibition of ATR (unknown origin) using Avi-tagged protein substrate by alphascreen assay	B	C[C@@H]1Cn2ncc(C3CCN(S(C)(=O)=O)CC3)c2CN1c1ccnc2[nH]ccc12		CHEMBL3355073	=	IC50	nM	1.0	CHEMBL5024	Homo sapiens	IC50	uM	0.001
	14979281	CHEMBL3379628	Inhibition of ATR (unknown origin) using Avi-tagged protein substrate by alphascreen assay	B	C[C@@H]1Cn2ncc(C3CCN(S(C)(=O)=O)CC3)c2CN1c1cc(Cl)nc2[nH]ccc12		CHEMBL3355074	=	IC50	nM	0.4	CHEMBL5024	Homo sapiens	IC50	uM	0.0004
	14979282	CHEMBL3379628	Inhibition of ATR (unknown origin) using Avi-tagged protein substrate by alphascreen assay	B	C[C@@H]1Cn2ncc(C3CCN(S(C)(=O)=O)CC3)c2CN1c1ccnc2[nH]ncc12		CHEMBL3355075	=	IC50	nM	29.0	CHEMBL5024	Homo sapiens	IC50	uM	0.029
	14979283	CHEMBL3379628	Inhibition of ATR (unknown origin) using Avi-tagged protein substrate by alphascreen assay	B	C[C@@H]1Cn2ncc(C3CCN(S(C)(=O)=O)CC3)c2CN1c1ccnc2[nH]cnc12		CHEMBL3352844	=	IC50	nM	2.0	CHEMBL5024	Homo sapiens	IC50	uM	0.002
	14979284	CHEMBL3379628	Inhibition of ATR (unknown origin) using Avi-tagged protein substrate by alphascreen assay	B	C[C@@H]1Cn2ncc(C3CCN(S(C)(=O)=O)CC3)c2CN1c1ccnc(N)c1		CHEMBL3355076	=	IC50	nM	440.0	CHEMBL5024	Homo sapiens	IC50	uM	0.44
	14979285	CHEMBL3379628	Inhibition of ATR (unknown origin) using Avi-tagged protein substrate by alphascreen assay	B	CC1(C)Cn2ncc(C3CCN(S(C)(=O)=O)CC3)c2CN1c1cc(Cl)nc2[nH]ccc12		CHEMBL3355077	=	IC50	nM	6200.0	CHEMBL5024	Homo sapiens	IC50	uM	6.2
	14979286	CHEMBL3379628	Inhibition of ATR (unknown origin) using Avi-tagged protein substrate by alphascreen assay	B	C[C@@H]1[C@@H](C)n2ncc(C3CCN(S(C)(=O)=O)CC3)c2CN1c1ccnc2[nH]ccc12		CHEMBL3355078	=	IC50	nM	2100.0	CHEMBL5024	Homo sapiens	IC50	uM	2.1
	14979287	CHEMBL3379628	Inhibition of ATR (unknown origin) using Avi-tagged protein substrate by alphascreen assay	B	C[C@@H]1Cc2ncn(C3CCN(S(C)(=O)=O)CC3)c2CN1c1ccnc2[nH]ccc12		CHEMBL3355079	=	IC50	nM	41.0	CHEMBL5024	Homo sapiens	IC50	uM	0.041
	14979288	CHEMBL3379628	Inhibition of ATR (unknown origin) using Avi-tagged protein substrate by alphascreen assay	B	C[C@@H]1Cn2ncc(C3CCN(S(C)(=O)=O)CC3)c2C(=O)N1c1ccnc2[nH]ccc12		CHEMBL3355080	=	IC50	nM	64.0	CHEMBL5024	Homo sapiens	IC50	uM	0.064
	14979362	CHEMBL3372398	Inhibition of human ATR using ATP substrate measured after 3 hrs	B	C[C@@H]1COCCN1c1nc(-c2nncc3[nH]ccc23)cc2c1ncn2C		CHEMBL3355480	=	IC50	nM	0.5	CHEMBL5024	Homo sapiens	IC50	uM	0.0005
	14979363	CHEMBL3372398	Inhibition of human ATR using ATP substrate measured after 3 hrs	B	CS(=O)(=O)Cn1cnc2c(N3C4CCC3COC4)nc(-c3cnc(N)nc3)cc21		CHEMBL3355479	=	IC50	nM	190.0	CHEMBL5024	Homo sapiens	IC50	uM	0.19
	14979364	CHEMBL3372398	Inhibition of human ATR using ATP substrate measured after 3 hrs	B	C[C@@H]1COCCN1c1nc(-c2cnc(N)nc2)cc2c1ncn2CS(C)(=O)=O		CHEMBL3355478	=	IC50	nM	6.0	CHEMBL5024	Homo sapiens	IC50	uM	0.006
	14979365	CHEMBL3372398	Inhibition of human ATR using ATP substrate measured after 3 hrs	B	CS(=O)(=O)Cn1cnc2c(N3C4CCC3COC4)nc(-c3cncc4[nH]ccc34)cc21		CHEMBL3355477	=	IC50	nM	34.0	CHEMBL5024	Homo sapiens	IC50	uM	0.034
	14979366	CHEMBL3372398	Inhibition of human ATR using ATP substrate measured after 3 hrs	B	C[C@@H]1COCCN1c1nc(-c2c(F)ncc3[nH]ccc23)cc2c1ncn2C		CHEMBL3355476	=	IC50	nM	0.1	CHEMBL5024	Homo sapiens	IC50	uM	0.0001
	14979367	CHEMBL3372398	Inhibition of human ATR using ATP substrate measured after 3 hrs	B	C[C@@H]1COCCN1c1nc(-c2cncc3[nH]ccc23)cc2c1ncn2C		CHEMBL3355475	=	IC50	nM	0.4	CHEMBL5024	Homo sapiens	IC50	uM	0.0004
	14979368	CHEMBL3372398	Inhibition of human ATR using ATP substrate measured after 3 hrs	B	C[C@@H]1COCCN1c1nc(-c2cncc3[nH]ccc23)cc2c1ncn2[C@@H](C)S(C)(=O)=O		CHEMBL3355474	=	IC50	nM	0.2	CHEMBL5024	Homo sapiens	IC50	uM	0.0002
	14979369	CHEMBL3372398	Inhibition of human ATR using ATP substrate measured after 3 hrs	B	C[C@@H]1COCCN1c1nc(-c2cccc3[nH]ccc23)cc2c1ncn2CS(C)(=O)=O		CHEMBL3355473	=	IC50	nM	1.0	CHEMBL5024	Homo sapiens	IC50	uM	0.001
	14979370	CHEMBL3372398	Inhibition of human ATR using ATP substrate measured after 3 hrs	B	CS(=O)(=O)Cn1cnc2c(N3CCOCC3)nc(-c3cccc4[nH]ccc34)cc21		CHEMBL3355472	=	IC50	nM	5.0	CHEMBL5024	Homo sapiens	IC50	uM	0.005
	14979371	CHEMBL3372398	Inhibition of human ATR using ATP substrate measured after 3 hrs	B	c1cc(-c2cc3c(ncn3CC3CC3)c(N3CCOCC3)n2)c2cc[nH]c2c1		CHEMBL3352848	=	IC50	nM	26.0	CHEMBL5024	Homo sapiens	IC50	uM	0.026
	14979372	CHEMBL3372398	Inhibition of human ATR using ATP substrate measured after 3 hrs	B	O=C(NC1CC1)c1cn2c(N3CCOCC3)nc(-c3cccc4[nH]ccc34)cc2n1		CHEMBL3355471	=	IC50	nM	39.0	CHEMBL5024	Homo sapiens	IC50	uM	0.039
	14979373	CHEMBL3372398	Inhibition of human ATR using ATP substrate measured after 3 hrs	B	C[C@@H]1COCCN1c1nc(-c2cccc3[nH]ccc23)cc2nccn12		CHEMBL3355470	=	IC50	nM	95.0	CHEMBL5024	Homo sapiens	IC50	uM	0.095
	14979374	CHEMBL3372398	Inhibition of human ATR using ATP substrate measured after 3 hrs	B	c1cc(-c2cc3nccn3c(N3CCOCC3)n2)c2cc[nH]c2c1		CHEMBL3355469	=	IC50	nM	96.0	CHEMBL5024	Homo sapiens	IC50	uM	0.096
Active	14997505	CHEMBL3367299	Activation of ATR in human PC3 cells assessed as ChK1 phosphorylation at Ser296 at 20 uM after 12 hrs by western blot analysis	B	C=C[C@@](C)(O)CC[C@@H]1C(C)=CC[C@@H]2C(C)(C)CCC[C@@]12C		CHEMBL3298794		Activity			CHEMBL5024	Homo sapiens	Activity		
Active	14997506	CHEMBL3367300	Activation of ATR in human DU145 cells assessed as ChK1 phosphorylation at Ser296 at 20 uM after 12 hrs by western blot analysis	B	C=C[C@@](C)(O)CC[C@@H]1C(C)=CC[C@@H]2C(C)(C)CCC[C@@]12C		CHEMBL3298794		Activity			CHEMBL5024	Homo sapiens	Activity		
	15005649	CHEMBL3374528	Inhibition of ATR (unknown origin)	B	CC(C)(C#N)c1ccc(N2C(=O)OCc3cnc4ccc(-c5cnc6ccccc6c5)cc4c32)cc1		CHEMBL3334621	=	IC50	nM	14.0	CHEMBL5024	Homo sapiens	IC50	nM	14.0
	15625309	CHEMBL3588380	Inhibition of ATR (unknown origin) at 30 uM relative to control	B	CCN1C(=O)CNc2ncc(-c3ccc(-c4nc[nH]n4)nc3C)nc21		CHEMBL3586573	=	Inhibition	%	50.0	CHEMBL5024	Homo sapiens	INH	%	50.0
212968	17602421	CHEMBL3705235	ATR Inhibition Assay: Assays were carried out in a mixture of 50 mM Tris/HCl (pH 7.5), 10 mM MgCl2 and 1 mM DTT. Final substrate concentrations were 10 M [-33P]ATP (3mCi 33P ATP/mmol ATP, Perkin Elmer) and 800 M target peptide (ASELPASQPQPFSAKKK). Assays were carried out at 25 C. in the presence of 5 nM full-length ATR. An assay stock buffer solution was prepared containing all of the reagents listed above, with the exception of ATP and the test compound of interest. 13.5 L of the stock solution was placed in a 96 well plate followed by addition of 2 L of DMSO stock containing serial dilutions of the test compound (typically starting from a final concentration of 15 M with 3-fold serial dilutions) in duplicate (final DMSO concentration 7%). The plate was pre-incubated for 10 minutes at 25 C. and the reaction initiated by addition of 15 L [-33P]ATP (final concentration 10 M). The reaction was stopped after 24 hours by the addition of 30 L 0.1M phosphoric acid containing 2 mM ATP. A multiscreen phosphocellulose filter 96-well plate (Millipore, Cat no. MAPHN0B50) was pretreated with 100 L 0.2M phosphoric acid prior to the addition of 45 L of the stopped assay mixture. The plate was washed with 5200 L 0.2M phosphoric acid. After drying, 100 L Optiphase 'SuperMix' liquid scintillation cocktail (Perkin Elmer) was added to the well prior to scintillation counting (1450 Microbeta Liquid Scintillation Counter, Wallac).	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3cc(-c4ccc([C@@H]5COCCN5)cc4)no3)n2)cc1		CHEMBL3642117	=	Ki	nM	0.503	CHEMBL5024	Homo sapiens	Ki	nM	0.503
212968	17602422	CHEMBL3705235	ATR Inhibition Assay: Assays were carried out in a mixture of 50 mM Tris/HCl (pH 7.5), 10 mM MgCl2 and 1 mM DTT. Final substrate concentrations were 10 M [-33P]ATP (3mCi 33P ATP/mmol ATP, Perkin Elmer) and 800 M target peptide (ASELPASQPQPFSAKKK). Assays were carried out at 25 C. in the presence of 5 nM full-length ATR. An assay stock buffer solution was prepared containing all of the reagents listed above, with the exception of ATP and the test compound of interest. 13.5 L of the stock solution was placed in a 96 well plate followed by addition of 2 L of DMSO stock containing serial dilutions of the test compound (typically starting from a final concentration of 15 M with 3-fold serial dilutions) in duplicate (final DMSO concentration 7%). The plate was pre-incubated for 10 minutes at 25 C. and the reaction initiated by addition of 15 L [-33P]ATP (final concentration 10 M). The reaction was stopped after 24 hours by the addition of 30 L 0.1M phosphoric acid containing 2 mM ATP. A multiscreen phosphocellulose filter 96-well plate (Millipore, Cat no. MAPHN0B50) was pretreated with 100 L 0.2M phosphoric acid prior to the addition of 45 L of the stopped assay mixture. The plate was washed with 5200 L 0.2M phosphoric acid. After drying, 100 L Optiphase 'SuperMix' liquid scintillation cocktail (Perkin Elmer) was added to the well prior to scintillation counting (1450 Microbeta Liquid Scintillation Counter, Wallac).	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3cc(-c4ccc([C@@H]5COCCN5)cc4)no3)n2)cc1		CHEMBL3642117	=	IC50	nM	200.0	CHEMBL5024	Homo sapiens	IC50	nM	200.0
221344	17610343	CHEMBL3705064	Enzyme Assay: ATR for use in the in vitro enzyme assay was obtained from HeLa nuclear extract (CIL Biotech, Mons, Belgium) by immunoprecipitation with rabbit polycolonal antiserum raised to amino acids 400-480 of ATR (Tibbetts R S et, al, 1999, GenesDev.13:152-157).	B	C[C@@H]1COCCN1c1cc(C=S(C)(N)=O)nc(-c2ccnc3[nH]ccc23)n1		CHEMBL3648327	=	IC50	nM	34.03	CHEMBL5024	Homo sapiens	IC50	nM	34.03
221345	17610344	CHEMBL3705064	Enzyme Assay: ATR for use in the in vitro enzyme assay was obtained from HeLa nuclear extract (CIL Biotech, Mons, Belgium) by immunoprecipitation with rabbit polycolonal antiserum raised to amino acids 400-480 of ATR (Tibbetts R S et, al, 1999, GenesDev.13:152-157).	B	C[C@H]1COCCN1c1cc(C2([S@@](C)(=N)=O)CC2)nc(-c2ccnc3[nH]ccc23)n1		CHEMBL3956836	=	IC50	nM	3.747	CHEMBL5024	Homo sapiens	IC50	nM	3.747
221346	17610345	CHEMBL3705064	Enzyme Assay: ATR for use in the in vitro enzyme assay was obtained from HeLa nuclear extract (CIL Biotech, Mons, Belgium) by immunoprecipitation with rabbit polycolonal antiserum raised to amino acids 400-480 of ATR (Tibbetts R S et, al, 1999, GenesDev.13:152-157).	B	CNc1nc2ccccc2n1-c1nc(N2CCOC[C@H]2C)cc(C2([S@](C)(=N)=O)CC2)n1		CHEMBL3648329	=	IC50	nM	5.607	CHEMBL5024	Homo sapiens	IC50	nM	5.607
221347	17610346	CHEMBL3705063	Cellular Assay: ATM and ATR have distinct and overlapping responses to DNA damage. They must participate together and responses must be co-ordinated. Both pathways may be activated by ionising radiation, however only ATR is activated by UV. Since UV treatment is not practical for use in a high throught-put cell assay, the UV mimetic 4NQ0 (Sigma) was chosen to activate the ATR DNA damage response pathway.	B	C[C@@H]1COCCN1c1cc(C=S(C)(N)=O)nc(-c2ccnc3[nH]ccc23)n1		CHEMBL3648327	=	IC50	nM	581.0	CHEMBL5024	Homo sapiens	IC50	nM	581.0
221348	17610347	CHEMBL3705063	Cellular Assay: ATM and ATR have distinct and overlapping responses to DNA damage. They must participate together and responses must be co-ordinated. Both pathways may be activated by ionising radiation, however only ATR is activated by UV. Since UV treatment is not practical for use in a high throught-put cell assay, the UV mimetic 4NQ0 (Sigma) was chosen to activate the ATR DNA damage response pathway.	B	C[C@@H]1COCCN1c1cc(C2([S@@](C)(=N)=O)CC2)nc(-c2ccnc3[nH]ccc23)n1		CHEMBL3648328	=	IC50	nM	235.5	CHEMBL5024	Homo sapiens	IC50	nM	235.5
221349	17610348	CHEMBL3705063	Cellular Assay: ATM and ATR have distinct and overlapping responses to DNA damage. They must participate together and responses must be co-ordinated. Both pathways may be activated by ionising radiation, however only ATR is activated by UV. Since UV treatment is not practical for use in a high throught-put cell assay, the UV mimetic 4NQ0 (Sigma) was chosen to activate the ATR DNA damage response pathway.	B	C[C@H]1COCCN1c1cc(C2([S@@](C)(=N)=O)CC2)nc(-c2ccnc3[nH]ccc23)n1		CHEMBL3956836	=	IC50	nM	58.34	CHEMBL5024	Homo sapiens	IC50	nM	58.34
221350	17610349	CHEMBL3705063	Cellular Assay: ATM and ATR have distinct and overlapping responses to DNA damage. They must participate together and responses must be co-ordinated. Both pathways may be activated by ionising radiation, however only ATR is activated by UV. Since UV treatment is not practical for use in a high throught-put cell assay, the UV mimetic 4NQ0 (Sigma) was chosen to activate the ATR DNA damage response pathway.	B	CNc1nc2ccccc2n1-c1nc(N2CCOC[C@H]2C)cc(C2([S@](C)(=N)=O)CC2)n1		CHEMBL3648329	=	IC50	nM	7.053	CHEMBL5024	Homo sapiens	IC50	nM	7.053
221351	17610350	CHEMBL3705063	Cellular Assay: ATM and ATR have distinct and overlapping responses to DNA damage. They must participate together and responses must be co-ordinated. Both pathways may be activated by ionising radiation, however only ATR is activated by UV. Since UV treatment is not practical for use in a high throught-put cell assay, the UV mimetic 4NQ0 (Sigma) was chosen to activate the ATR DNA damage response pathway.	B	C[C@@H]1COCCN1c1cc(C2([S@@](C)(=N)=O)CC2)nc(-c2ccnc3[nH]ccc23)n1		CHEMBL3648328	=	IC50	nM	21.82	CHEMBL5024	Homo sapiens	IC50	nM	21.82
221352	17610351	CHEMBL3705063	Cellular Assay: ATM and ATR have distinct and overlapping responses to DNA damage. They must participate together and responses must be co-ordinated. Both pathways may be activated by ionising radiation, however only ATR is activated by UV. Since UV treatment is not practical for use in a high throught-put cell assay, the UV mimetic 4NQ0 (Sigma) was chosen to activate the ATR DNA damage response pathway.	B	C=S(N)(=O)C1(c2cc(N3CCOC[C@H]3C)nc(-c3cccc4[nH]ccc34)n2)CC1		CHEMBL3648330	=	IC50	nM	75.77	CHEMBL5024	Homo sapiens	IC50	nM	75.77
221353	17610352	CHEMBL3705063	Cellular Assay: ATM and ATR have distinct and overlapping responses to DNA damage. They must participate together and responses must be co-ordinated. Both pathways may be activated by ionising radiation, however only ATR is activated by UV. Since UV treatment is not practical for use in a high throught-put cell assay, the UV mimetic 4NQ0 (Sigma) was chosen to activate the ATR DNA damage response pathway.	B	C=S(N)(=O)C1(c2cc(N3CCOC[C@H]3C)nc(-c3cccc4[nH]ccc34)n2)CC1		CHEMBL3648330	=	IC50	nM	12.92	CHEMBL5024	Homo sapiens	IC50	nM	12.92
221354	17610353	CHEMBL3705063	Cellular Assay: ATM and ATR have distinct and overlapping responses to DNA damage. They must participate together and responses must be co-ordinated. Both pathways may be activated by ionising radiation, however only ATR is activated by UV. Since UV treatment is not practical for use in a high throught-put cell assay, the UV mimetic 4NQ0 (Sigma) was chosen to activate the ATR DNA damage response pathway.	B	C=S(N)(=O)C1(c2cc(N3CCOC[C@H]3C)nc(-n3c(N)nc4ccccc43)n2)CC1		CHEMBL3648331	=	IC50	nM	2.578	CHEMBL5024	Homo sapiens	IC50	nM	2.578
221355	17610354	CHEMBL3705063	Cellular Assay: ATM and ATR have distinct and overlapping responses to DNA damage. They must participate together and responses must be co-ordinated. Both pathways may be activated by ionising radiation, however only ATR is activated by UV. Since UV treatment is not practical for use in a high throught-put cell assay, the UV mimetic 4NQ0 (Sigma) was chosen to activate the ATR DNA damage response pathway.	B	C=S(N)(=O)C1(c2cc(N3CCOC[C@H]3C)nc(-n3c(N)nc4ccccc43)n2)CC1		CHEMBL3648331	=	IC50	nM	2.757	CHEMBL5024	Homo sapiens	IC50	nM	2.757
221356	17610355	CHEMBL3705063	Cellular Assay: ATM and ATR have distinct and overlapping responses to DNA damage. They must participate together and responses must be co-ordinated. Both pathways may be activated by ionising radiation, however only ATR is activated by UV. Since UV treatment is not practical for use in a high throught-put cell assay, the UV mimetic 4NQ0 (Sigma) was chosen to activate the ATR DNA damage response pathway.	B	C=S(N)(=O)C1(c2cc(N3CCOC[C@H]3C)nc(-n3c(NC)nc4c(F)cccc43)n2)CC1		CHEMBL3648332	=	IC50	nM	159.3	CHEMBL5024	Homo sapiens	IC50	nM	159.3
221357	17610356	CHEMBL3705063	Cellular Assay: ATM and ATR have distinct and overlapping responses to DNA damage. They must participate together and responses must be co-ordinated. Both pathways may be activated by ionising radiation, however only ATR is activated by UV. Since UV treatment is not practical for use in a high throught-put cell assay, the UV mimetic 4NQ0 (Sigma) was chosen to activate the ATR DNA damage response pathway.	B	C=S(N)(=O)C1(c2cc(N3CCOC[C@H]3C)nc(-n3c(NC)nc4c(F)cccc43)n2)CC1		CHEMBL3648332	=	IC50	nM	109.0	CHEMBL5024	Homo sapiens	IC50	nM	109.0
221358	17610357	CHEMBL3705063	Cellular Assay: ATM and ATR have distinct and overlapping responses to DNA damage. They must participate together and responses must be co-ordinated. Both pathways may be activated by ionising radiation, however only ATR is activated by UV. Since UV treatment is not practical for use in a high throught-put cell assay, the UV mimetic 4NQ0 (Sigma) was chosen to activate the ATR DNA damage response pathway.	B	C=S(N)(=O)C1(c2cc(N3CCOC[C@H]3C)nc(-c3cncc4[nH]ccc34)n2)CC1		CHEMBL3648333	=	IC50	nM	13.76	CHEMBL5024	Homo sapiens	IC50	nM	13.76
221359	17610358	CHEMBL3705063	Cellular Assay: ATM and ATR have distinct and overlapping responses to DNA damage. They must participate together and responses must be co-ordinated. Both pathways may be activated by ionising radiation, however only ATR is activated by UV. Since UV treatment is not practical for use in a high throught-put cell assay, the UV mimetic 4NQ0 (Sigma) was chosen to activate the ATR DNA damage response pathway.	B	C=S(N)(=O)C(C)(C)c1cc(N2CCOC[C@H]2C)nc(-n2c(NC)nc3ccccc32)n1		CHEMBL3648334	=	IC50	nM	12.79	CHEMBL5024	Homo sapiens	IC50	nM	12.79
221360	17610359	CHEMBL3705063	Cellular Assay: ATM and ATR have distinct and overlapping responses to DNA damage. They must participate together and responses must be co-ordinated. Both pathways may be activated by ionising radiation, however only ATR is activated by UV. Since UV treatment is not practical for use in a high throught-put cell assay, the UV mimetic 4NQ0 (Sigma) was chosen to activate the ATR DNA damage response pathway.	B	C=S(N)(=O)C(C)(C)c1cc(N2CCOC[C@H]2C)nc(-n2c(NC)nc3ccccc32)n1		CHEMBL3648334	=	IC50	nM	8.428	CHEMBL5024	Homo sapiens	IC50	nM	8.428
221361	17610360	CHEMBL3705063	Cellular Assay: ATM and ATR have distinct and overlapping responses to DNA damage. They must participate together and responses must be co-ordinated. Both pathways may be activated by ionising radiation, however only ATR is activated by UV. Since UV treatment is not practical for use in a high throught-put cell assay, the UV mimetic 4NQ0 (Sigma) was chosen to activate the ATR DNA damage response pathway.	B	C=S(N)(=O)C1(c2cc(N3CCOC[C@H]3C)nc(-n3c(NC)nc4ccccc43)n2)CCOCC1		CHEMBL3648335	=	IC50	nM	53.61	CHEMBL5024	Homo sapiens	IC50	nM	53.61
221362	17610361	CHEMBL3705063	Cellular Assay: ATM and ATR have distinct and overlapping responses to DNA damage. They must participate together and responses must be co-ordinated. Both pathways may be activated by ionising radiation, however only ATR is activated by UV. Since UV treatment is not practical for use in a high throught-put cell assay, the UV mimetic 4NQ0 (Sigma) was chosen to activate the ATR DNA damage response pathway.	B	C=S(N)(=O)C1(c2cc(N3CCOC[C@H]3C)nc(-n3c(NC)nc4ccccc43)n2)CCOCC1		CHEMBL3648335	=	IC50	nM	39.77	CHEMBL5024	Homo sapiens	IC50	nM	39.77
221363	17610362	CHEMBL3705063	Cellular Assay: ATM and ATR have distinct and overlapping responses to DNA damage. They must participate together and responses must be co-ordinated. Both pathways may be activated by ionising radiation, however only ATR is activated by UV. Since UV treatment is not practical for use in a high throught-put cell assay, the UV mimetic 4NQ0 (Sigma) was chosen to activate the ATR DNA damage response pathway.	B	C=S(N)(=O)C1(c2cc(N3CCOC[C@H]3C)nc(-c3cccc4[nH]ccc34)n2)CCOCC1		CHEMBL3648336	=	IC50	nM	51.12	CHEMBL5024	Homo sapiens	IC50	nM	51.12
221364	17610363	CHEMBL3705063	Cellular Assay: ATM and ATR have distinct and overlapping responses to DNA damage. They must participate together and responses must be co-ordinated. Both pathways may be activated by ionising radiation, however only ATR is activated by UV. Since UV treatment is not practical for use in a high throught-put cell assay, the UV mimetic 4NQ0 (Sigma) was chosen to activate the ATR DNA damage response pathway.	B	C=S(N)(=O)C(C)(C)c1cc(N2CCOC[C@H]2C)nc(-n2c(NC)nc3c(F)cccc32)n1		CHEMBL3648337	=	IC50	nM	62.55	CHEMBL5024	Homo sapiens	IC50	nM	62.55
221365	17610364	CHEMBL3705063	Cellular Assay: ATM and ATR have distinct and overlapping responses to DNA damage. They must participate together and responses must be co-ordinated. Both pathways may be activated by ionising radiation, however only ATR is activated by UV. Since UV treatment is not practical for use in a high throught-put cell assay, the UV mimetic 4NQ0 (Sigma) was chosen to activate the ATR DNA damage response pathway.	B	C=S(N)(=O)C(C)(C)c1cc(N2CCOC[C@H]2C)nc(-n2c(NC)nc3c(F)cccc32)n1		CHEMBL3648337	=	IC50	nM	70.85	CHEMBL5024	Homo sapiens	IC50	nM	70.85
221366	17610365	CHEMBL3705063	Cellular Assay: ATM and ATR have distinct and overlapping responses to DNA damage. They must participate together and responses must be co-ordinated. Both pathways may be activated by ionising radiation, however only ATR is activated by UV. Since UV treatment is not practical for use in a high throught-put cell assay, the UV mimetic 4NQ0 (Sigma) was chosen to activate the ATR DNA damage response pathway.	B	C=S(N)(=O)C(C)(C)c1cc(N2CCOC[C@H]2C)nc(-n2c(NC)nc3ccc(F)cc32)n1		CHEMBL3648338	=	IC50	nM	33.13	CHEMBL5024	Homo sapiens	IC50	nM	33.13
221367	17610366	CHEMBL3705063	Cellular Assay: ATM and ATR have distinct and overlapping responses to DNA damage. They must participate together and responses must be co-ordinated. Both pathways may be activated by ionising radiation, however only ATR is activated by UV. Since UV treatment is not practical for use in a high throught-put cell assay, the UV mimetic 4NQ0 (Sigma) was chosen to activate the ATR DNA damage response pathway.	B	C=S(N)(=O)C(C)(C)c1cc(N2CCOC[C@H]2C)nc(-n2c(NC)nc3cc(F)ccc32)n1		CHEMBL3648340	=	IC50	nM	16.18	CHEMBL5024	Homo sapiens	IC50	nM	16.18
221368	17610367	CHEMBL3705063	Cellular Assay: ATM and ATR have distinct and overlapping responses to DNA damage. They must participate together and responses must be co-ordinated. Both pathways may be activated by ionising radiation, however only ATR is activated by UV. Since UV treatment is not practical for use in a high throught-put cell assay, the UV mimetic 4NQ0 (Sigma) was chosen to activate the ATR DNA damage response pathway.	B	C=S(N)(=O)C(C)(C)c1cc(N2CCOC[C@H]2C)nc(-n2c(NC)nc3cc(F)ccc32)n1		CHEMBL3648340	=	IC50	nM	18.28	CHEMBL5024	Homo sapiens	IC50	nM	18.28
221369	17610368	CHEMBL3705063	Cellular Assay: ATM and ATR have distinct and overlapping responses to DNA damage. They must participate together and responses must be co-ordinated. Both pathways may be activated by ionising radiation, however only ATR is activated by UV. Since UV treatment is not practical for use in a high throught-put cell assay, the UV mimetic 4NQ0 (Sigma) was chosen to activate the ATR DNA damage response pathway.	B	C=S(N)(=O)C(C)(C)c1cc(N2CCOC[C@H]2C)nc(-n2c(NC)nc3ccc(F)cc32)n1		CHEMBL3648338	=	IC50	nM	44.4	CHEMBL5024	Homo sapiens	IC50	nM	44.4
221370	17610369	CHEMBL3705063	Cellular Assay: ATM and ATR have distinct and overlapping responses to DNA damage. They must participate together and responses must be co-ordinated. Both pathways may be activated by ionising radiation, however only ATR is activated by UV. Since UV treatment is not practical for use in a high throught-put cell assay, the UV mimetic 4NQ0 (Sigma) was chosen to activate the ATR DNA damage response pathway.	B	C=S(N)(=O)C1(c2cc(N3CCOC[C@H]3C)nc(-n3c(NC)nc4ccc(F)cc43)n2)CC1		CHEMBL3648339	=	IC50	nM	28.99	CHEMBL5024	Homo sapiens	IC50	nM	28.99
221371	17610370	CHEMBL3705063	Cellular Assay: ATM and ATR have distinct and overlapping responses to DNA damage. They must participate together and responses must be co-ordinated. Both pathways may be activated by ionising radiation, however only ATR is activated by UV. Since UV treatment is not practical for use in a high throught-put cell assay, the UV mimetic 4NQ0 (Sigma) was chosen to activate the ATR DNA damage response pathway.	B	C=S(N)(=O)C1(c2cc(N3CCOC[C@H]3C)nc(-n3c(NC)nc4cc(F)ccc43)n2)CC1		CHEMBL3648341	=	IC50	nM	10.07	CHEMBL5024	Homo sapiens	IC50	nM	10.07
221372	17610371	CHEMBL3705063	Cellular Assay: ATM and ATR have distinct and overlapping responses to DNA damage. They must participate together and responses must be co-ordinated. Both pathways may be activated by ionising radiation, however only ATR is activated by UV. Since UV treatment is not practical for use in a high throught-put cell assay, the UV mimetic 4NQ0 (Sigma) was chosen to activate the ATR DNA damage response pathway.	B	C=S(N)(=O)C1(c2cc(N3CCOC[C@H]3C)nc(-n3c(NC)nc4cc(F)ccc43)n2)CC1		CHEMBL3648341	=	IC50	nM	17.96	CHEMBL5024	Homo sapiens	IC50	nM	17.96
221373	17610372	CHEMBL3705063	Cellular Assay: ATM and ATR have distinct and overlapping responses to DNA damage. They must participate together and responses must be co-ordinated. Both pathways may be activated by ionising radiation, however only ATR is activated by UV. Since UV treatment is not practical for use in a high throught-put cell assay, the UV mimetic 4NQ0 (Sigma) was chosen to activate the ATR DNA damage response pathway.	B	C=S(N)(=O)C1(c2cc(N3CCOC[C@H]3C)nc(-n3c(NC)nc4ccc(F)cc43)n2)CC1		CHEMBL3648339	=	IC50	nM	47.03	CHEMBL5024	Homo sapiens	IC50	nM	47.03
264069	17646561	CHEMBL3705961	Inhibition Assay: Compounds were screened for their ability to inhibit ATR kinase using a radioactive-phosphate incorporation assay. Assays were carried out in a mixture of 50 mM Tris/HCl (pH 7.5), 10 mM MgCl2 and 1 mM DTT. Final substrate concentrations were 10 M [-33P]ATP (3mCi 33P ATP/mmol ATP, Perkin Elmer) and 800 M target peptide (ASELPASQPQPFSAKKK).Assays were carried out at 25 C. in the presence of 5 nM full-length ATR. An assay stock buffer solution was prepared containing all of the reagents listed above, with the exception of ATP and the test compound of interest. 13.5 L of the stock solution was placed in a 96 well plate followed by addition of 2 L of DMSO stock containing serial dilutions of the test compound (typically starting from a final concentration of 15 M with 3-fold serial dilutions) in duplicate (final DMSO concentration 7%). The plate was pre-incubated for 10 minutes at 25 C. and the reaction initiated by addition of 15 L [-33P]ATP.	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(C3CC(c4ccccc4)=NO3)n2)cc1		CHEMBL2409216	=	Ki	nM	16.0	CHEMBL5024	Homo sapiens	Ki	nM	16.0
264070	17646562	CHEMBL3705961	Inhibition Assay: Compounds were screened for their ability to inhibit ATR kinase using a radioactive-phosphate incorporation assay. Assays were carried out in a mixture of 50 mM Tris/HCl (pH 7.5), 10 mM MgCl2 and 1 mM DTT. Final substrate concentrations were 10 M [-33P]ATP (3mCi 33P ATP/mmol ATP, Perkin Elmer) and 800 M target peptide (ASELPASQPQPFSAKKK).Assays were carried out at 25 C. in the presence of 5 nM full-length ATR. An assay stock buffer solution was prepared containing all of the reagents listed above, with the exception of ATP and the test compound of interest. 13.5 L of the stock solution was placed in a 96 well plate followed by addition of 2 L of DMSO stock containing serial dilutions of the test compound (typically starting from a final concentration of 15 M with 3-fold serial dilutions) in duplicate (final DMSO concentration 7%). The plate was pre-incubated for 10 minutes at 25 C. and the reaction initiated by addition of 15 L [-33P]ATP.	B	CNCc1ccc(C2=NOC(c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)C2)cc1		CHEMBL2409217	=	Ki	nM	90.0	CHEMBL5024	Homo sapiens	Ki	nM	90.0
265536	17647855	CHEMBL3705648	Inhibition Assay: Compounds were screened for their ability to inhibit ATR kinase using a radioactive-phosphate incorporation assay. Assays were carried out in a mixture of 50 mM Tris/HCl (pH 7.5), 10 mM MgCl2 and 1 mM DTT. Final substrate concentrations were 10 uM [gamma-33P]ATP (3 mCi 33P ATP/mmol ATP, Perkin Elmer) and 800 uM target peptide (ASELPASQPQPFSAKKK).Assays were carried out at 25 C. in the presence of 5 nM full-length ATR. An assay stock buffer solution was prepared containing all of the reagents listed above, with the exception of ATP and the test compound of interest. 13.5 uL of the stock solution was placed in a 96 well plate followed by addition of 2 uL of DMSO stock containing serial dilutions of the test compound (typically starting from a final concentration of 15 uM with 3-fold serial dilutions) in duplicate (final DMSO concentration 7%). The plate was pre-incubated for 10 minutes at 25 C.	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3cn(-c4ccccc4)nn3)n2)cc1		CHEMBL3695214	=	Ki	nM	6.0	CHEMBL5024	Homo sapiens	Ki	nM	6.0
334308	17712550	CHEMBL3887343	Cell Based Assay: ATR (Ataxia Telangiectasia+Rad3-related kinase) is a PI3-kinase-related kinase which phosphorylates multiple substrates on serine or threonine residues in response to DNA damage or replication blocks. Chk1, a downstream protein kinase of ATR, plays a key role in DNA damage checkpoint control. Activation of Chk1 involves phosphorylation of Ser317 and Ser345 (the latter regarded as the preferential target for phosphorylation/activation by ATR).This was a cell based assay to measure inhibition of ATR kinase, by measuring a decrease in phosphorylation of Chk1 (Ser 345) in HT29 cells, following treatment with compound and the UV mimetic 4NQO (Sigma #N8141). HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 ul EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compounds in 100% DMSO were added to assay plates by acoustic dispensing.	B	Cn1nc(C2CCN(C(=O)CCO)CC2)nc1-c1cnc(N)c(-c2nnc(C(C)(C)C)o2)n1		CHEMBL3920043	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
334309	17712551	CHEMBL3887343	Cell Based Assay: ATR (Ataxia Telangiectasia+Rad3-related kinase) is a PI3-kinase-related kinase which phosphorylates multiple substrates on serine or threonine residues in response to DNA damage or replication blocks. Chk1, a downstream protein kinase of ATR, plays a key role in DNA damage checkpoint control. Activation of Chk1 involves phosphorylation of Ser317 and Ser345 (the latter regarded as the preferential target for phosphorylation/activation by ATR).This was a cell based assay to measure inhibition of ATR kinase, by measuring a decrease in phosphorylation of Chk1 (Ser 345) in HT29 cells, following treatment with compound and the UV mimetic 4NQO (Sigma #N8141). HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 ul EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compounds in 100% DMSO were added to assay plates by acoustic dispensing.	B	CCn1nc(C2CCN(C(=O)CCO)CC2)nc1-c1cnc(N)c(-c2nnc(C(C)(C)C)o2)n1		CHEMBL3894518	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
334310	17712552	CHEMBL3887343	Cell Based Assay: ATR (Ataxia Telangiectasia+Rad3-related kinase) is a PI3-kinase-related kinase which phosphorylates multiple substrates on serine or threonine residues in response to DNA damage or replication blocks. Chk1, a downstream protein kinase of ATR, plays a key role in DNA damage checkpoint control. Activation of Chk1 involves phosphorylation of Ser317 and Ser345 (the latter regarded as the preferential target for phosphorylation/activation by ATR).This was a cell based assay to measure inhibition of ATR kinase, by measuring a decrease in phosphorylation of Chk1 (Ser 345) in HT29 cells, following treatment with compound and the UV mimetic 4NQO (Sigma #N8141). HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 ul EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compounds in 100% DMSO were added to assay plates by acoustic dispensing.	B	C[C@H](O)CC(=O)N1CCC(c2nc(-c3cnc(N)c(-c4nnc(C(C)(C)C)o4)n3)n(C)n2)CC1		CHEMBL3890694	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
334311	17712553	CHEMBL3887343	Cell Based Assay: ATR (Ataxia Telangiectasia+Rad3-related kinase) is a PI3-kinase-related kinase which phosphorylates multiple substrates on serine or threonine residues in response to DNA damage or replication blocks. Chk1, a downstream protein kinase of ATR, plays a key role in DNA damage checkpoint control. Activation of Chk1 involves phosphorylation of Ser317 and Ser345 (the latter regarded as the preferential target for phosphorylation/activation by ATR).This was a cell based assay to measure inhibition of ATR kinase, by measuring a decrease in phosphorylation of Chk1 (Ser 345) in HT29 cells, following treatment with compound and the UV mimetic 4NQO (Sigma #N8141). HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 ul EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compounds in 100% DMSO were added to assay plates by acoustic dispensing.	B	C[C@H](O)CC(=O)N1CCC(c2nc(-c3cnc(N)c(-c4nnc(C(C)(C)C)o4)n3)n(C)n2)CC1		CHEMBL3890694	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
334312	17712554	CHEMBL3887343	Cell Based Assay: ATR (Ataxia Telangiectasia+Rad3-related kinase) is a PI3-kinase-related kinase which phosphorylates multiple substrates on serine or threonine residues in response to DNA damage or replication blocks. Chk1, a downstream protein kinase of ATR, plays a key role in DNA damage checkpoint control. Activation of Chk1 involves phosphorylation of Ser317 and Ser345 (the latter regarded as the preferential target for phosphorylation/activation by ATR).This was a cell based assay to measure inhibition of ATR kinase, by measuring a decrease in phosphorylation of Chk1 (Ser 345) in HT29 cells, following treatment with compound and the UV mimetic 4NQO (Sigma #N8141). HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 ul EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compounds in 100% DMSO were added to assay plates by acoustic dispensing.	B	C[C@H](CO)C(=O)N1CCC(c2nc(-c3cnc(N)c(-c4nnc(C(C)(C)C)o4)n3)n(C)n2)CC1		CHEMBL4107650	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
334313	17712555	CHEMBL3887343	Cell Based Assay: ATR (Ataxia Telangiectasia+Rad3-related kinase) is a PI3-kinase-related kinase which phosphorylates multiple substrates on serine or threonine residues in response to DNA damage or replication blocks. Chk1, a downstream protein kinase of ATR, plays a key role in DNA damage checkpoint control. Activation of Chk1 involves phosphorylation of Ser317 and Ser345 (the latter regarded as the preferential target for phosphorylation/activation by ATR).This was a cell based assay to measure inhibition of ATR kinase, by measuring a decrease in phosphorylation of Chk1 (Ser 345) in HT29 cells, following treatment with compound and the UV mimetic 4NQO (Sigma #N8141). HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 ul EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compounds in 100% DMSO were added to assay plates by acoustic dispensing.	B	Cn1nc(C2CCN(C(=O)C(C)(C)O)CC2)nc1-c1cnc(N)c(-c2nnc(C(C)(C)C)o2)n1		CHEMBL3935719	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
334314	17712556	CHEMBL3887343	Cell Based Assay: ATR (Ataxia Telangiectasia+Rad3-related kinase) is a PI3-kinase-related kinase which phosphorylates multiple substrates on serine or threonine residues in response to DNA damage or replication blocks. Chk1, a downstream protein kinase of ATR, plays a key role in DNA damage checkpoint control. Activation of Chk1 involves phosphorylation of Ser317 and Ser345 (the latter regarded as the preferential target for phosphorylation/activation by ATR).This was a cell based assay to measure inhibition of ATR kinase, by measuring a decrease in phosphorylation of Chk1 (Ser 345) in HT29 cells, following treatment with compound and the UV mimetic 4NQO (Sigma #N8141). HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 ul EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compounds in 100% DMSO were added to assay plates by acoustic dispensing.	B	Cn1nc(C2CCN(C(=O)CC(=O)O)CC2)nc1-c1cnc(N)c(-c2nnc(C(C)(C)C)o2)n1		CHEMBL3926852	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
427744	17789414	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CN(C)CCCOc1ccc(-c2ccc3ncc4c(c3c2)n(C2CCOCC2)c(=O)n4C)cn1		CHEMBL3960662	=	IC50	nM	6160.0	CHEMBL5024	Homo sapiens	IC50	nM	6160.0
427745	17789415	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4ccc(-c5ccc(OCCCN(C)C)nc5)cc4c32)C1		CHEMBL3936734	>	IC50	nM	29000.0	CHEMBL5024	Homo sapiens	IC50	nM	29000.0
427746	17789416	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CN(C)CCCOc1ccc(-c2cc3c(cc2F)ncc2c3n(C3(C)CCOCC3)c(=O)n2C)cn1		CHEMBL3951966	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
427747	17789417	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CN(C)CCCOc1ccc(-c2ccc3ncc4c(c3c2)n(C2COC2)c(=O)n4C)cn1		CHEMBL3924247	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
427748	17789418	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CN(C)CCCOc1ccc(-c2ccc3ncc4c(c3c2)n([C@H]2C[C@@H](O)C2)c(=O)n4C)cn1		CHEMBL3889770	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
427749	17789419	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4cc(F)c(-c5ccc(OCCCN(C)C)nc5)cc4c32)C1		CHEMBL3950905	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
427750	17789420	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CN(C)CCCOc1ccc(-c2ccc3ncc4c(c3c2)n(C2(C)CCOCC2)c(=O)n4C)cn1		CHEMBL3961688	=	IC50	nM	10800.0	CHEMBL5024	Homo sapiens	IC50	nM	10800.0
427751	17789421	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CN(C)CCCOc1ccc(-c2cc3c(cc2F)ncc2c3n(C3CCOCC3)c(=O)n2C)cn1		CHEMBL3986918	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
427752	17789422	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CN(C)CCCOc1ccc(-c2cc3c(cc2F)ncc2c3n(C3COC3)c(=O)n2C)cn1		CHEMBL3957991	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
427753	17789423	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CN(C)CCCOc1ccc(-c2cc3c(cc2F)ncc2c3n([C@@H]3CCCOC3)c(=O)n2C)cn1		CHEMBL4110596	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
427754	17789424	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CN(C)CCCOc1ccc(-c2cc3c(cc2F)ncc2c3n([C@H]3CCCOC3)c(=O)n2C)cn1		CHEMBL3912673	>	IC50	nM	29600.0	CHEMBL5024	Homo sapiens	IC50	nM	29600.0
427755	17789425	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CO[C@H]1C[C@@H](n2c(=O)[nH]c3cnc4ccc(-c5ccc(OCCCN(C)C)nc5)cc4c32)C1		CHEMBL3898563	>	IC50	nM	25200.0	CHEMBL5024	Homo sapiens	IC50	nM	25200.0
427756	17789426	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CN(C)CCCOc1ccc(-c2ccc3ncc4[nH]c(=O)n(C5CCOCC5)c4c3c2)cn1		CHEMBL3907190	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
427757	17789427	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	Cn1c(=O)n([C@H]2C[C@@H](O)C2)c2c3cc(-c4ccc(OCCCN5CCC5)nc4)ccc3ncc21		CHEMBL3984179	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
427758	17789428	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	Cn1c(=O)n([C@H]2C[C@@H](O)C2)c2c3cc(-c4ccc(OCCCN5CCCC5)nc4)ccc3ncc21		CHEMBL3898165	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
427759	17789429	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CN(C)CCCOc1ccc(-c2ccc3ncc4c(c3c2)n([C@@H]2CCCOC2)c(=O)n4C)cn1		CHEMBL4111966	>	IC50	nM	22800.0	CHEMBL5024	Homo sapiens	IC50	nM	22800.0
427760	17789430	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CN(C)CCCOc1ccc(-c2ccc3ncc4c(c3c2)n([C@H]2CCCOC2)c(=O)n4C)cn1		CHEMBL3890490	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
427761	17789431	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4ccc(-c5ccc(OCCCN(C)C)nc5F)cc4c32)C1		CHEMBL3958682	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
427762	17789432	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4cc(F)c(-c5ccc(OCCCN(C)C)nc5F)cc4c32)C1		CHEMBL3898577	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
427763	17789433	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CN(C)CCCOc1ccc(-c2ccc3ncc4c(c3c2)n([C@H]2CCCOC2)c(=O)n4C)c(F)n1		CHEMBL3935033	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
427764	17789434	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CN(C)CCCOc1ccc(-c2ccc3ncc4c(c3c2)n(C2CCOCC2)c(=O)n4C)c(F)n1		CHEMBL3927821	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
427765	17789435	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CN(C)CCCOc1ccc(-c2ccc3ncc4c(c3c2)n([C@@H]2CCCOC2)c(=O)n4C)c(F)n1		CHEMBL4109764	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
427766	17789436	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	Cn1c(=O)n([C@H]2CCCOC2)c2c3cc(-c4ccc(OCCCN5CCCC5)nc4)c(F)cc3ncc21		CHEMBL3890119	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
427767	17789437	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	Cn1c(=O)n([C@@H]2CCCOC2)c2c3cc(-c4ccc(OCCCN5CCCC5)nc4)c(F)cc3ncc21		CHEMBL4114060	>	IC50	nM	18800.0	CHEMBL5024	Homo sapiens	IC50	nM	18800.0
427768	17789438	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CO[C@@H]1CC[C@@H](n2c(=O)n(C)c3cnc4ccc(-c5ccc(OCCCN(C)C)nc5)cc4c32)C1		CHEMBL4112870	>	IC50	nM	20700.0	CHEMBL5024	Homo sapiens	IC50	nM	20700.0
427769	17789439	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CO[C@H]1CC[C@H](n2c(=O)n(C)c3cnc4ccc(-c5ccc(OCCCN(C)C)nc5)cc4c32)C1		CHEMBL3923182	>	IC50	nM	21800.0	CHEMBL5024	Homo sapiens	IC50	nM	21800.0
427770	17789440	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4cc(F)c(-c5ccc(OCCCN6CCCC6)nc5)cc4c32)C1		CHEMBL3895211	>	IC50	nM	23300.0	CHEMBL5024	Homo sapiens	IC50	nM	23300.0
427771	17789441	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4ccc(-c5ccc(OCCCN6CCCC6)nc5)cc4c32)C1		CHEMBL3936943	>	IC50	nM	22800.0	CHEMBL5024	Homo sapiens	IC50	nM	22800.0
427772	17789442	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	Cn1c(=O)n([C@H]2CCCOC2)c2c3cc(-c4ccc(OCCCN5CCCC5)nc4)ccc3ncc21		CHEMBL3947316	=	IC50	nM	19000.0	CHEMBL5024	Homo sapiens	IC50	nM	19000.0
427773	17789443	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	Cn1c(=O)n(C2CCOCC2)c2c3cc(-c4ccc(OCCCN5CCCC5)nc4)ccc3ncc21		CHEMBL3963290	=	IC50	nM	19000.0	CHEMBL5024	Homo sapiens	IC50	nM	19000.0
427774	17789444	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	Cn1c(=O)n([C@H]2CCCOC2)c2c3cc(-c4ccc(OCCCN5CCCCC5)nc4)ccc3ncc21		CHEMBL3932205	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
427775	17789445	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	Cn1c(=O)n([C@@H]2CCCOC2)c2c3cc(-c4ccc(OCCCN5CCCCC5)nc4)ccc3ncc21		CHEMBL4112039	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
427776	17789446	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4ccc(-c5ccc(OCCCN6CCCCC6)nc5)cc4c32)C1		CHEMBL3960323	>	IC50	nM	24700.0	CHEMBL5024	Homo sapiens	IC50	nM	24700.0
427777	17789447	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	Cn1c(=O)n([C@@H]2CCCOC2)c2c3cc(-c4ccc(OCCCN5CCC5)nc4)ccc3ncc21		CHEMBL4109786	>	IC50	nM	16900.0	CHEMBL5024	Homo sapiens	IC50	nM	16900.0
427778	17789448	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CO[C@H]1C[C@@H](n2c(=O)[nH]c3cnc4ccc(-c5ccc(OCCCN6CCCC6)nc5)cc4c32)C1		CHEMBL3955034	=	IC50	nM	17800.0	CHEMBL5024	Homo sapiens	IC50	nM	17800.0
427779	17789449	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	O=c1[nH]c2cnc3ccc(-c4ccc(OCCCN5CCCCC5)nc4)cc3c2n1C1CCOCC1		CHEMBL3972478	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
427780	17789450	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	Cn1c(=O)n(C2CCOCC2)c2c3cc(-c4ccc(OCCCN5CCCCC5)nc4)ccc3ncc21		CHEMBL3946340	>	IC50	nM	29400.0	CHEMBL5024	Homo sapiens	IC50	nM	29400.0
427781	17789451	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4ccc(-c5ccc(OCCCN6CCC6)nc5)cc4c32)C1		CHEMBL3979811	>	IC50	nM	24400.0	CHEMBL5024	Homo sapiens	IC50	nM	24400.0
427782	17789452	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	Cn1c(=O)n(C2CCOCC2)c2c3cc(-c4ccc(OCCCN5CCC5)nc4)ccc3ncc21		CHEMBL3912416	=	IC50	nM	10700.0	CHEMBL5024	Homo sapiens	IC50	nM	10700.0
427783	17789453	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CNCCCOc1ccc(-c2ccc3ncc4c(c3c2)n(C2CCOCC2)c(=O)n4C)cn1		CHEMBL3984782	=	IC50	nM	1330.0	CHEMBL5024	Homo sapiens	IC50	nM	1330.0
427784	17789454	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CNCCCOc1ccc(-c2ccc3ncc4c(c3c2)n([C@H]2CCCOC2)c(=O)n4C)cn1		CHEMBL3890358	=	IC50	nM	3940.0	CHEMBL5024	Homo sapiens	IC50	nM	3940.0
427785	17789455	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CNCCCOc1ccc(-c2ccc3ncc4c(c3c2)n([C@H]2C[C@@H](OC)C2)c(=O)n4C)cn1		CHEMBL3954517	=	IC50	nM	4370.0	CHEMBL5024	Homo sapiens	IC50	nM	4370.0
427786	17789456	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CNCCCOc1ccc(-c2ccc3ncc4c(c3c2)n([C@@H]2CCCOC2)c(=O)n4C)cn1		CHEMBL4114155	=	IC50	nM	2690.0	CHEMBL5024	Homo sapiens	IC50	nM	2690.0
427787	17789457	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CN(C)CCCOc1ccc(-c2ccc3ncc4c(c3c2)n([C@@H]2CCOC2)c(=O)n4C)cn1		CHEMBL4110389	>	IC50	nM	19200.0	CHEMBL5024	Homo sapiens	IC50	nM	19200.0
427788	17789458	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CN(C)CCCOc1ccc(-c2ccc3ncc4c(c3c2)n([C@H]2CCOC2)c(=O)n4C)cn1		CHEMBL3932222	=	IC50	nM	9600.0	CHEMBL5024	Homo sapiens	IC50	nM	9600.0
427789	17789459	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CN(C)CCCOc1ccc(-c2ccc3ncc4c(c3c2)n(C2CCC2)c(=O)n4C)cn1		CHEMBL3943165	>	IC50	nM	26000.0	CHEMBL5024	Homo sapiens	IC50	nM	26000.0
427790	17789460	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	Cn1c(=O)n([C@H]2CCCOC2)c2c3cc(-c4ccc(OCCCN5CCCCC5)nc4)c(F)cc3ncc21		CHEMBL3972724	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
427791	17789461	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CN(C)CCCOc1ccc(-c2cc3c(cc2F)ncc2c3n([C@H]3CCCOC3)c(=O)n2C)c(F)n1		CHEMBL3891448	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
427792	17789462	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CN(C)CCCOc1ccc(-c2ccc3ncc4c(c3c2)n([C@H]2CCOC2)c(=O)n4C)c(F)n1		CHEMBL3955067	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
427793	17789463	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CN(C)CCCOc1ccc(-c2ccc3ncc4c(c3c2)n([C@@H]2CCOC2)c(=O)n4C)c(F)n1		CHEMBL4108353	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
427794	17789464	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CN(C)CCCOc1ccc(-c2ccc3ncc4c(c3c2)n(C2CCC2)c(=O)n4C)c(F)n1		CHEMBL3974856	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
427795	17789465	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CN(C)CCCOc1ccc(-c2ccc3ncc4c(c3c2)n(C2COC2)c(=O)n4C)c(F)n1		CHEMBL3932835	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
427796	17789466	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	Cn1c(=O)n(C2CCOCC2)c2c3cc(-c4ccc(OCCCN5CCCCC5)nc4)c(F)cc3ncc21		CHEMBL3946515	>	IC50	nM	27100.0	CHEMBL5024	Homo sapiens	IC50	nM	27100.0
427797	17789467	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	Cn1c(=O)n([C@@H]2CCOC2)c2c3cc(-c4ccc(OCCCN5CCCCC5)nc4)ccc3ncc21		CHEMBL4110616	>	IC50	nM	22400.0	CHEMBL5024	Homo sapiens	IC50	nM	22400.0
427798	17789468	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	Cn1c(=O)n([C@H]2CCOC2)c2c3cc(-c4ccc(OCCCN5CCCCC5)nc4)ccc3ncc21		CHEMBL3964241	>	IC50	nM	16100.0	CHEMBL5024	Homo sapiens	IC50	nM	16100.0
427799	17789469	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	Cn1c(=O)n(C2COC2)c2c3cc(-c4ccc(OCCCN5CCCCC5)nc4)ccc3ncc21		CHEMBL3899194	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
427800	17789470	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	Cn1c(=O)n(C2CCC2)c2c3cc(-c4ccc(OCCCN5CCCCC5)nc4)ccc3ncc21		CHEMBL3970378	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
427801	17789471	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	Cn1c(=O)n(C2CCC2)c2c3cc(-c4ccc(OCCCN5CCCC5)nc4)ccc3ncc21		CHEMBL3890876	>	IC50	nM	28100.0	CHEMBL5024	Homo sapiens	IC50	nM	28100.0
427802	17789472	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	Cn1c(=O)n([C@@H]2CCCOC2)c2c3cc(-c4ccc(OCCCN5CCCC5)nc4)ccc3ncc21		CHEMBL4110135	>	IC50	nM	19100.0	CHEMBL5024	Homo sapiens	IC50	nM	19100.0
427803	17789473	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	Cn1c(=O)n([C@@H]2CCCOC2)c2c3cc(-c4ccc(OCCCN5CCC5)nc4)ccc3ncc21		CHEMBL4109786	>	IC50	nM	24000.0	CHEMBL5024	Homo sapiens	IC50	nM	24000.0
427804	17789474	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	Cn1c(=O)n([C@H]2CCCOC2)c2c3cc(-c4ccc(OCCCN5CCCC5)nc4F)ccc3ncc21		CHEMBL3906409	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
427805	17789475	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CO[C@H]1CC[C@H](n2c(=O)n(C)c3cnc4cc(F)c(-c5ccc(OCCCN(C)C)nc5)cc4c32)C1		CHEMBL3929864	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
427806	17789476	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CO[C@@H]1CC[C@@H](n2c(=O)n(C)c3cnc4ccc(-c5ccc(NCCCN6CCCCC6)nc5)cc4c32)C1		CHEMBL4115552	>	IC50	nM	24100.0	CHEMBL5024	Homo sapiens	IC50	nM	24100.0
427807	17789477	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CO[C@H]1CC[C@H](n2c(=O)n(C)c3cnc4ccc(-c5ccc(NCCCN6CCCCC6)nc5)cc4c32)C1		CHEMBL3952396	>	IC50	nM	26600.0	CHEMBL5024	Homo sapiens	IC50	nM	26600.0
427808	17789478	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CO[C@H]1CC[C@H](n2c(=O)n(C)c3cnc4ccc(-c5ccc(OCCCN6CCCC6)nc5)cc4c32)C1		CHEMBL3904625	=	IC50	nM	7850.0	CHEMBL5024	Homo sapiens	IC50	nM	7850.0
427809	17789479	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CO[C@@H]1CC[C@@H](n2c(=O)n(C)c3cnc4ccc(-c5ccc(OCCCN6CCCC6)nc5)cc4c32)C1		CHEMBL4108514	=	IC50	nM	15200.0	CHEMBL5024	Homo sapiens	IC50	nM	15200.0
427810	17789480	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CO[C@@H]1CC[C@@H](n2c(=O)n(C)c3cnc4ccc(-c5ccc(OCCCN(C)C)nc5F)cc4c32)C1		CHEMBL4115047	>	IC50	nM	29000.0	CHEMBL5024	Homo sapiens	IC50	nM	29000.0
427811	17789481	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CO[C@H]1CC[C@H](n2c(=O)n(C)c3cnc4ccc(-c5ccc(OCCCN(C)C)nc5F)cc4c32)C1		CHEMBL3898641	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
427812	17789482	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CO[C@H]1CC[C@@H](n2c(=O)n(C)c3cnc4cc(F)c(-c5ccc(OCCCN(C)C)nc5)cc4c32)C1		CHEMBL4110808	>	IC50	nM	24900.0	CHEMBL5024	Homo sapiens	IC50	nM	24900.0
427813	17789483	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	CO[C@@H]1CC[C@H](n2c(=O)n(C)c3cnc4cc(F)c(-c5ccc(OCCCN(C)C)nc5)cc4c32)C1		CHEMBL3923162	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	nM	30000.0
427961	17789631	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(C2CCNCC2)c(=O)n4C)cn1		CHEMBL3938266	=	IC50	nM	281.0	CHEMBL5024	Homo sapiens	IC50	nM	281.0
427962	17789632	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	COC(=O)N1CCC(n2c(=O)n(C)c3cnc4ccc(-c5ccc(OC)nc5)cc4c32)CC1		CHEMBL3967825	=	IC50	nM	68.6	CHEMBL5024	Homo sapiens	IC50	nM	68.6
427963	17789633	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(C2CCN(C(C)=O)CC2)c(=O)n4C)cn1		CHEMBL3946658	=	IC50	nM	64.4	CHEMBL5024	Homo sapiens	IC50	nM	64.4
427964	17789634	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	Cn1c(=O)n(C2CCOCC2)c2c3cc(-c4cnn(CCCO)c4)ccc3ncc21		CHEMBL3915261	=	IC50	nM	418.0	CHEMBL5024	Homo sapiens	IC50	nM	418.0
427965	17789635	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	Cn1c(=O)n(C2CNC2)c2c3cc(-c4cnc5[nH]ccc5c4)ccc3ncc21		CHEMBL3937842	=	IC50	nM	1480.0	CHEMBL5024	Homo sapiens	IC50	nM	1480.0
427966	17789636	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	Cn1c(=O)n(C2CC2)c2c3cc(-c4cnc5[nH]ccc5c4)ccc3ncc21		CHEMBL3914044	=	IC50	nM	55.3	CHEMBL5024	Homo sapiens	IC50	nM	55.3
427967	17789637	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	Cn1c(=O)n(C2CC2)c2c3cc(-c4cnc(N)nc4)ccc3ncc21		CHEMBL3968419	=	IC50	nM	162.0	CHEMBL5024	Homo sapiens	IC50	nM	162.0
427968	17789638	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	Cn1c(=O)n(C2CCOCC2)c2c3cc(-c4cnc(N)nc4)ccc3ncc21		CHEMBL3935310	=	IC50	nM	12.9	CHEMBL5024	Homo sapiens	IC50	nM	12.9
427969	17789639	CHEMBL3888992	Cellular Assay: Assay b) HT29 cells (ECACC #85061109) were seeded into 384 well assay plates (Costar #3712) at a density of 6000 cells/well in 40 l EMEM medium containing 1% L glutamine and 10% FBS and allowed to adhere overnight. The following morning compound of Formula (I) in 100% DMSO was added to assay plates by acoustic dispensing. After 1 h incubation at 37 C. and 5% CO2, 40 nl of 3 mM 4NQO in 100% DMSO was added to all wells by acoustic dispensing, except minimum control wells which were left untreated with 4NQO to generate a null response control. Plates were returned to the incubator for a further 1 h. Then cells were fixed by adding 20 l of 3.7% formaldehyde in PBS solution and incubating for 20 mins at r.t. Then 20 l of 0.1% Triton X100 in PBS was added and incubated for 10 minutes at r.t., to permeabalise cells. Then the plates were washed once with 50 l/well PBS, using a Biotek EL405 plate washer. Phospho-Chk1 Ser 345 antibody (Cell Signalling Technology #2348) was diluted 150 fold in PBS containing 0.05% polysorbate/Tween and 15 l was added to each well and incubated over night at r.t. The next morning plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and then 20 l of secondary Ab solution, containing 500 fold diluted Alexa Fluor 488 Goat anti-rabbit IgG (Molecular Probes #A-11008) and 0.002 mg/ml Hoeschst dye (Molecular Probes #H-3570), in PBST, was added. After 2 h incubation at r.t., the plates were washed three times with 50 l/well PBS, using a Biotek EL405 plate washer, and plates were then sealed with black plate seals until read. Plates were read using an ArrayScan VTI instrument, using an XF53 filter with 10 objective. A two laser set up was used to analyse nuclear staining with Hoeschst (405 nm) and secondary antibody staining of pChk1 (488 nm).	B	COc1ncc(-c2ccc3ncc4c(c3c2)n(C2CC2)c(=O)n4C)cc1NS(=O)(=O)C1CC1		CHEMBL3970131	=	IC50	nM	68.6	CHEMBL5024	Homo sapiens	IC50	nM	68.6
Inactive	17883904	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883905	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883906	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883907	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883908	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883909	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883910	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883911	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883912	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883913	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883914	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883915	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883916	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883917	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883918	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883919	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883920	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883921	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883922	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17883923	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	=	Kd	nM	5.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	5.0
Inactive	17883924	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883925	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883926	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883927	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883928	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883929	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883930	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883931	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883932	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883933	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883934	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883935	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883936	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883937	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883938	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883939	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883940	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883941	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883942	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883943	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883944	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883945	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883946	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883947	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883948	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883949	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883950	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883951	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883952	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883953	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883954	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883955	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883956	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883957	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883958	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883959	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883960	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883961	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883962	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883963	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883964	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883965	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883966	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883967	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883968	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883969	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883970	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883971	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883972	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883973	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883974	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883975	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883976	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883977	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883978	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883979	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883980	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883981	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883982	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883983	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883984	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883985	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883986	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883987	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883988	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883989	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883990	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883991	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883992	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883993	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883994	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883995	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883996	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883997	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883998	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883999	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884000	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884001	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884002	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884003	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884004	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884005	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884006	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884007	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884008	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884009	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884010	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884011	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884012	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884013	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884014	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884015	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884016	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884017	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884018	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884019	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884020	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884021	CHEMBL3991629	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL5024	Homo sapiens	Kd apparent	nM	30000.0
Active	18057547	CHEMBL4012579	Binding affinity to ATR protein in human INA-6 cells after 3 hrs by nanoLC-MS/MS method	B	O=C(CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12)NCCOCCOCCNCCOc1ccc(C(C(=O)NCc2ccccc2)N(C(=O)CCc2ccccc2)C2CC2)cc1		CHEMBL4092773		Activity			CHEMBL5024	Homo sapiens	Activity		
Active	18057548	CHEMBL4012579	Binding affinity to ATR protein in human INA-6 cells after 3 hrs by nanoLC-MS/MS method	B	O=C(CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12)NCCOCCOCCNCCOc1ccc(C(C(=O)NCc2ccccc2)N(C(=O)CCc2ccc(O)cc2)C2CC2)cc1		CHEMBL4100500		Activity			CHEMBL5024	Homo sapiens	Activity		
Active	18057549	CHEMBL4012579	Binding affinity to ATR protein in human INA-6 cells after 3 hrs by nanoLC-MS/MS method	B	O=C(CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12)NCCOCCOCCNCCCCOc1ccc(CCC(=O)N(C2CC2)C(C(=O)NCc2ccccc2)c2ccc(Br)cc2)cc1		CHEMBL4074753		Activity			CHEMBL5024	Homo sapiens	Activity		
Active	18057618	CHEMBL4012609	Binding affinity to ATR protein in human INA-6 cells after 3 hrs by Western blot method	B	O=C(CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12)NCCOCCOCCNCCOc1ccc(C(C(=O)NCc2ccccc2)N(C(=O)CCc2ccc(O)cc2)C2CC2)cc1		CHEMBL4100500		Activity			CHEMBL5024	Homo sapiens	Activity		
Active	18100279	CHEMBL4021837	Inhibition of ATR in human U2OS cells assessed as reduction in etoposide-induced Chk-1 phosphorylation at Ser345 residue at 10 uM preincubated for 1 hr followed by etoposide challenge measured after 20 mins by Western blot analysis	B	CS(=O)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL1766779		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
Active	18100280	CHEMBL4021837	Inhibition of ATR in human U2OS cells assessed as reduction in etoposide-induced Chk-1 phosphorylation at Ser345 residue at 10 uM preincubated for 1 hr followed by etoposide challenge measured after 20 mins by Western blot analysis	B	C/S(=N\C#N)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL4094246		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
Active	18100281	CHEMBL4021837	Inhibition of ATR in human U2OS cells assessed as reduction in etoposide-induced Chk-1 phosphorylation at Ser345 residue at 10 uM preincubated for 1 hr followed by etoposide challenge measured after 20 mins by Western blot analysis	B	CS(=O)(=NC#N)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL4073618		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
Active	18100282	CHEMBL4021837	Inhibition of ATR in human U2OS cells assessed as reduction in etoposide-induced Chk-1 phosphorylation at Ser345 residue at 10 uM preincubated for 1 hr followed by etoposide challenge measured after 20 mins by Western blot analysis	B	CS(=N)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL4086635		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
Active	18100283	CHEMBL4021837	Inhibition of ATR in human U2OS cells assessed as reduction in etoposide-induced Chk-1 phosphorylation at Ser345 residue at 10 uM preincubated for 1 hr followed by etoposide challenge measured after 20 mins by Western blot analysis	B	CN=S(C)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL4065037		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
Active	18100284	CHEMBL4021838	Inhibition of ATR in human U2OS cells assessed as reduction in hydroxyurea-induced Chk-1 phosphorylation at Ser345 residue at 10 uM preincubated for 1 hr followed by hydroxyurea challenge measured after 1 hr by Western blot analysis	B	C/S(=N\C#N)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL4094246		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
Active	18100285	CHEMBL4021838	Inhibition of ATR in human U2OS cells assessed as reduction in hydroxyurea-induced Chk-1 phosphorylation at Ser345 residue at 10 uM preincubated for 1 hr followed by hydroxyurea challenge measured after 1 hr by Western blot analysis	B	CS(=O)(=NC#N)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL4073618		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
Active	18100286	CHEMBL4021838	Inhibition of ATR in human U2OS cells assessed as reduction in hydroxyurea-induced Chk-1 phosphorylation at Ser345 residue at 10 uM preincubated for 1 hr followed by hydroxyurea challenge measured after 1 hr by Western blot analysis	B	CS(=N)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL4086635		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
Active	18100287	CHEMBL4021838	Inhibition of ATR in human U2OS cells assessed as reduction in hydroxyurea-induced Chk-1 phosphorylation at Ser345 residue at 10 uM preincubated for 1 hr followed by hydroxyurea challenge measured after 1 hr by Western blot analysis	B	CN=S(C)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL4065037		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
Active	18100297	CHEMBL4021841	Inhibition of ATR in human Ramos cells assessed as reduction in Chk-2 phosphorylation level at 10 uM after 48 hrs by Western blot analysis	B	CS(=O)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL1766779		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
Active	18100298	CHEMBL4021841	Inhibition of ATR in human Ramos cells assessed as reduction in Chk-2 phosphorylation level at 10 uM after 48 hrs by Western blot analysis	B	C/S(=N\C#N)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL4094246		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
Active	18100299	CHEMBL4021841	Inhibition of ATR in human Ramos cells assessed as reduction in Chk-2 phosphorylation level at 10 uM after 48 hrs by Western blot analysis	B	CS(=O)(=NC#N)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL4073618		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
Active	18100300	CHEMBL4021841	Inhibition of ATR in human Ramos cells assessed as reduction in Chk-2 phosphorylation level at 10 uM after 48 hrs by Western blot analysis	B	CS(=N)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL4086635		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
Active	18100301	CHEMBL4021841	Inhibition of ATR in human Ramos cells assessed as reduction in Chk-2 phosphorylation level at 10 uM after 48 hrs by Western blot analysis	B	CN=S(C)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL4065037		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
	18100425	CHEMBL4021902	Inhibition of ATR in human U2OS cells assessed as reduction in hydroxyurea-induced Chk-1 phosphorylation at Ser345 residue by measuring ratio of GAPDH level to phosphorylated Chk-1 level at 3 uM preincubated for 1 hr followed by hydroxyurea challenge measured after 2 hrs by Western blot analysis	B	CS(=O)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL1766779	=	Ratio		13.0	CHEMBL5024	Homo sapiens	Ratio		13.0
	18100426	CHEMBL4021902	Inhibition of ATR in human U2OS cells assessed as reduction in hydroxyurea-induced Chk-1 phosphorylation at Ser345 residue by measuring ratio of GAPDH level to phosphorylated Chk-1 level at 3 uM preincubated for 1 hr followed by hydroxyurea challenge measured after 2 hrs by Western blot analysis	B	C/S(=N\C#N)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL4094246	=	Ratio		40.1	CHEMBL5024	Homo sapiens	Ratio		40.1
	18100427	CHEMBL4021902	Inhibition of ATR in human U2OS cells assessed as reduction in hydroxyurea-induced Chk-1 phosphorylation at Ser345 residue by measuring ratio of GAPDH level to phosphorylated Chk-1 level at 3 uM preincubated for 1 hr followed by hydroxyurea challenge measured after 2 hrs by Western blot analysis	B	CS(=O)(=NC#N)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL4073618	=	Ratio		58.1	CHEMBL5024	Homo sapiens	Ratio		58.1
	18100428	CHEMBL4021902	Inhibition of ATR in human U2OS cells assessed as reduction in hydroxyurea-induced Chk-1 phosphorylation at Ser345 residue by measuring ratio of GAPDH level to phosphorylated Chk-1 level at 3 uM preincubated for 1 hr followed by hydroxyurea challenge measured after 2 hrs by Western blot analysis	B	CS(=N)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL4086635	=	Ratio		28.3	CHEMBL5024	Homo sapiens	Ratio		28.3
	18100429	CHEMBL4021902	Inhibition of ATR in human U2OS cells assessed as reduction in hydroxyurea-induced Chk-1 phosphorylation at Ser345 residue by measuring ratio of GAPDH level to phosphorylated Chk-1 level at 3 uM preincubated for 1 hr followed by hydroxyurea challenge measured after 2 hrs by Western blot analysis	B	CN=S(C)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL4065037	=	Ratio		46.1	CHEMBL5024	Homo sapiens	Ratio		46.1
	18100430	CHEMBL4021903	Inhibition of ATR in human U2OS cells assessed as reduction in hydroxyurea-induced Chk-1 phosphorylation at Ser345 residue by measuring ratio of GAPDH level to phosphorylated Chk-1 level at 10 uM preincubated for 1 hr followed by hydroxyurea challenge measured after 2 hrs by Western blot analysis	B	CS(=O)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL1766779	=	Ratio		16.3	CHEMBL5024	Homo sapiens	Ratio		16.3
	18100431	CHEMBL4021903	Inhibition of ATR in human U2OS cells assessed as reduction in hydroxyurea-induced Chk-1 phosphorylation at Ser345 residue by measuring ratio of GAPDH level to phosphorylated Chk-1 level at 10 uM preincubated for 1 hr followed by hydroxyurea challenge measured after 2 hrs by Western blot analysis	B	C/S(=N\C#N)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL4094246	=	Ratio		22.5	CHEMBL5024	Homo sapiens	Ratio		22.5
	18100432	CHEMBL4021903	Inhibition of ATR in human U2OS cells assessed as reduction in hydroxyurea-induced Chk-1 phosphorylation at Ser345 residue by measuring ratio of GAPDH level to phosphorylated Chk-1 level at 10 uM preincubated for 1 hr followed by hydroxyurea challenge measured after 2 hrs by Western blot analysis	B	CS(=O)(=NC#N)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL4073618	=	Ratio		43.1	CHEMBL5024	Homo sapiens	Ratio		43.1
	18100433	CHEMBL4021903	Inhibition of ATR in human U2OS cells assessed as reduction in hydroxyurea-induced Chk-1 phosphorylation at Ser345 residue by measuring ratio of GAPDH level to phosphorylated Chk-1 level at 10 uM preincubated for 1 hr followed by hydroxyurea challenge measured after 2 hrs by Western blot analysis	B	CS(=N)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL4086635	=	Ratio		21.1	CHEMBL5024	Homo sapiens	Ratio		21.1
	18100434	CHEMBL4021903	Inhibition of ATR in human U2OS cells assessed as reduction in hydroxyurea-induced Chk-1 phosphorylation at Ser345 residue by measuring ratio of GAPDH level to phosphorylated Chk-1 level at 10 uM preincubated for 1 hr followed by hydroxyurea challenge measured after 2 hrs by Western blot analysis	B	CN=S(C)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL4065037	=	Ratio		36.4	CHEMBL5024	Homo sapiens	Ratio		36.4
Dose-dependent effect	18100435	CHEMBL4021904	Inhibition of ATR in human U2OS cells assessed as reduction in hydroxyurea-induced Chk-1 phosphorylation at Ser345 residue preincubated for 1 hr followed by hydroxyurea challenge measured after 2 hrs by Western blot analysis	B	C/S(=N\C#N)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL4094246		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
Dose-dependent effect	18100436	CHEMBL4021904	Inhibition of ATR in human U2OS cells assessed as reduction in hydroxyurea-induced Chk-1 phosphorylation at Ser345 residue preincubated for 1 hr followed by hydroxyurea challenge measured after 2 hrs by Western blot analysis	B	CS(=O)(=NC#N)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL4073618		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
Dose-dependent effect	18100437	CHEMBL4021904	Inhibition of ATR in human U2OS cells assessed as reduction in hydroxyurea-induced Chk-1 phosphorylation at Ser345 residue preincubated for 1 hr followed by hydroxyurea challenge measured after 2 hrs by Western blot analysis	B	CS(=N)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL4086635		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
Dose-dependent effect	18100438	CHEMBL4021904	Inhibition of ATR in human U2OS cells assessed as reduction in hydroxyurea-induced Chk-1 phosphorylation at Ser345 residue preincubated for 1 hr followed by hydroxyurea challenge measured after 2 hrs by Western blot analysis	B	CN=S(C)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL4065037		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
Dose-dependent effect	18100439	CHEMBL4021905	Inhibition of ATR in human U2OS cells assessed as reduction in hydroxyurea-induced H2AX phosphorylation at Ser139 residue at 3 to 10 uM preincubated for 1 hr followed by hydroxyurea challenge measured after 2 hrs by Western blot analysis	B	C/S(=N\C#N)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL4094246		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
Dose-dependent effect	18100440	CHEMBL4021905	Inhibition of ATR in human U2OS cells assessed as reduction in hydroxyurea-induced H2AX phosphorylation at Ser139 residue at 3 to 10 uM preincubated for 1 hr followed by hydroxyurea challenge measured after 2 hrs by Western blot analysis	B	CS(=O)(=NC#N)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL4073618		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
Dose-dependent effect	18100441	CHEMBL4021905	Inhibition of ATR in human U2OS cells assessed as reduction in hydroxyurea-induced H2AX phosphorylation at Ser139 residue at 3 to 10 uM preincubated for 1 hr followed by hydroxyurea challenge measured after 2 hrs by Western blot analysis	B	CS(=N)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL4086635		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
Dose-dependent effect	18100442	CHEMBL4021905	Inhibition of ATR in human U2OS cells assessed as reduction in hydroxyurea-induced H2AX phosphorylation at Ser139 residue at 3 to 10 uM preincubated for 1 hr followed by hydroxyurea challenge measured after 2 hrs by Western blot analysis	B	CN=S(C)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL4065037		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
	18153348	CHEMBL4034261	Inhibition of ATR ATP binding site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1	Outside typical range	CHEMBL4084955	=	Inhibition	%	-10.5	CHEMBL5024	Homo sapiens	INH	%	-10.5
	18274752	CHEMBL4118296	Inhibition of ATR in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled FYIMMCKPK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	-8.1	CHEMBL5024	Homo sapiens	INH	%	-8.1
	18274753	CHEMBL4118296	Inhibition of ATR in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled FYIMMCKPK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl	Outside typical range	CHEMBL3884839	=	Inhibition	%	-17.0	CHEMBL5024	Homo sapiens	INH	%	-17.0
	18274754	CHEMBL4118296	Inhibition of ATR in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled FYIMMCKPK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	2.0	CHEMBL5024	Homo sapiens	INH	%	2.0
	18419985	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	COCc1ccc(-c2cc3c(cc2F)ncc2c3n([C@H]3CC[C@H](OC)CC3)c(=O)n2C)cn1		CHEMBL4171264	>	IC50	nM	26000.0	CHEMBL5024	Homo sapiens	IC50	uM	26.0
	18419992	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4cc(F)c(-c5ccc(OCCCN(C)C)nc5F)cc4c32)C1		CHEMBL3898577	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18420001	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	NC(=O)c1cnc2ccc(-c3cccnc3)cc2c1NC1CCOCC1		CHEMBL4174323	=	IC50	nM	3100.0	CHEMBL5024	Homo sapiens	IC50	uM	3.1
	18420012	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	O=c1[nH]c2cnc3ccc(-c4cccnc4)cc3c2n1C1CCOCC1		CHEMBL4159181	=	IC50	nM	51.0	CHEMBL5024	Homo sapiens	IC50	uM	0.051
	18420016	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	Cn1c(=O)n(C2CCOCC2)c2c3cc(-c4cccnc4)ccc3ncc21		CHEMBL4169828	=	IC50	nM	87.0	CHEMBL5024	Homo sapiens	IC50	uM	0.087
	18420028	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4cc(F)c(-c5ccc(OCCCN(C)C)nc5)cc4c32)C1		CHEMBL3950905	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18420037	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4cc(F)c(-c5ccc(OCCN(C)C)nc5)cc4c32)C1		CHEMBL4173181	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18420045	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4cc(F)c(-c5ccc(CS(C)(=O)=O)nc5)cc4c32)C1		CHEMBL4172761	>	IC50	nM	16000.0	CHEMBL5024	Homo sapiens	IC50	uM	16.0
	18420053	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4cc(F)c(-c5ccc(CO)nc5)cc4c32)C1		CHEMBL4164853	=	IC50	nM	15000.0	CHEMBL5024	Homo sapiens	IC50	uM	15.0
	18420062	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4cc(F)c(-c5ccc(NC(=O)CCCN(C)C)nc5)cc4c32)C1		CHEMBL4161022	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18420071	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4cc(F)c(-c5ccc(C(=O)NCCN(C)C)nc5)cc4c32)C1		CHEMBL4171626	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18420080	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4cc(F)c(-c5ccc(N(C)CCN(C)C)nc5)cc4c32)C1		CHEMBL4164430	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18420089	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4cc(F)c(-c5ccc(NCCN(C)C)nc5)cc4c32)C1		CHEMBL4175071	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18420098	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	COCc1ccc(-c2cc3c(cc2F)ncc2c3n([C@@H](C)C3CCOCC3)c(=O)n2C)cn1		CHEMBL4170883	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18420107	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	CN(C)CCCOc1ccc(-c2cc3c(cc2F)ncc2c3n(C3CCOCC3)c(=O)n2C)cn1		CHEMBL3986918	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18420116	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	COCc1ccc(-c2cc3c(cc2F)ncc2c3n(C3CCOCC3)c(=O)n2C)cn1		CHEMBL4162952	>	IC50	nM	20000.0	CHEMBL5024	Homo sapiens	IC50	uM	20.0
	18420121	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	CCC(CC)CNc1c(C(N)=O)cnc2cc(F)c(-c3cnc(NCCN4CCCC4)nc3)cc12		CHEMBL4167277	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18420130	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	COCc1ccc(-c2cc3c(cc2F)ncc2c3n([C@H]3C[C@@H](O)C3)c(=O)n2C)cn1		CHEMBL4176135	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18420139	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	COCc1ccc(-c2cc3c(cc2F)ncc2c3n([C@H]3C[C@H](OC)C3)c(=O)n2C)cn1		CHEMBL4168290	>	IC50	nM	28000.0	CHEMBL5024	Homo sapiens	IC50	uM	28.0
	18420152	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	COCc1ccc(-c2cc3c(cc2F)ncc2c3n([C@H]3C[C@@H](OC)C3)c(=O)n2C)cn1		CHEMBL4160664	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18420162	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	CC(C)n1c(=O)n(C2CCOCC2)c2c3cc(-c4cccnc4)ccc3ncc21		CHEMBL4159593	>	IC50	nM	27600.0	CHEMBL5024	Homo sapiens	IC50	uM	27.6
	18420166	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	CN(C)CCCOc1ccc(-c2ccc3ncc4c(c3c2)n(C2COC2)c(=O)n4C)cn1		CHEMBL3924247	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18420175	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4ccc(-c5ccc(OCCCN(C)C)nc5)cc4c32)C1		CHEMBL3936734	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18420193	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4ccc(-c5ccc(OCCCN(C)C)nc5F)cc4c32)C1		CHEMBL3958682	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18420202	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	CNCCCOc1ccc(-c2ccc3ncc4c(c3c2)n([C@H]2C[C@@H](OC)C2)c(=O)n4C)cn1		CHEMBL3954517	=	IC50	nM	4400.0	CHEMBL5024	Homo sapiens	IC50	uM	4.4
	18420212	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4ccc(-c5ccc(OCCCN6CCC6)nc5)cc4c32)C1		CHEMBL3979811	>	IC50	nM	24000.0	CHEMBL5024	Homo sapiens	IC50	uM	24.0
	18420221	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4ccc(-c5ccc(OCCCN6CCCC6)nc5)cc4c32)C1		CHEMBL3936943	>	IC50	nM	24000.0	CHEMBL5024	Homo sapiens	IC50	uM	24.0
	18420230	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4ccc(-c5ccc(OCCCN6CCCCC6)nc5)cc4c32)C1		CHEMBL3960323	>	IC50	nM	2600.0	CHEMBL5024	Homo sapiens	IC50	uM	2.6
	18420239	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4ccc(-c5ccc(OCCCN6CCOCC6)nc5)cc4c32)C1		CHEMBL4173494	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18420245	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	CO[C@H]1C[C@@H](n2c(=O)n(C)c3cnc4ccc(-c5ccc(OCCCN6CCC(O)CC6)nc5)cc4c32)C1		CHEMBL4176012	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18420251	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	Cn1c(=O)n([C@H]2CCCOC2)c2c3cc(-c4ccc(OCCCN5CCCCC5)nc4)c(F)cc3ncc21		CHEMBL3972724	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18420260	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	CN(C)CCCOc1ccc(-c2ccc3ncc4c(c3c2)n([C@H]2CCCOC2)c(=O)n4C)cn1		CHEMBL3890490	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18420269	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	CN(C)CCCOc1ccc(-c2ccc3ncc4c(c3c2)n([C@@H]2CCCOC2)c(=O)n4C)cn1		CHEMBL4111966	>	IC50	nM	23000.0	CHEMBL5024	Homo sapiens	IC50	uM	23.0
	18420278	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	CN(C)CCCOc1ccc(-c2ccc3ncc4c(c3c2)n([C@H]2C[C@@H](O)C2)c(=O)n4C)cn1		CHEMBL3889770	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18420287	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	COCc1ccc(-c2ccc3ncc4c(c3c2)n(C2CCOCC2)c(=O)n4C)cn1		CHEMBL4167508	>	IC50	nM	13000.0	CHEMBL5024	Homo sapiens	IC50	uM	13.0
	18420296	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	Cn1c(=O)n(C2CCOCC2)c2c3cc(-c4ccc(OCCCN5CCCCC5)nc4)c(F)cc3ncc21		CHEMBL3946515	>	IC50	nM	29000.0	CHEMBL5024	Homo sapiens	IC50	uM	29.0
	18420305	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	CN(C)CCCOc1ccc(-c2ccc3ncc4c(c3c2)n(C2CCOCC2)c(=O)n4C)cn1		CHEMBL3960662	=	IC50	nM	6200.0	CHEMBL5024	Homo sapiens	IC50	uM	6.2
	18420372	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	Cn1c(=O)n(C2CCOCC2)c2c3cc(-c4ccc(OCCC[N+](C)(C)[O-])nc4)ccc3ncc21		CHEMBL4162142	=	IC50	nM	10000.0	CHEMBL5024	Homo sapiens	IC50	uM	10.0
	18420374	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	CN(C)CCCOc1ccc(-c2ccc3ncc4c(c3n2)n(C2CCOCC2)c(=O)n4C)cn1		CHEMBL4163629	=	IC50	nM	2000.0	CHEMBL5024	Homo sapiens	IC50	uM	2.0
	18420379	CHEMBL4153771	Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay	B	CN(C)CCCOc1ccc(-c2ccc3nnc4c(c3c2)n(C2CCOCC2)c(=O)n4C)cn1		CHEMBL4172819	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
Not Active	18463713	CHEMBL4181129	Inhibition of ATR in human HeLa cells assessed as decrease in SN38-induced H2AX phosphorylation at 0.01 to 1 uM after 10 hrs by Western blot analysis	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21		CHEMBL4212680		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
	18507894	CHEMBL4190873	Inhibition of human recombinant FLAG-tagged full length ATR expressed in mammalian cell line co-expressing human recombinant cMyc-tagged full length ATRIP at 1 uM using GST-cMyc-p53 as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	96.0	CHEMBL5024	Homo sapiens	INH	%	96.0
	18507939	CHEMBL4190835	Inhibition of human recombinant FLAG-tagged full length ATR expressed in mammalian cell line co-expressing human recombinant cMyc-tagged full length ATRIP	B	Nc1nc2c(s1)CC(n1nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc31)CC2		CHEMBL4207205	=	IC50	nM	547.0	CHEMBL5024	Homo sapiens	IC50	uM	0.547
	18507940	CHEMBL4190835	Inhibition of human recombinant FLAG-tagged full length ATR expressed in mammalian cell line co-expressing human recombinant cMyc-tagged full length ATRIP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCc2ccccc2C1		CHEMBL4207265	=	IC50	nM	158.0	CHEMBL5024	Homo sapiens	IC50	uM	0.158
	18507941	CHEMBL4190835	Inhibition of human recombinant FLAG-tagged full length ATR expressed in mammalian cell line co-expressing human recombinant cMyc-tagged full length ATRIP	B	C[C@@H]1COCCN1c1cc(C2(S(C)(=N)=O)CC2)nc(-c2cncc3[nH]ccc23)n1		CHEMBL4211377	=	IC50	nM	86.0	CHEMBL5024	Homo sapiens	IC50	uM	0.086
	18507942	CHEMBL4190835	Inhibition of human recombinant FLAG-tagged full length ATR expressed in mammalian cell line co-expressing human recombinant cMyc-tagged full length ATRIP	B	CNCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)on2)cc1		CHEMBL3989870	=	IC50	nM	15.0	CHEMBL5024	Homo sapiens	IC50	uM	0.015
	18507943	CHEMBL4190835	Inhibition of human recombinant FLAG-tagged full length ATR expressed in mammalian cell line co-expressing human recombinant cMyc-tagged full length ATRIP	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	IC50	nM	66.0	CHEMBL5024	Homo sapiens	IC50	uM	0.066
	18507944	CHEMBL4190835	Inhibition of human recombinant FLAG-tagged full length ATR expressed in mammalian cell line co-expressing human recombinant cMyc-tagged full length ATRIP	B	CS(=O)(=O)N1CCC(n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)CC1		CHEMBL4215278	=	IC50	nM	1320.0	CHEMBL5024	Homo sapiens	IC50	uM	1.32
	18507945	CHEMBL4190835	Inhibition of human recombinant FLAG-tagged full length ATR expressed in mammalian cell line co-expressing human recombinant cMyc-tagged full length ATRIP	B	Nc1nc2c(s1)CC(n1nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc31)CC2		CHEMBL4207205	=	IC50	nM	269.0	CHEMBL5024	Homo sapiens	IC50	uM	0.269
	18507946	CHEMBL4190835	Inhibition of human recombinant FLAG-tagged full length ATR expressed in mammalian cell line co-expressing human recombinant cMyc-tagged full length ATRIP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1Cc2ccccc2C1		CHEMBL4210861	=	IC50	nM	654.0	CHEMBL5024	Homo sapiens	IC50	uM	0.654
	18507947	CHEMBL4190835	Inhibition of human recombinant FLAG-tagged full length ATR expressed in mammalian cell line co-expressing human recombinant cMyc-tagged full length ATRIP	B	Nc1ncnc2c1c(-c1ccc(N3CCCC3)nc1)nn2C1CCc2ccccc2C1		CHEMBL4215814	=	IC50	nM	19100.0	CHEMBL5024	Homo sapiens	IC50	uM	19.1
	18507948	CHEMBL4190835	Inhibition of human recombinant FLAG-tagged full length ATR expressed in mammalian cell line co-expressing human recombinant cMyc-tagged full length ATRIP	B	Nc1ncnc2c1c(-c1cnc3[nH]c(=O)ccc3c1)nn2C1CCc2ccccc2C1		CHEMBL4209026	=	IC50	nM	22400.0	CHEMBL5024	Homo sapiens	IC50	uM	22.4
	18507949	CHEMBL4190835	Inhibition of human recombinant FLAG-tagged full length ATR expressed in mammalian cell line co-expressing human recombinant cMyc-tagged full length ATRIP	B	Nc1ncnc2c1c(-c1c[nH]c3ncccc13)nn2C1CCc2ccccc2C1		CHEMBL4212747	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18507950	CHEMBL4190835	Inhibition of human recombinant FLAG-tagged full length ATR expressed in mammalian cell line co-expressing human recombinant cMyc-tagged full length ATRIP	B	Nc1ncnc2c1c(-c1cnc3cc[nH]c3c1)nn2C1CCc2ccccc2C1		CHEMBL4210228	=	IC50	nM	4620.0	CHEMBL5024	Homo sapiens	IC50	uM	4.62
	18507951	CHEMBL4190835	Inhibition of human recombinant FLAG-tagged full length ATR expressed in mammalian cell line co-expressing human recombinant cMyc-tagged full length ATRIP	B	Cn1ccc2cc(-c3nn(C4CCc5ccccc5C4)c4ncnc(N)c34)cnc21		CHEMBL4213994	=	IC50	nM	580.0	CHEMBL5024	Homo sapiens	IC50	uM	0.58
	18507952	CHEMBL4190835	Inhibition of human recombinant FLAG-tagged full length ATR expressed in mammalian cell line co-expressing human recombinant cMyc-tagged full length ATRIP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	IC50	nM	1420.0	CHEMBL5024	Homo sapiens	IC50	uM	1.42
	18507953	CHEMBL4190835	Inhibition of human recombinant FLAG-tagged full length ATR expressed in mammalian cell line co-expressing human recombinant cMyc-tagged full length ATRIP	B	Nc1ccc(-c2nn(C3CCc4ccccc4C3)c3ncnc(N)c23)cn1		CHEMBL4204301	=	IC50	nM	19300.0	CHEMBL5024	Homo sapiens	IC50	uM	19.3
	18507954	CHEMBL4190835	Inhibition of human recombinant FLAG-tagged full length ATR expressed in mammalian cell line co-expressing human recombinant cMyc-tagged full length ATRIP	B	Nc1ncnc2c1c(-c1cccnc1)nn2C1CCc2ccccc2C1		CHEMBL4212315	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18507955	CHEMBL4190835	Inhibition of human recombinant FLAG-tagged full length ATR expressed in mammalian cell line co-expressing human recombinant cMyc-tagged full length ATRIP	B	Nc1ncnc2c1c(-c1ccc3[nH]ccc3c1)nn2C1CCc2ccccc2C1		CHEMBL4209086	=	IC50	nM	1590.0	CHEMBL5024	Homo sapiens	IC50	uM	1.59
	18507956	CHEMBL4190835	Inhibition of human recombinant FLAG-tagged full length ATR expressed in mammalian cell line co-expressing human recombinant cMyc-tagged full length ATRIP	B	Nc1ccnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCc2ccccc2C1		CHEMBL4203385	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18507959	CHEMBL4190835	Inhibition of human recombinant FLAG-tagged full length ATR expressed in mammalian cell line co-expressing human recombinant cMyc-tagged full length ATRIP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCc2ccccc2C1		CHEMBL4207265	=	IC50	nM	212.0	CHEMBL5024	Homo sapiens	IC50	uM	0.212
	18507960	CHEMBL4190835	Inhibition of human recombinant FLAG-tagged full length ATR expressed in mammalian cell line co-expressing human recombinant cMyc-tagged full length ATRIP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCc2ccccc2C1		CHEMBL4207265	=	IC50	nM	304.0	CHEMBL5024	Homo sapiens	IC50	uM	0.304
	18507961	CHEMBL4190835	Inhibition of human recombinant FLAG-tagged full length ATR expressed in mammalian cell line co-expressing human recombinant cMyc-tagged full length ATRIP	B	Nc1ncnc2c1c(-c1ccc(Br)c(O)c1)nn2C1CCc2ccccc21		CHEMBL4211185	=	IC50	nM	1860.0	CHEMBL5024	Homo sapiens	IC50	uM	1.86
	18507962	CHEMBL4190835	Inhibition of human recombinant FLAG-tagged full length ATR expressed in mammalian cell line co-expressing human recombinant cMyc-tagged full length ATRIP	B	Nc1ncnc2c1c(-c1ccc(Br)c(O)c1)nn2C1Cc2ccccc2C1		CHEMBL3964073	=	IC50	nM	3560.0	CHEMBL5024	Homo sapiens	IC50	uM	3.56
	18507963	CHEMBL4190835	Inhibition of human recombinant FLAG-tagged full length ATR expressed in mammalian cell line co-expressing human recombinant cMyc-tagged full length ATRIP	B	Nc1nc2c(s1)CC(n1nc(-c3cc(F)c4[nH]ccc4c3)c3c(N)ncnc31)CC2		CHEMBL4216036	=	IC50	nM	2630.0	CHEMBL5024	Homo sapiens	IC50	uM	2.63
	18507964	CHEMBL4190835	Inhibition of human recombinant FLAG-tagged full length ATR expressed in mammalian cell line co-expressing human recombinant cMyc-tagged full length ATRIP	B	c1ccc2c(c1)CCC(n1nc(-c3cnc4[nH]ccc4c3)c3cncnc31)C2		CHEMBL4206529	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18508005	CHEMBL4191240	Inhibition of recombinant full-length human ATR at 10 uM using GST-cMyc-p53 as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	106.0	CHEMBL5024	Homo sapiens	INH	%	106.0
Not Active	18553306	CHEMBL4199840	Inhibition of ATR in human HT-29 cells assessed as reduction in camptothecin-induced Chk1 phosphorylation at Ser345 residue up to 10 uM pretreated for 1 hr followed by camptothecin addition	B	CS(=O)(=O)Cc1cc(-c2cnc(N)cc2C(F)(F)F)nc(N2CCOCC2)n1		CHEMBL4210320		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
Not Active	18553307	CHEMBL4199840	Inhibition of ATR in human HT-29 cells assessed as reduction in camptothecin-induced Chk1 phosphorylation at Ser345 residue up to 10 uM pretreated for 1 hr followed by camptothecin addition	B	CS(=O)(=O)C1(c2cc(-c3cnc(N)cc3C(F)(F)F)nc(N3CCOCC3)n2)CC1		CHEMBL4215969		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
Not Active	18553308	CHEMBL4199840	Inhibition of ATR in human HT-29 cells assessed as reduction in camptothecin-induced Chk1 phosphorylation at Ser345 residue up to 10 uM pretreated for 1 hr followed by camptothecin addition	B	C[C@H]1COCCN1c1nc(-c2cnc(N)cc2C(F)(F)F)cc(C2(S(C)(=O)=O)CC2)n1		CHEMBL4206442		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
Not Active	18553309	CHEMBL4199840	Inhibition of ATR in human HT-29 cells assessed as reduction in camptothecin-induced Chk1 phosphorylation at Ser345 residue up to 10 uM pretreated for 1 hr followed by camptothecin addition	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
Active	18553310	CHEMBL4199841	Inhibition of ATR in human HT-29 cells assessed as reduction in camptothecin-induced Chk1 phosphorylation at Ser345 residue at 10 uM pretreated for 1 hr followed by camptothecin addition	B	C[C@H]1COCCN1c1nc(-c2cnc(N)cc2F)cc(C2(S(C)(=O)=O)CC2)n1		CHEMBL4211915		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
	18556158	CHEMBL4200457	Inhibition of ATR in human HT-29 cells measured after 1 hr by Hoechst 33258 staining based fluorescence assay	B	COCc1ccc(-c2ccc3ncc(C(N)=O)c(N[C@@H](C)C4CCOCC4)c3c2)cn1		CHEMBL4218734	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18556159	CHEMBL4200457	Inhibition of ATR in human HT-29 cells measured after 1 hr by Hoechst 33258 staining based fluorescence assay	B	COCc1ccc(-c2cc3c(N[C@@H](C)c4ccn(C)n4)c(C(N)=O)cnc3cc2F)cn1		CHEMBL4166405	>	IC50	nM	19000.0	CHEMBL5024	Homo sapiens	IC50	uM	19.0
	18556160	CHEMBL4200457	Inhibition of ATR in human HT-29 cells measured after 1 hr by Hoechst 33258 staining based fluorescence assay	B	COCc1ccc(-c2cc3c(N[C@@H](C)c4nn(C)cc4C)c(C(N)=O)cnc3cc2F)cn1		CHEMBL4215266	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18556161	CHEMBL4200457	Inhibition of ATR in human HT-29 cells measured after 1 hr by Hoechst 33258 staining based fluorescence assay	B	COCc1ccc(-c2ccc3nnc(C(N)=O)c(N[C@@H](C)C4CCOCC4)c3c2)cn1		CHEMBL4209427	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18556162	CHEMBL4200457	Inhibition of ATR in human HT-29 cells measured after 1 hr by Hoechst 33258 staining based fluorescence assay	B	COCc1ccc(-c2ccc3nnc(C(N)=O)c(N[C@@H](C)c4ccn(C)n4)c3c2)cn1		CHEMBL4210849	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18556163	CHEMBL4200457	Inhibition of ATR in human HT-29 cells measured after 1 hr by Hoechst 33258 staining based fluorescence assay	B	COCc1ccc(-c2ccc3nnc(C(N)=O)c(N[C@@H](C)c4nn(C)cc4C)c3c2)cn1		CHEMBL4216325	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18556164	CHEMBL4200457	Inhibition of ATR in human HT-29 cells measured after 1 hr by Hoechst 33258 staining based fluorescence assay	B	CNC(=O)c1nnc2ccc(-c3ccc(COC)nc3)cc2c1N[C@@H](C)C1CCOCC1		CHEMBL4205554	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18556165	CHEMBL4200457	Inhibition of ATR in human HT-29 cells measured after 1 hr by Hoechst 33258 staining based fluorescence assay	B	C[C@H](Nc1c(C(N)=O)nnc2ccc(-c3ccc(OCCCN(C)C)nc3)cc12)C1CCOCC1		CHEMBL4217549	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18556166	CHEMBL4200457	Inhibition of ATR in human HT-29 cells measured after 1 hr by Hoechst 33258 staining based fluorescence assay	B	C[C@H](Nc1c(C(N)=O)nnc2ccc(-c3ccc(OCCCN(C)C)nc3)cc12)c1ccn(C)n1		CHEMBL4217902	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18556167	CHEMBL4200457	Inhibition of ATR in human HT-29 cells measured after 1 hr by Hoechst 33258 staining based fluorescence assay	B	Cc1cn(C)nc1[C@H](C)Nc1c(C(N)=O)nnc2ccc(-c3ccc(OCCCN(C)C)nc3)cc12		CHEMBL4212961	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18556168	CHEMBL4200457	Inhibition of ATR in human HT-29 cells measured after 1 hr by Hoechst 33258 staining based fluorescence assay	B	C[C@H](Nc1c(C(N)=O)nnc2ccc(-c3ccc(OCCCN4CCCC4)nc3)cc12)C1CCOCC1		CHEMBL4213503	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18556169	CHEMBL4200457	Inhibition of ATR in human HT-29 cells measured after 1 hr by Hoechst 33258 staining based fluorescence assay	B	C[C@H](Nc1c(C(N)=O)nnc2ccc(-c3ccc(OCCCN4CCCC4)nc3)cc12)c1ccn(C)n1		CHEMBL4208569	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18556170	CHEMBL4200457	Inhibition of ATR in human HT-29 cells measured after 1 hr by Hoechst 33258 staining based fluorescence assay	B	Cc1cn(C)nc1[C@H](C)Nc1c(C(N)=O)nnc2ccc(-c3ccc(OCCCN4CCCC4)nc3)cc12		CHEMBL4210045	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18556171	CHEMBL4200457	Inhibition of ATR in human HT-29 cells measured after 1 hr by Hoechst 33258 staining based fluorescence assay	B	C[C@H](Nc1c(C(N)=O)nnc2ccc(-c3ccc(OCCN(C)C)nc3)cc12)c1ccn(C)n1		CHEMBL4205148	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18556172	CHEMBL4200457	Inhibition of ATR in human HT-29 cells measured after 1 hr by Hoechst 33258 staining based fluorescence assay	B	CNC(=O)c1nnc2ccc(-c3ccc(OCCN(C)C)nc3)cc2c1N[C@@H](C)C1CCOCC1		CHEMBL4205675	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18556173	CHEMBL4200457	Inhibition of ATR in human HT-29 cells measured after 1 hr by Hoechst 33258 staining based fluorescence assay	B	C[C@H](Nc1c(C(N)=O)nnc2ccc(-c3ccc(NCCN(C)C)nc3)cc12)C1CCOCC1		CHEMBL4217379	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18556174	CHEMBL4200457	Inhibition of ATR in human HT-29 cells measured after 1 hr by Hoechst 33258 staining based fluorescence assay	B	CNC(=O)c1nnc2ccc(-c3ccc(OCCCN(C)C)nc3)cc2c1N[C@@H](C)C1CCOCC1		CHEMBL4218854	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18556175	CHEMBL4200457	Inhibition of ATR in human HT-29 cells measured after 1 hr by Hoechst 33258 staining based fluorescence assay	B	CNC(=O)c1nnc2ccc(-c3ccc(OCCCN(C)C)nc3)cc2c1N[C@@H](C)c1nn(C)cc1C		CHEMBL4213919	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18665494	CHEMBL4233288	Inhibition of ATR (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4251324	>	IC50	nM	10000.0	CHEMBL5024	Homo sapiens	IC50	nM	10000.0
	18665564	CHEMBL4233288	Inhibition of ATR (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	10000.0	CHEMBL5024	Homo sapiens	IC50	nM	10000.0
	18674538	CHEMBL4235313	Inhibition of ATR (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	10000.0	CHEMBL5024	Homo sapiens	Ki	nM	10000.0
	18674539	CHEMBL4235313	Inhibition of ATR (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	>	Ki	nM	10000.0	CHEMBL5024	Homo sapiens	Ki	nM	10000.0
	18674540	CHEMBL4235313	Inhibition of ATR (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525	>	Ki	nM	10000.0	CHEMBL5024	Homo sapiens	Ki	nM	10000.0
	18707010	CHEMBL4256222	Inhibition of ATR in human HT29 cells assessed as reduction in Chk1 phosphorylation at Ser345 residues after 4 hrs by Alexa Fluor 488 staining based fluorescence assay	B	CNc1cnc2[nH]ccc2c1-c1nc2c(c(C(C)(C)S(C)(=O)=O)n1)OC[C@@H]1COC[C@@H](C)N21		CHEMBL4284592	<	IC50	nM	10.0	CHEMBL5024	Homo sapiens	IC50	nM	10.0
	18707011	CHEMBL4256222	Inhibition of ATR in human HT29 cells assessed as reduction in Chk1 phosphorylation at Ser345 residues after 4 hrs by Alexa Fluor 488 staining based fluorescence assay	B	CNc1cnc2[nH]ccc2c1-c1nc2c(c(C(C)(C)O)n1)OC[C@@H]1COC[C@@H](C)N21		CHEMBL4295245	=	IC50	nM	10.0	CHEMBL5024	Homo sapiens	IC50	nM	10.0
	18707012	CHEMBL4256222	Inhibition of ATR in human HT29 cells assessed as reduction in Chk1 phosphorylation at Ser345 residues after 4 hrs by Alexa Fluor 488 staining based fluorescence assay	B	CNc1nccn1-c1nc2c(c(C(C)(C)S(C)(=O)=O)n1)OC[C@@H]1COC[C@@H](C)N21		CHEMBL4287971	=	IC50	nM	10.0	CHEMBL5024	Homo sapiens	IC50	nM	10.0
	18707013	CHEMBL4256222	Inhibition of ATR in human HT29 cells assessed as reduction in Chk1 phosphorylation at Ser345 residues after 4 hrs by Alexa Fluor 488 staining based fluorescence assay	B	CNc1nc2ccccc2n1-c1nc2c(c(C(C)(C)S(C)(=O)=O)n1)OC[C@@H]1COC[C@@H](C)N21		CHEMBL4280068	<	IC50	nM	10.0	CHEMBL5024	Homo sapiens	IC50	nM	10.0
	18707014	CHEMBL4256222	Inhibition of ATR in human HT29 cells assessed as reduction in Chk1 phosphorylation at Ser345 residues after 4 hrs by Alexa Fluor 488 staining based fluorescence assay	B	C[C@@H]1COC[C@H]2COc3c(nc(N(C)c4ccn[nH]4)nc3C(C)(C)S(C)(=O)=O)N21		CHEMBL4282665	=	IC50	nM	10.0	CHEMBL5024	Homo sapiens	IC50	nM	10.0
	18707015	CHEMBL4256222	Inhibition of ATR in human HT29 cells assessed as reduction in Chk1 phosphorylation at Ser345 residues after 4 hrs by Alexa Fluor 488 staining based fluorescence assay	B	CCNc1cnc2[nH]ccc2c1-c1nc2c(c(C(C)(C)S(C)(=O)=O)n1)OC[C@@H]1COC[C@@H](C)N21		CHEMBL4293269	=	IC50	nM	10.0	CHEMBL5024	Homo sapiens	IC50	nM	10.0
	18707016	CHEMBL4256223	Inhibition of ATR in human U2OS cells harboring ER-LBD fused TopBPI activation domain (978 to 1286 residues) assessed as reduction in 4-OHT-mediated nuclear translocation of TopBPI fragment by measuring gammaH2AX level after 24 hrs by Alexa Fluor 488 staining based fluorescence assay	B	CNc1cnc2[nH]ccc2c1-c1nc2c(c(C(C)(C)S(C)(=O)=O)n1)OC[C@@H]1COC[C@@H](C)N21		CHEMBL4284592	=	IC50	nM	10.0	CHEMBL5024	Homo sapiens	IC50	nM	10.0
	18707017	CHEMBL4256223	Inhibition of ATR in human U2OS cells harboring ER-LBD fused TopBPI activation domain (978 to 1286 residues) assessed as reduction in 4-OHT-mediated nuclear translocation of TopBPI fragment by measuring gammaH2AX level after 24 hrs by Alexa Fluor 488 staining based fluorescence assay	B	CNc1cnc2[nH]ccc2c1-c1nc2c(c(C(C)(C)O)n1)OC[C@@H]1COC[C@@H](C)N21		CHEMBL4295245	=	IC50	nM	10.0	CHEMBL5024	Homo sapiens	IC50	nM	10.0
	18707018	CHEMBL4256223	Inhibition of ATR in human U2OS cells harboring ER-LBD fused TopBPI activation domain (978 to 1286 residues) assessed as reduction in 4-OHT-mediated nuclear translocation of TopBPI fragment by measuring gammaH2AX level after 24 hrs by Alexa Fluor 488 staining based fluorescence assay	B	CNc1nccn1-c1nc2c(c(C(C)(C)S(C)(=O)=O)n1)OC[C@@H]1COC[C@@H](C)N21		CHEMBL4287971	=	IC50	nM	100.0	CHEMBL5024	Homo sapiens	IC50	nM	100.0
	18707019	CHEMBL4256223	Inhibition of ATR in human U2OS cells harboring ER-LBD fused TopBPI activation domain (978 to 1286 residues) assessed as reduction in 4-OHT-mediated nuclear translocation of TopBPI fragment by measuring gammaH2AX level after 24 hrs by Alexa Fluor 488 staining based fluorescence assay	B	CNc1nc2ccccc2n1-c1nc2c(c(C(C)(C)S(C)(=O)=O)n1)OC[C@@H]1COC[C@@H](C)N21		CHEMBL4280068	<	IC50	nM	10.0	CHEMBL5024	Homo sapiens	IC50	nM	10.0
	18779240	CHEMBL4269677	Inhibition of ATR in human HeLa cell nuclear extract using GST-fused p53N66 as substrate preincubated for 10 mins followed by ATP addition and measured after 1 hr by ELISA	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3ccnc4[nH]ccc34)n2)CC1		CHEMBL4281158	=	IC50	nM	37.0	CHEMBL5024	Homo sapiens	IC50	uM	0.037
	18779241	CHEMBL4269677	Inhibition of ATR in human HeLa cell nuclear extract using GST-fused p53N66 as substrate preincubated for 10 mins followed by ATP addition and measured after 1 hr by ELISA	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-n3c(N)nc4ccccc43)n2)CC1		CHEMBL4291783	=	IC50	nM	3.0	CHEMBL5024	Homo sapiens	IC50	uM	0.003
	18779242	CHEMBL4269677	Inhibition of ATR in human HeLa cell nuclear extract using GST-fused p53N66 as substrate preincubated for 10 mins followed by ATP addition and measured after 1 hr by ELISA	B	C[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-c2ccnc3[nH]ccc23)n1		CHEMBL4286472	=	IC50	nM	5.0	CHEMBL5024	Homo sapiens	IC50	uM	0.005
	18779243	CHEMBL4269677	Inhibition of ATR in human HeLa cell nuclear extract using GST-fused p53N66 as substrate preincubated for 10 mins followed by ATP addition and measured after 1 hr by ELISA	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cncc4[nH]ccc34)n2)CC1		CHEMBL4278556	=	IC50	nM	5.0	CHEMBL5024	Homo sapiens	IC50	uM	0.005
	18779244	CHEMBL4269677	Inhibition of ATR in human HeLa cell nuclear extract using GST-fused p53N66 as substrate preincubated for 10 mins followed by ATP addition and measured after 1 hr by ELISA	B	C[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-c2cccc3[nH]ccc23)n1		CHEMBL2325697	=	IC50	nM	5.0	CHEMBL5024	Homo sapiens	IC50	uM	0.005
	18779245	CHEMBL4269677	Inhibition of ATR in human HeLa cell nuclear extract using GST-fused p53N66 as substrate preincubated for 10 mins followed by ATP addition and measured after 1 hr by ELISA	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cccc4[nH]ccc34)n2)CC1		CHEMBL2325704	=	IC50	nM	8.0	CHEMBL5024	Homo sapiens	IC50	uM	0.008
	18779246	CHEMBL4269677	Inhibition of ATR in human HeLa cell nuclear extract using GST-fused p53N66 as substrate preincubated for 10 mins followed by ATP addition and measured after 1 hr by ELISA	B	CS(=O)(=O)C1(c2cc(N3CC4CCC(C3)O4)nc(-c3cccc4[nH]ccc34)n2)CC1		CHEMBL2325699	=	IC50	nM	7.0	CHEMBL5024	Homo sapiens	IC50	uM	0.007
	18779247	CHEMBL4269677	Inhibition of ATR in human HeLa cell nuclear extract using GST-fused p53N66 as substrate preincubated for 10 mins followed by ATP addition and measured after 1 hr by ELISA	B	CS(=O)(=O)C1(c2cc(C3=CCOCC3)nc(-c3cccc4[nH]ccc34)n2)CC1		CHEMBL4287961	=	IC50	nM	18.0	CHEMBL5024	Homo sapiens	IC50	uM	0.018
	18779248	CHEMBL4269677	Inhibition of ATR in human HeLa cell nuclear extract using GST-fused p53N66 as substrate preincubated for 10 mins followed by ATP addition and measured after 1 hr by ELISA	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cc(F)cc4[nH]ccc34)n2)CC1		CHEMBL2325439	=	IC50	nM	15.0	CHEMBL5024	Homo sapiens	IC50	uM	0.015
	18779249	CHEMBL4269677	Inhibition of ATR in human HeLa cell nuclear extract using GST-fused p53N66 as substrate preincubated for 10 mins followed by ATP addition and measured after 1 hr by ELISA	B	CNC(=O)c1cc(-c2nc(N3CCOCC3)cc(C3(S(C)(=O)=O)CC3)n2)c2cc[nH]c2c1		CHEMBL2325726	=	IC50	nM	140.0	CHEMBL5024	Homo sapiens	IC50	uM	0.14
	18779250	CHEMBL4269677	Inhibition of ATR in human HeLa cell nuclear extract using GST-fused p53N66 as substrate preincubated for 10 mins followed by ATP addition and measured after 1 hr by ELISA	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cccc4[nH]cnc34)n2)CC1		CHEMBL2325717	=	IC50	nM	180.0	CHEMBL5024	Homo sapiens	IC50	uM	0.18
	18779286	CHEMBL4269678	Inhibition of ATR in human HT29 cells after 60 mins by Hoechst 33258 staining-based assay	B	C[C@@H]1COCCN1c1cc(C2([S@](C)(=N)=O)CC2)nc(-c2cc[nH]c3nccc2-3)n1		CHEMBL4285417	=	IC50	nM	74.0	CHEMBL5024	Homo sapiens	IC50	uM	0.074
	18779287	CHEMBL4269677	Inhibition of ATR in human HeLa cell nuclear extract using GST-fused p53N66 as substrate preincubated for 10 mins followed by ATP addition and measured after 1 hr by ELISA	B	C[C@@H]1COCCN1c1cc(C2([S@](C)(=N)=O)CC2)nc(-c2cc[nH]c3nccc2-3)n1		CHEMBL4285417	=	IC50	nM	4.0	CHEMBL5024	Homo sapiens	IC50	uM	0.004
	18779288	CHEMBL4269677	Inhibition of ATR in human HeLa cell nuclear extract using GST-fused p53N66 as substrate preincubated for 10 mins followed by ATP addition and measured after 1 hr by ELISA	B	C[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-c2cncc3[nH]ccc23)n1		CHEMBL4281240	=	IC50	nM	2.0	CHEMBL5024	Homo sapiens	IC50	uM	0.002
Not Determined	18779289	CHEMBL4269677	Inhibition of ATR in human HeLa cell nuclear extract using GST-fused p53N66 as substrate preincubated for 10 mins followed by ATP addition and measured after 1 hr by ELISA	B	C[C@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-c2cncc3[nH]ccc23)n1		CHEMBL4289120		IC50			CHEMBL5024	Homo sapiens	IC50		
Not Determined	18779290	CHEMBL4269677	Inhibition of ATR in human HeLa cell nuclear extract using GST-fused p53N66 as substrate preincubated for 10 mins followed by ATP addition and measured after 1 hr by ELISA	B	CS(=O)(=O)C1(c2cc(N3CC4CCC(C3)O4)nc(-c3cncc4[nH]ccc34)n2)CC1		CHEMBL4284647		IC50			CHEMBL5024	Homo sapiens	IC50		
Not Determined	18779291	CHEMBL4269677	Inhibition of ATR in human HeLa cell nuclear extract using GST-fused p53N66 as substrate preincubated for 10 mins followed by ATP addition and measured after 1 hr by ELISA	B	CS(=O)(=O)C1(c2cc(N3C4CCC3COC4)nc(-c3cncc4[nH]ccc34)n2)CC1		CHEMBL4292532		IC50			CHEMBL5024	Homo sapiens	IC50		
	18779292	CHEMBL4269677	Inhibition of ATR in human HeLa cell nuclear extract using GST-fused p53N66 as substrate preincubated for 10 mins followed by ATP addition and measured after 1 hr by ELISA	B	C[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-n2c(N)nc3ccccc32)n1		CHEMBL4288033	=	IC50	nM	1.0	CHEMBL5024	Homo sapiens	IC50	uM	0.001
	18779293	CHEMBL4269677	Inhibition of ATR in human HeLa cell nuclear extract using GST-fused p53N66 as substrate preincubated for 10 mins followed by ATP addition and measured after 1 hr by ELISA	B	CC(=O)Nc1nc2ccccc2n1-c1nc(N2CCOC[C@H]2C)cc(C2(S(C)(=O)=O)CC2)n1		CHEMBL4277395	=	IC50	nM	14.0	CHEMBL5024	Homo sapiens	IC50	uM	0.014
	18779294	CHEMBL4269677	Inhibition of ATR in human HeLa cell nuclear extract using GST-fused p53N66 as substrate preincubated for 10 mins followed by ATP addition and measured after 1 hr by ELISA	B	CNc1nc2ccccc2n1-c1nc(N2CCOC[C@H]2C)cc(C2(S(C)(=O)=O)CC2)n1		CHEMBL4291436	=	IC50	nM	2.0	CHEMBL5024	Homo sapiens	IC50	uM	0.002
	18779295	CHEMBL4269677	Inhibition of ATR in human HeLa cell nuclear extract using GST-fused p53N66 as substrate preincubated for 10 mins followed by ATP addition and measured after 1 hr by ELISA	B	C[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-n2c(N)nc3c(F)cccc32)n1		CHEMBL4280793	=	IC50	nM	10.0	CHEMBL5024	Homo sapiens	IC50	uM	0.01
	18779296	CHEMBL4269677	Inhibition of ATR in human HeLa cell nuclear extract using GST-fused p53N66 as substrate preincubated for 10 mins followed by ATP addition and measured after 1 hr by ELISA	B	C[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-n2c(N)nc3cc(F)ccc32)n1		CHEMBL4286105	=	IC50	nM	2.0	CHEMBL5024	Homo sapiens	IC50	uM	0.002
	18779297	CHEMBL4269677	Inhibition of ATR in human HeLa cell nuclear extract using GST-fused p53N66 as substrate preincubated for 10 mins followed by ATP addition and measured after 1 hr by ELISA	B	C[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-n2c(N)nc3ccc(F)cc32)n1		CHEMBL4294006	=	IC50	nM	8.0	CHEMBL5024	Homo sapiens	IC50	uM	0.008
	18779298	CHEMBL4269677	Inhibition of ATR in human HeLa cell nuclear extract using GST-fused p53N66 as substrate preincubated for 10 mins followed by ATP addition and measured after 1 hr by ELISA	B	C[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-n2c(N)nc3cccc(F)c32)n1		CHEMBL4277999	=	IC50	nM	90.0	CHEMBL5024	Homo sapiens	IC50	uM	0.09
	18779299	CHEMBL4269677	Inhibition of ATR in human HeLa cell nuclear extract using GST-fused p53N66 as substrate preincubated for 10 mins followed by ATP addition and measured after 1 hr by ELISA	B	C[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-n2c(N)nc3c(Cl)cccc32)n1		CHEMBL4284450	=	IC50	nM	17.0	CHEMBL5024	Homo sapiens	IC50	uM	0.017
	18779300	CHEMBL4269677	Inhibition of ATR in human HeLa cell nuclear extract using GST-fused p53N66 as substrate preincubated for 10 mins followed by ATP addition and measured after 1 hr by ELISA	B	COc1cccc2c1nc(N)n2-c1nc(N2CCOC[C@H]2C)cc(C2(S(C)(=O)=O)CC2)n1		CHEMBL4279950	=	IC50	nM	270.0	CHEMBL5024	Homo sapiens	IC50	uM	0.27
	18779301	CHEMBL4269677	Inhibition of ATR in human HeLa cell nuclear extract using GST-fused p53N66 as substrate preincubated for 10 mins followed by ATP addition and measured after 1 hr by ELISA	B	C[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-n2c(N)nc3cc(Cl)ccc32)n1		CHEMBL4287852	=	IC50	nM	21.0	CHEMBL5024	Homo sapiens	IC50	uM	0.021
	18779302	CHEMBL4269677	Inhibition of ATR in human HeLa cell nuclear extract using GST-fused p53N66 as substrate preincubated for 10 mins followed by ATP addition and measured after 1 hr by ELISA	B	C[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-n2c(N)nc3cc(C#N)ccc32)n1		CHEMBL4292722	=	IC50	nM	4000.0	CHEMBL5024	Homo sapiens	IC50	uM	4.0
	18779303	CHEMBL4269677	Inhibition of ATR in human HeLa cell nuclear extract using GST-fused p53N66 as substrate preincubated for 10 mins followed by ATP addition and measured after 1 hr by ELISA	B	COc1ccc2c(c1)nc(N)n2-c1nc(N2CCOC[C@H]2C)cc(C2(S(C)(=O)=O)CC2)n1		CHEMBL4282440	=	IC50	nM	550.0	CHEMBL5024	Homo sapiens	IC50	uM	0.55
	18779304	CHEMBL4269677	Inhibition of ATR in human HeLa cell nuclear extract using GST-fused p53N66 as substrate preincubated for 10 mins followed by ATP addition and measured after 1 hr by ELISA	B	C[C@@H]1COCCN1c1cc(C2([S@@+](C)[O-])CC2)nc(-c2ccnc3[nH]ccc23)n1		CHEMBL4294647	=	IC50	nM	16.0	CHEMBL5024	Homo sapiens	IC50	uM	0.016
	18779305	CHEMBL4269677	Inhibition of ATR in human HeLa cell nuclear extract using GST-fused p53N66 as substrate preincubated for 10 mins followed by ATP addition and measured after 1 hr by ELISA	B	C[C@@H]1COCCN1c1cc(C2([S@+](C)[O-])CC2)nc(-c2ccnc3[nH]ccc23)n1		CHEMBL4284359	=	IC50	nM	11.0	CHEMBL5024	Homo sapiens	IC50	uM	0.011
Not Determined	18779306	CHEMBL4269677	Inhibition of ATR in human HeLa cell nuclear extract using GST-fused p53N66 as substrate preincubated for 10 mins followed by ATP addition and measured after 1 hr by ELISA	B	C[C@@H]1COCCN1c1cc(C2([S@@](C)(=N)=O)CC2)nc(-c2ccnc3[nH]ccc23)n1		CHEMBL3648328		IC50			CHEMBL5024	Homo sapiens	IC50		
Not Determined	18779307	CHEMBL4269677	Inhibition of ATR in human HeLa cell nuclear extract using GST-fused p53N66 as substrate preincubated for 10 mins followed by ATP addition and measured after 1 hr by ELISA	B	C[C@@H]1COCCN1c1cc(C2(S(C)(=N)=O)CC2)nc(-c2cncc3[nH]ccc23)n1		CHEMBL4211377		IC50			CHEMBL5024	Homo sapiens	IC50		
	18779308	CHEMBL4269677	Inhibition of ATR in human HeLa cell nuclear extract using GST-fused p53N66 as substrate preincubated for 10 mins followed by ATP addition and measured after 1 hr by ELISA	B	CNc1nc2ccccc2n1-c1nc(N2CCOC[C@H]2C)cc(C2([S@](C)(=N)=O)CC2)n1		CHEMBL3648329	=	IC50	nM	6.0	CHEMBL5024	Homo sapiens	IC50	uM	0.006
Not Determined	18779309	CHEMBL4269677	Inhibition of ATR in human HeLa cell nuclear extract using GST-fused p53N66 as substrate preincubated for 10 mins followed by ATP addition and measured after 1 hr by ELISA	B	CNc1nc2ccccc2n1-c1nc(N2CCOC[C@H]2C)cc(C2([S@@](C)(=N)=O)CC2)n1		CHEMBL4281973		IC50			CHEMBL5024	Homo sapiens	IC50		
	18779310	CHEMBL4269678	Inhibition of ATR in human HT29 cells after 60 mins by Hoechst 33258 staining-based assay	B	C[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-c2cccc3[nH]ccc23)n1		CHEMBL2325697	=	IC50	nM	61.0	CHEMBL5024	Homo sapiens	IC50	uM	0.061
	18779311	CHEMBL4269678	Inhibition of ATR in human HT29 cells after 60 mins by Hoechst 33258 staining-based assay	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cccc4[nH]ccc34)n2)CC1		CHEMBL2325704	=	IC50	nM	290.0	CHEMBL5024	Homo sapiens	IC50	uM	0.29
	18779312	CHEMBL4269678	Inhibition of ATR in human HT29 cells after 60 mins by Hoechst 33258 staining-based assay	B	CS(=O)(=O)C1(c2cc(N3CC4CCC(C3)O4)nc(-c3cccc4[nH]ccc34)n2)CC1		CHEMBL2325699	=	IC50	nM	110.0	CHEMBL5024	Homo sapiens	IC50	uM	0.11
	18779313	CHEMBL4269678	Inhibition of ATR in human HT29 cells after 60 mins by Hoechst 33258 staining-based assay	B	CS(=O)(=O)C1(c2cc(C3=CCOCC3)nc(-c3cccc4[nH]ccc34)n2)CC1		CHEMBL4287961	=	IC50	nM	270.0	CHEMBL5024	Homo sapiens	IC50	uM	0.27
	18779314	CHEMBL4269678	Inhibition of ATR in human HT29 cells after 60 mins by Hoechst 33258 staining-based assay	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cc(F)cc4[nH]ccc34)n2)CC1		CHEMBL2325439	=	IC50	nM	130.0	CHEMBL5024	Homo sapiens	IC50	uM	0.13
	18779315	CHEMBL4269678	Inhibition of ATR in human HT29 cells after 60 mins by Hoechst 33258 staining-based assay	B	CNC(=O)c1cc(-c2nc(N3CCOCC3)cc(C3(S(C)(=O)=O)CC3)n2)c2cc[nH]c2c1		CHEMBL2325726	=	IC50	nM	16500.0	CHEMBL5024	Homo sapiens	IC50	uM	16.5
	18779316	CHEMBL4269678	Inhibition of ATR in human HT29 cells after 60 mins by Hoechst 33258 staining-based assay	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cccc4[nH]cnc34)n2)CC1		CHEMBL2325717	=	IC50	nM	6200.0	CHEMBL5024	Homo sapiens	IC50	uM	6.2
	18779317	CHEMBL4269678	Inhibition of ATR in human HT29 cells after 60 mins by Hoechst 33258 staining-based assay	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3ccnc4[nH]ccc34)n2)CC1		CHEMBL4281158	=	IC50	nM	350.0	CHEMBL5024	Homo sapiens	IC50	uM	0.35
	18779318	CHEMBL4269678	Inhibition of ATR in human HT29 cells after 60 mins by Hoechst 33258 staining-based assay	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-n3c(N)nc4ccccc43)n2)CC1		CHEMBL4291783	=	IC50	nM	51.0	CHEMBL5024	Homo sapiens	IC50	uM	0.051
	18779319	CHEMBL4269678	Inhibition of ATR in human HT29 cells after 60 mins by Hoechst 33258 staining-based assay	B	C[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-c2ccnc3[nH]ccc23)n1		CHEMBL4286472	=	IC50	nM	100.0	CHEMBL5024	Homo sapiens	IC50	uM	0.1
	18779320	CHEMBL4269678	Inhibition of ATR in human HT29 cells after 60 mins by Hoechst 33258 staining-based assay	B	CS(=O)(=O)C1(c2cc(N3CCOCC3)nc(-c3cncc4[nH]ccc34)n2)CC1		CHEMBL4278556	=	IC50	nM	85.0	CHEMBL5024	Homo sapiens	IC50	uM	0.085
	18779321	CHEMBL4269678	Inhibition of ATR in human HT29 cells after 60 mins by Hoechst 33258 staining-based assay	B	C[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-c2cncc3[nH]ccc23)n1		CHEMBL4281240	=	IC50	nM	12.0	CHEMBL5024	Homo sapiens	IC50	uM	0.012
	18779322	CHEMBL4269678	Inhibition of ATR in human HT29 cells after 60 mins by Hoechst 33258 staining-based assay	B	C[C@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-c2cncc3[nH]ccc23)n1		CHEMBL4289120	=	IC50	nM	360.0	CHEMBL5024	Homo sapiens	IC50	uM	0.36
	18779323	CHEMBL4269678	Inhibition of ATR in human HT29 cells after 60 mins by Hoechst 33258 staining-based assay	B	CS(=O)(=O)C1(c2cc(N3CC4CCC(C3)O4)nc(-c3cncc4[nH]ccc34)n2)CC1		CHEMBL4284647	=	IC50	nM	86.0	CHEMBL5024	Homo sapiens	IC50	uM	0.086
	18779324	CHEMBL4269678	Inhibition of ATR in human HT29 cells after 60 mins by Hoechst 33258 staining-based assay	B	CS(=O)(=O)C1(c2cc(N3C4CCC3COC4)nc(-c3cncc4[nH]ccc34)n2)CC1		CHEMBL4292532	=	IC50	nM	260.0	CHEMBL5024	Homo sapiens	IC50	uM	0.26
	18779325	CHEMBL4269678	Inhibition of ATR in human HT29 cells after 60 mins by Hoechst 33258 staining-based assay	B	C[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-n2c(N)nc3ccccc32)n1		CHEMBL4288033	=	IC50	nM	15.0	CHEMBL5024	Homo sapiens	IC50	uM	0.015
	18779326	CHEMBL4269678	Inhibition of ATR in human HT29 cells after 60 mins by Hoechst 33258 staining-based assay	B	CC(=O)Nc1nc2ccccc2n1-c1nc(N2CCOC[C@H]2C)cc(C2(S(C)(=O)=O)CC2)n1		CHEMBL4277395	=	IC50	nM	17.0	CHEMBL5024	Homo sapiens	IC50	uM	0.017
	18779327	CHEMBL4269678	Inhibition of ATR in human HT29 cells after 60 mins by Hoechst 33258 staining-based assay	B	CNc1nc2ccccc2n1-c1nc(N2CCOC[C@H]2C)cc(C2(S(C)(=O)=O)CC2)n1		CHEMBL4291436	=	IC50	nM	8.0	CHEMBL5024	Homo sapiens	IC50	uM	0.008
	18779328	CHEMBL4269678	Inhibition of ATR in human HT29 cells after 60 mins by Hoechst 33258 staining-based assay	B	C[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-n2c(N)nc3c(F)cccc32)n1		CHEMBL4280793	=	IC50	nM	130.0	CHEMBL5024	Homo sapiens	IC50	uM	0.13
	18779329	CHEMBL4269678	Inhibition of ATR in human HT29 cells after 60 mins by Hoechst 33258 staining-based assay	B	C[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-n2c(N)nc3cc(F)ccc32)n1		CHEMBL4286105	=	IC50	nM	35.0	CHEMBL5024	Homo sapiens	IC50	uM	0.035
	18779330	CHEMBL4269678	Inhibition of ATR in human HT29 cells after 60 mins by Hoechst 33258 staining-based assay	B	C[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-n2c(N)nc3ccc(F)cc32)n1		CHEMBL4294006	=	IC50	nM	120.0	CHEMBL5024	Homo sapiens	IC50	uM	0.12
	18779331	CHEMBL4269678	Inhibition of ATR in human HT29 cells after 60 mins by Hoechst 33258 staining-based assay	B	C[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-n2c(N)nc3cccc(F)c32)n1		CHEMBL4277999	=	IC50	nM	5100.0	CHEMBL5024	Homo sapiens	IC50	uM	5.1
	18779332	CHEMBL4269678	Inhibition of ATR in human HT29 cells after 60 mins by Hoechst 33258 staining-based assay	B	C[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-n2c(N)nc3c(Cl)cccc32)n1		CHEMBL4284450	=	IC50	nM	5300.0	CHEMBL5024	Homo sapiens	IC50	uM	5.3
	18779333	CHEMBL4269678	Inhibition of ATR in human HT29 cells after 60 mins by Hoechst 33258 staining-based assay	B	COc1cccc2c1nc(N)n2-c1nc(N2CCOC[C@H]2C)cc(C2(S(C)(=O)=O)CC2)n1		CHEMBL4279950	=	IC50	nM	5300.0	CHEMBL5024	Homo sapiens	IC50	uM	5.3
	18779334	CHEMBL4269678	Inhibition of ATR in human HT29 cells after 60 mins by Hoechst 33258 staining-based assay	B	C[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-n2c(N)nc3cc(Cl)ccc32)n1		CHEMBL4287852	=	IC50	nM	870.0	CHEMBL5024	Homo sapiens	IC50	uM	0.87
	18779335	CHEMBL4269678	Inhibition of ATR in human HT29 cells after 60 mins by Hoechst 33258 staining-based assay	B	C[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-n2c(N)nc3cc(C#N)ccc32)n1		CHEMBL4292722	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	18779336	CHEMBL4269678	Inhibition of ATR in human HT29 cells after 60 mins by Hoechst 33258 staining-based assay	B	COc1ccc2c(c1)nc(N)n2-c1nc(N2CCOC[C@H]2C)cc(C2(S(C)(=O)=O)CC2)n1		CHEMBL4282440	=	IC50	nM	15000.0	CHEMBL5024	Homo sapiens	IC50	uM	15.0
	18779337	CHEMBL4269678	Inhibition of ATR in human HT29 cells after 60 mins by Hoechst 33258 staining-based assay	B	C[C@@H]1COCCN1c1cc(C2([S@@+](C)[O-])CC2)nc(-c2ccnc3[nH]ccc23)n1		CHEMBL4294647	=	IC50	nM	180.0	CHEMBL5024	Homo sapiens	IC50	uM	0.18
	18779338	CHEMBL4269678	Inhibition of ATR in human HT29 cells after 60 mins by Hoechst 33258 staining-based assay	B	C[C@@H]1COCCN1c1cc(C2([S@+](C)[O-])CC2)nc(-c2ccnc3[nH]ccc23)n1		CHEMBL4284359	=	IC50	nM	90.0	CHEMBL5024	Homo sapiens	IC50	uM	0.09
	18779339	CHEMBL4269678	Inhibition of ATR in human HT29 cells after 60 mins by Hoechst 33258 staining-based assay	B	C[C@@H]1COCCN1c1cc(C2([S@@](C)(=N)=O)CC2)nc(-c2ccnc3[nH]ccc23)n1		CHEMBL3648328	=	IC50	nM	240.0	CHEMBL5024	Homo sapiens	IC50	uM	0.24
	18779340	CHEMBL4269678	Inhibition of ATR in human HT29 cells after 60 mins by Hoechst 33258 staining-based assay	B	C[C@@H]1COCCN1c1cc(C2(S(C)(=N)=O)CC2)nc(-c2cncc3[nH]ccc23)n1		CHEMBL4211377	=	IC50	nM	14.0	CHEMBL5024	Homo sapiens	IC50	uM	0.014
	18779341	CHEMBL4269678	Inhibition of ATR in human HT29 cells after 60 mins by Hoechst 33258 staining-based assay	B	CNc1nc2ccccc2n1-c1nc(N2CCOC[C@H]2C)cc(C2([S@](C)(=N)=O)CC2)n1		CHEMBL3648329	=	IC50	nM	9.0	CHEMBL5024	Homo sapiens	IC50	uM	0.009
	18779342	CHEMBL4269678	Inhibition of ATR in human HT29 cells after 60 mins by Hoechst 33258 staining-based assay	B	CNc1nc2ccccc2n1-c1nc(N2CCOC[C@H]2C)cc(C2([S@@](C)(=N)=O)CC2)n1		CHEMBL4281973	=	IC50	nM	23.0	CHEMBL5024	Homo sapiens	IC50	uM	0.023
	18861707	CHEMBL4308970	Inhibition of ATR in human HCT116 cells assessed as after 1 hr by Western blot analysis	B	Nc1ccc(-c2ccc3ncc4ccc(=O)n(-c5cccc(C(F)(F)F)c5)c4c3c2)cn1		CHEMBL1765602	=	EC50	nM	35.0	CHEMBL5024	Homo sapiens	EC50	nM	35.0
	19042347	CHEMBL4352755	Inhibition of ATR in human HCT116 cells assessed as reduction in histone H2AX phosphorylation by Hoechst staining-based immunofluorescence microscopic analysis	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3nnc(-c4ccccc4)s3)n2)cc1		CHEMBL4434665	=	IC50	nM	1700.0	CHEMBL5024	Homo sapiens	IC50	uM	1.7
	19042355	CHEMBL4352750	Inhibition of recombinant human full-length N-terminal Flag epitope-tagged ATR expressed in HEK293T cells using ASELPASQPQPFSAKKK peptide as substrate measured after 24 hrs in presence of [gamma-33P] ATP by microbeta liquid scintillation counting analysis	B	CNCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)on2)c(Cl)c1		CHEMBL4448538	=	Ki	nM	0.75	CHEMBL5024	Homo sapiens	Ki	nM	0.75
	19042356	CHEMBL4352750	Inhibition of recombinant human full-length N-terminal Flag epitope-tagged ATR expressed in HEK293T cells using ASELPASQPQPFSAKKK peptide as substrate measured after 24 hrs in presence of [gamma-33P] ATP by microbeta liquid scintillation counting analysis	B	CNCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)on2)cc1Cl		CHEMBL4541587	=	Ki	nM	2.4	CHEMBL5024	Homo sapiens	Ki	nM	2.4
	19042357	CHEMBL4352750	Inhibition of recombinant human full-length N-terminal Flag epitope-tagged ATR expressed in HEK293T cells using ASELPASQPQPFSAKKK peptide as substrate measured after 24 hrs in presence of [gamma-33P] ATP by microbeta liquid scintillation counting analysis	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3cc(-c4ccc([C@@H](C)N)cc4)no3)n2)cc1		CHEMBL4566104	=	Ki	nM	0.53	CHEMBL5024	Homo sapiens	Ki	nM	0.53
	19042358	CHEMBL4352750	Inhibition of recombinant human full-length N-terminal Flag epitope-tagged ATR expressed in HEK293T cells using ASELPASQPQPFSAKKK peptide as substrate measured after 24 hrs in presence of [gamma-33P] ATP by microbeta liquid scintillation counting analysis	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3cc(-c4ccc([C@H](C)N)cc4)no3)n2)cc1		CHEMBL4467848	=	Ki	nM	1.24	CHEMBL5024	Homo sapiens	Ki	nM	1.24
	19042359	CHEMBL4352750	Inhibition of recombinant human full-length N-terminal Flag epitope-tagged ATR expressed in HEK293T cells using ASELPASQPQPFSAKKK peptide as substrate measured after 24 hrs in presence of [gamma-33P] ATP by microbeta liquid scintillation counting analysis	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3cc(-c4ccc(CNC5CCOCC5)cc4)no3)n2)cc1		CHEMBL4444602	=	Ki	nM	0.14	CHEMBL5024	Homo sapiens	Ki	nM	0.14
	19042360	CHEMBL4352750	Inhibition of recombinant human full-length N-terminal Flag epitope-tagged ATR expressed in HEK293T cells using ASELPASQPQPFSAKKK peptide as substrate measured after 24 hrs in presence of [gamma-33P] ATP by microbeta liquid scintillation counting analysis	B	CCNCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)on2)cc1		CHEMBL4533440	=	Ki	nM	0.21	CHEMBL5024	Homo sapiens	Ki	nM	0.21
	19042361	CHEMBL4352750	Inhibition of recombinant human full-length N-terminal Flag epitope-tagged ATR expressed in HEK293T cells using ASELPASQPQPFSAKKK peptide as substrate measured after 24 hrs in presence of [gamma-33P] ATP by microbeta liquid scintillation counting analysis	B	CNCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)on2)cc1		CHEMBL3989870	=	Ki	nM	0.165	CHEMBL5024	Homo sapiens	Ki	nM	0.165
	19042362	CHEMBL4352750	Inhibition of recombinant human full-length N-terminal Flag epitope-tagged ATR expressed in HEK293T cells using ASELPASQPQPFSAKKK peptide as substrate measured after 24 hrs in presence of [gamma-33P] ATP by microbeta liquid scintillation counting analysis	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3cc(-c4ccc(CN)cc4)no3)n2)cc1		CHEMBL4443525	=	Ki	nM	0.27	CHEMBL5024	Homo sapiens	Ki	nM	0.27
	19042363	CHEMBL4352750	Inhibition of recombinant human full-length N-terminal Flag epitope-tagged ATR expressed in HEK293T cells using ASELPASQPQPFSAKKK peptide as substrate measured after 24 hrs in presence of [gamma-33P] ATP by microbeta liquid scintillation counting analysis	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3nnc(-c4ccccc4)s3)n2)cc1		CHEMBL4434665	=	Ki	nM	1.0	CHEMBL5024	Homo sapiens	Ki	uM	0.001
	19042364	CHEMBL4352750	Inhibition of recombinant human full-length N-terminal Flag epitope-tagged ATR expressed in HEK293T cells using ASELPASQPQPFSAKKK peptide as substrate measured after 24 hrs in presence of [gamma-33P] ATP by microbeta liquid scintillation counting analysis	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ncc(-c4ccccc4)o3)n2)cc1		CHEMBL4558884	=	Ki	nM	4.0	CHEMBL5024	Homo sapiens	Ki	uM	0.004
	19042365	CHEMBL4352750	Inhibition of recombinant human full-length N-terminal Flag epitope-tagged ATR expressed in HEK293T cells using ASELPASQPQPFSAKKK peptide as substrate measured after 24 hrs in presence of [gamma-33P] ATP by microbeta liquid scintillation counting analysis	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3cc(-c4ccccc4)no3)n2)cc1		CHEMBL4440048	=	Ki	nM	1.0	CHEMBL5024	Homo sapiens	Ki	uM	0.001
	19042366	CHEMBL4352750	Inhibition of recombinant human full-length N-terminal Flag epitope-tagged ATR expressed in HEK293T cells using ASELPASQPQPFSAKKK peptide as substrate measured after 24 hrs in presence of [gamma-33P] ATP by microbeta liquid scintillation counting analysis	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(C3CC(c4ccccc4)=NO3)n2)cc1		CHEMBL2409216	=	Ki	nM	90.0	CHEMBL5024	Homo sapiens	Ki	uM	0.09
	19042367	CHEMBL4352750	Inhibition of recombinant human full-length N-terminal Flag epitope-tagged ATR expressed in HEK293T cells using ASELPASQPQPFSAKKK peptide as substrate measured after 24 hrs in presence of [gamma-33P] ATP by microbeta liquid scintillation counting analysis	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3cn(-c4ccccc4)nn3)n2)cc1		CHEMBL3695214	=	Ki	nM	6.0	CHEMBL5024	Homo sapiens	Ki	uM	0.006
	19042368	CHEMBL4352750	Inhibition of recombinant human full-length N-terminal Flag epitope-tagged ATR expressed in HEK293T cells using ASELPASQPQPFSAKKK peptide as substrate measured after 24 hrs in presence of [gamma-33P] ATP by microbeta liquid scintillation counting analysis	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3cc(-c4ccccc4)on3)n2)cc1		CHEMBL4530813	=	Ki	nM	2.0	CHEMBL5024	Homo sapiens	Ki	uM	0.002
	19042369	CHEMBL4352750	Inhibition of recombinant human full-length N-terminal Flag epitope-tagged ATR expressed in HEK293T cells using ASELPASQPQPFSAKKK peptide as substrate measured after 24 hrs in presence of [gamma-33P] ATP by microbeta liquid scintillation counting analysis	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3nnc(-c4ccccc4)o3)n2)cc1		CHEMBL4467820	=	Ki	nM	1.0	CHEMBL5024	Homo sapiens	Ki	uM	0.001
	19042370	CHEMBL4352750	Inhibition of recombinant human full-length N-terminal Flag epitope-tagged ATR expressed in HEK293T cells using ASELPASQPQPFSAKKK peptide as substrate measured after 24 hrs in presence of [gamma-33P] ATP by microbeta liquid scintillation counting analysis	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3noc(-c4ccccc4)n3)n2)cc1		CHEMBL4445532	=	Ki	nM	5.0	CHEMBL5024	Homo sapiens	Ki	uM	0.005
	19042371	CHEMBL4352750	Inhibition of recombinant human full-length N-terminal Flag epitope-tagged ATR expressed in HEK293T cells using ASELPASQPQPFSAKKK peptide as substrate measured after 24 hrs in presence of [gamma-33P] ATP by microbeta liquid scintillation counting analysis	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3nc(-c4ccccc4)no3)n2)cc1		CHEMBL4593939	=	Ki	nM	26.0	CHEMBL5024	Homo sapiens	Ki	uM	0.026
	19042372	CHEMBL4352750	Inhibition of recombinant human full-length N-terminal Flag epitope-tagged ATR expressed in HEK293T cells using ASELPASQPQPFSAKKK peptide as substrate measured after 24 hrs in presence of [gamma-33P] ATP by microbeta liquid scintillation counting analysis	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3cnc(-c4ccccc4)o3)n2)cc1		CHEMBL4473876	=	Ki	nM	21.0	CHEMBL5024	Homo sapiens	Ki	uM	0.021
	19042373	CHEMBL4352755	Inhibition of ATR in human HCT116 cells assessed as reduction in histone H2AX phosphorylation by Hoechst staining-based immunofluorescence microscopic analysis	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ncc(-c4ccccc4)o3)n2)cc1		CHEMBL4558884	>	IC50	nM	2500.0	CHEMBL5024	Homo sapiens	IC50	uM	2.5
	19042374	CHEMBL4352755	Inhibition of ATR in human HCT116 cells assessed as reduction in histone H2AX phosphorylation by Hoechst staining-based immunofluorescence microscopic analysis	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3nc(-c4ccccc4)no3)n2)cc1		CHEMBL4593939	>	IC50	nM	2500.0	CHEMBL5024	Homo sapiens	IC50	uM	2.5
	19042375	CHEMBL4352755	Inhibition of ATR in human HCT116 cells assessed as reduction in histone H2AX phosphorylation by Hoechst staining-based immunofluorescence microscopic analysis	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3noc(-c4ccccc4)n3)n2)cc1		CHEMBL4445532	=	IC50	nM	2300.0	CHEMBL5024	Homo sapiens	IC50	uM	2.3
	19042376	CHEMBL4352755	Inhibition of ATR in human HCT116 cells assessed as reduction in histone H2AX phosphorylation by Hoechst staining-based immunofluorescence microscopic analysis	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3nnc(-c4ccccc4)o3)n2)cc1		CHEMBL4467820	=	IC50	nM	410.0	CHEMBL5024	Homo sapiens	IC50	uM	0.41
	19042377	CHEMBL4352755	Inhibition of ATR in human HCT116 cells assessed as reduction in histone H2AX phosphorylation by Hoechst staining-based immunofluorescence microscopic analysis	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3cc(-c4ccccc4)on3)n2)cc1		CHEMBL4530813	=	IC50	nM	800.0	CHEMBL5024	Homo sapiens	IC50	uM	0.8
	19042378	CHEMBL4352755	Inhibition of ATR in human HCT116 cells assessed as reduction in histone H2AX phosphorylation by Hoechst staining-based immunofluorescence microscopic analysis	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3cn(-c4ccccc4)nn3)n2)cc1		CHEMBL3695214	>	IC50	nM	2500.0	CHEMBL5024	Homo sapiens	IC50	uM	2.5
	19042379	CHEMBL4352755	Inhibition of ATR in human HCT116 cells assessed as reduction in histone H2AX phosphorylation by Hoechst staining-based immunofluorescence microscopic analysis	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(C3CC(c4ccccc4)=NO3)n2)cc1		CHEMBL2409216	>	IC50	nM	2500.0	CHEMBL5024	Homo sapiens	IC50	uM	2.5
	19042380	CHEMBL4352755	Inhibition of ATR in human HCT116 cells assessed as reduction in histone H2AX phosphorylation by Hoechst staining-based immunofluorescence microscopic analysis	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3cc(-c4ccccc4)no3)n2)cc1		CHEMBL4440048	=	IC50	nM	1100.0	CHEMBL5024	Homo sapiens	IC50	uM	1.1
	19042381	CHEMBL4352755	Inhibition of ATR in human HCT116 cells assessed as reduction in histone H2AX phosphorylation by Hoechst staining-based immunofluorescence microscopic analysis	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL1766793	=	IC50	nM	1030.0	CHEMBL5024	Homo sapiens	IC50	uM	1.03
	19042413	CHEMBL4352750	Inhibition of recombinant human full-length N-terminal Flag epitope-tagged ATR expressed in HEK293T cells using ASELPASQPQPFSAKKK peptide as substrate measured after 24 hrs in presence of [gamma-33P] ATP by microbeta liquid scintillation counting analysis	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL1766793	=	Ki	nM	4.0	CHEMBL5024	Homo sapiens	Ki	uM	0.004
	19042414	CHEMBL4352755	Inhibition of ATR in human HCT116 cells assessed as reduction in histone H2AX phosphorylation by Hoechst staining-based immunofluorescence microscopic analysis	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3cc(-c4ccc(CN)cc4)no3)n2)cc1		CHEMBL4443525	>	IC50	nM	25000.0	CHEMBL5024	Homo sapiens	IC50	uM	25.0
	19042415	CHEMBL4352755	Inhibition of ATR in human HCT116 cells assessed as reduction in histone H2AX phosphorylation by Hoechst staining-based immunofluorescence microscopic analysis	B	CNCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)on2)cc1		CHEMBL3989870	=	IC50	nM	19.0	CHEMBL5024	Homo sapiens	IC50	uM	0.019
	19042416	CHEMBL4352755	Inhibition of ATR in human HCT116 cells assessed as reduction in histone H2AX phosphorylation by Hoechst staining-based immunofluorescence microscopic analysis	B	CCNCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)on2)cc1		CHEMBL4533440	=	IC50	nM	76.0	CHEMBL5024	Homo sapiens	IC50	uM	0.076
	19042417	CHEMBL4352755	Inhibition of ATR in human HCT116 cells assessed as reduction in histone H2AX phosphorylation by Hoechst staining-based immunofluorescence microscopic analysis	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3cc(-c4ccc(CNC5CCOCC5)cc4)no3)n2)cc1		CHEMBL4444602	=	IC50	nM	13.0	CHEMBL5024	Homo sapiens	IC50	uM	0.013
	19042418	CHEMBL4352755	Inhibition of ATR in human HCT116 cells assessed as reduction in histone H2AX phosphorylation by Hoechst staining-based immunofluorescence microscopic analysis	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3cc(-c4ccc([C@H](C)N)cc4)no3)n2)cc1		CHEMBL4467848	=	IC50	nM	300.0	CHEMBL5024	Homo sapiens	IC50	uM	0.3
	19042419	CHEMBL4352755	Inhibition of ATR in human HCT116 cells assessed as reduction in histone H2AX phosphorylation by Hoechst staining-based immunofluorescence microscopic analysis	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3cc(-c4ccc([C@@H](C)N)cc4)no3)n2)cc1		CHEMBL4566104	=	IC50	nM	130.0	CHEMBL5024	Homo sapiens	IC50	uM	0.13
	19042420	CHEMBL4352755	Inhibition of ATR in human HCT116 cells assessed as reduction in histone H2AX phosphorylation by Hoechst staining-based immunofluorescence microscopic analysis	B	CNCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)on2)cc1Cl		CHEMBL4541587	=	IC50	nM	130.0	CHEMBL5024	Homo sapiens	IC50	uM	0.13
	19042421	CHEMBL4352755	Inhibition of ATR in human HCT116 cells assessed as reduction in histone H2AX phosphorylation by Hoechst staining-based immunofluorescence microscopic analysis	B	CNCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)on2)c(Cl)c1		CHEMBL4448538	=	IC50	nM	210.0	CHEMBL5024	Homo sapiens	IC50	uM	0.21
Dose-dependent effect	19106031	CHEMBL4369566	Inhibition of ATR in human HCT116 cells assessed as reduction in cisplatin-induced CHK1 expression preincubated for 24 hrs followed by cisplatin addition and measured after 48 hrs by Western blot analysis	B	Cc1cccc(-c2nnc(-c3c[nH]c4ncc(-c5ccc(S(C)(=O)=O)cc5)cc4c3=O)o2)c1		CHEMBL4458113		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
Dose-dependent effect	19106032	CHEMBL4369566	Inhibition of ATR in human HCT116 cells assessed as reduction in cisplatin-induced CHK1 expression preincubated for 24 hrs followed by cisplatin addition and measured after 48 hrs by Western blot analysis	B	Cc1ccc(-c2nnc(-c3c[nH]c4ncc(-c5ccc(S(C)(=O)=O)cc5)cc4c3=O)o2)cc1		CHEMBL4436591		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
	19157009	CHEMBL4381573	Inhibition of ATR (unknown origin) assessed as reduction in CHK1 phosphorylation by cell based assay	B	C[C@H]1COCCN1c1nc(N2CCOC[C@H]2C)c2nc(-c3cc[nH]n3)sc2n1		CHEMBL4518369	=	IC50	nM	394.0	CHEMBL5024	Homo sapiens	IC50	nM	394.0
	19260480	CHEMBL4403983	Inhibition of ATR in human HT-29 cells assessed as reduction in 4NQO-induced CHK1 phosphorylation at S345 residue preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst staining-based imaging analysis	B	Cc1cc2ncnn2cc1Nc1ncc2c(n1)n(C1CCOCC1)c(=O)n2C		CHEMBL4439259	>	IC50	nM	29000.0	CHEMBL5024	Homo sapiens	IC50	uM	29.0
	19276077	CHEMBL4408080	Inhibition of recombinant human full length ATR at 1 uM using GST-cMyc-p53 as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	0.0	CHEMBL5024	Homo sapiens	INH	%	0.0
	19468806	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	19468807	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	O=c1cc(-c2cccc3c2Sc2ccccc2C3)oc(N2CCOCC2)c1		CHEMBL4569967	=	IC50	nM	8500.0	CHEMBL5024	Homo sapiens	IC50	uM	8.5
	19468808	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	COc1cc2ncnc(-n3nc(-c4ccccn4)nc3N)c2cc1OC		CHEMBL2143829	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	19468809	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	CCC(CC)CNc1c(C(N)=O)cnc2ccc(C#N)cc12		CHEMBL4593348	=	IC50	nM	4400.0	CHEMBL5024	Homo sapiens	IC50	uM	4.4
	19468810	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	C[C@@H](Nc1c(C(N)=O)cnc2ccc(C#N)cc12)c1ccc(Cl)cc1		CHEMBL4527822	=	IC50	nM	4700.0	CHEMBL5024	Homo sapiens	IC50	uM	4.7
	19468811	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	C[C@@H](Nc1c(C(N)=O)cnc2ccc(-c3cccnc3)cc12)c1ccc(Cl)cc1		CHEMBL4565988	=	IC50	nM	1900.0	CHEMBL5024	Homo sapiens	IC50	uM	1.9
	19468812	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	C[C@@H](Nc1ccnc2ccc(-c3cccnc3)cc12)c1ccc(Cl)cc1		CHEMBL4567252	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	19468813	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	C[C@@H](Nc1c(C(=O)O)cnc2ccc(-c3cccnc3)cc12)c1ccc(Cl)cc1		CHEMBL4589441	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	19468814	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	CNC(=O)c1cnc2ccc(-c3cccnc3)cc2c1N[C@H](C)c1ccc(Cl)cc1		CHEMBL4568247	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	19468815	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	CCC(CC)CNc1c(C(N)=O)cnc2ccc(-c3cccnc3)cc12		CHEMBL4543897	>	IC50	nM	11000.0	CHEMBL5024	Homo sapiens	IC50	uM	11.0
	19468816	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	CCC(CC)COc1c(C(N)=O)cnc2ccc(-c3cccnc3)cc12		CHEMBL4576684	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	19468817	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	NC(=O)c1cnc2ccc(-c3cccnc3)cc2c1NC1CCCC1		CHEMBL4578468	=	IC50	nM	1200.0	CHEMBL5024	Homo sapiens	IC50	uM	1.2
	19468818	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	NC(=O)c1cnc2ccc(-c3cccnc3)cc2c1SC1CCCC1		CHEMBL4581380	>	IC50	nM	23000.0	CHEMBL5024	Homo sapiens	IC50	uM	23.0
	19468819	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	NC(=O)c1cnc2ccc(-c3cccnc3)cc2c1NC1CCCCC1		CHEMBL4514524	=	IC50	nM	3200.0	CHEMBL5024	Homo sapiens	IC50	uM	3.2
	19468820	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	NC(=O)c1cnc2ccc(-c3cccnc3)cc2c1NC1CCOCC1		CHEMBL4174323	=	IC50	nM	3100.0	CHEMBL5024	Homo sapiens	IC50	uM	3.1
	19468821	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	NC(=O)c1cnc2ccc(-c3cccnc3)cc2c1NCC1CCCCC1		CHEMBL4550293	=	IC50	nM	3000.0	CHEMBL5024	Homo sapiens	IC50	uM	3.0
	19468822	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	NC(=O)c1cnc2ccc(-c3cccnc3)cc2c1NCC1CCOCC1		CHEMBL4531643	=	IC50	nM	11000.0	CHEMBL5024	Homo sapiens	IC50	uM	11.0
	19468823	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	C[C@@H](Nc1c(C(N)=O)cnc2ccc(-c3cccnc3)cc12)C1CCOCC1		CHEMBL4544394	=	IC50	nM	3500.0	CHEMBL5024	Homo sapiens	IC50	uM	3.5
	19468824	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	C[C@H](Nc1c(C(N)=O)cnc2ccc(-c3cccnc3)cc12)C1CCOCC1		CHEMBL4548199	>	IC50	nM	14000.0	CHEMBL5024	Homo sapiens	IC50	uM	14.0
	19468825	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	C[C@@H](Nc1c(C(N)=O)cnc2ccc(-c3cccnc3)cc12)c1ccn(C)n1		CHEMBL4552140	>	IC50	nM	18000.0	CHEMBL5024	Homo sapiens	IC50	uM	18.0
	19468826	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	C[C@H](Nc1c(C(N)=O)cnc2ccc(-c3cccnc3)cc12)c1ccn(C)n1		CHEMBL4591401	=	IC50	nM	640.0	CHEMBL5024	Homo sapiens	IC50	uM	0.64
	19468827	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	CCC(CC)CNc1c(C(N)=O)cnc2ccc(-c3ccncc3)cc12		CHEMBL4569880	=	IC50	nM	730.0	CHEMBL5024	Homo sapiens	IC50	uM	0.73
	19468828	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	CCC(CC)CNc1c(C(N)=O)cnc2ccc(-c3cccnn3)cc12		CHEMBL4585977	>	IC50	nM	15000.0	CHEMBL5024	Homo sapiens	IC50	uM	15.0
	19468829	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	CCC(CC)CNc1c(C(N)=O)cnc2ccc(-c3ccnnc3)cc12		CHEMBL4535526	=	IC50	nM	2600.0	CHEMBL5024	Homo sapiens	IC50	uM	2.6
	19468830	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	CCC(CC)CNc1c(C(N)=O)cnc2ccc(-c3cncnc3)cc12		CHEMBL4585489	>	IC50	nM	18000.0	CHEMBL5024	Homo sapiens	IC50	uM	18.0
	19468831	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	CCC(CC)CNc1c(C(N)=O)cnc2ccc(-c3ccc(C)nc3)cc12		CHEMBL4567042	=	IC50	nM	5500.0	CHEMBL5024	Homo sapiens	IC50	uM	5.5
	19468832	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	CCC(CC)CNc1c(C(N)=O)cnc2ccc(-c3ccc(COC)cc3)cc12		CHEMBL4551177	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	19468833	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	CCC(CC)CNc1c(C(N)=O)cnc2ccc(-c3ccc(CS(C)(=O)=O)cc3)cc12		CHEMBL4519670	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	19468834	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	CCC(CC)CNc1c(C(N)=O)cnc2ccc(-c3ccc(CO)nc3)cc12		CHEMBL4588822	>	IC50	nM	13000.0	CHEMBL5024	Homo sapiens	IC50	uM	13.0
	19468835	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	CCC(CC)CNc1c(C(N)=O)cnc2ccc(-c3ccc(COC)nc3)cc12		CHEMBL4560522	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	19468836	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	CCC(CC)CNc1c(C(N)=O)cnc2ccc(-c3ccc(CS(C)(=O)=O)nc3)cc12		CHEMBL4576302	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	19468837	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	CCC(CC)CNc1c(C(N)=O)c(C)nc2ccc(-c3cccnc3)cc12		CHEMBL4574647	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	19468838	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	CCC(CC)CNc1c(C(N)=O)cnc2c(C)cc(-c3cccnc3)cc12		CHEMBL4543599	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	19468839	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	NC(=O)c1cnc2ccc(-c3cccnc3)c(F)c2c1NC1CCOCC1		CHEMBL4532124	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	19468840	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	NC(=O)c1cnc2cc(F)c(-c3cccnc3)cc2c1NC1CCOCC1		CHEMBL4540906	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	19468841	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	NC(=O)c1cnc2cc(Cl)c(-c3cccnc3)cc2c1NC1CCOCC1		CHEMBL4543236	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	19468842	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	NC(=O)c1cnc2c(F)cc(-c3cccnc3)cc2c1NC1CCOCC1		CHEMBL4584911	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	19468843	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	NC(=O)c1cnc2c(Cl)cc(-c3cccnc3)cc2c1NC1CCOCC1		CHEMBL4536989	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	19468844	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	COCc1ccc(-c2ccc3ncc(C(N)=O)c(N[C@@H](C)C4CCOCC4)c3c2)cn1		CHEMBL4218734	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	19468845	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	COCc1ccc(-c2cc3c(N[C@@H](C)C4CCOCC4)c(C(N)=O)cnc3cc2F)cn1		CHEMBL4533539	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	19468846	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	COCc1ccc(-c2cc3c(N[C@@H](C)c4ccn(C)n4)c(C(N)=O)cnc3cc2F)cn1		CHEMBL4166405	>	IC50	nM	19000.0	CHEMBL5024	Homo sapiens	IC50	uM	19.0
	19468847	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	COCc1ccc(-c2ccc3ncc(C(N)=O)c(N[C@@H](C)c4ccn(C)n4)c3c2)c(F)n1		CHEMBL4548927	>	IC50	nM	25000.0	CHEMBL5024	Homo sapiens	IC50	uM	25.0
	19468848	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	COCc1ccc(-c2cc3c(N[C@@H](C)c4ccn(C)n4)c(C(N)=O)cnc3cc2F)c(F)n1		CHEMBL4563993	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	19468849	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	COCc1ccc(-c2cc3c(N[C@@H](C)c4nn(C)cc4F)c(C(N)=O)cnc3cc2F)cn1		CHEMBL4517663	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	19468850	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	COCc1ccc(-c2cc3c(N[C@@H](C)c4nn(C)cc4C)c(C(N)=O)cnc3cc2F)cn1		CHEMBL4215266	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	19468851	CHEMBL4478168	Inhibition of ATR in human HT-29 cells assessed as reduction in Chk1 phosphorylation at Ser-345 residue after 60 mins in presence of 4-nitroquinoline-1-oxide by Hoechst 33258 staining based plate reader analysis	B	CCC(CC)CNc1c(C(N)=O)cnc2ccc(-c3cnn(C)c3)cc12		CHEMBL4549865	=	IC50	nM	7100.0	CHEMBL5024	Homo sapiens	IC50	uM	7.1
	20639400	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	CC(C)Oc1cc(N2CCOCC2)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4641384	=	IC50	nM	125.0	CHEMBL5024	Homo sapiens	IC50	nM	125.0
	20639401	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	CC(C)Oc1cc(N2CCOC[C@H]2C)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4636667	=	IC50	nM	38.0	CHEMBL5024	Homo sapiens	IC50	nM	38.0
	20639402	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	CC(C)Oc1cc(N2C3CCC2COC3)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4641978	=	IC50	nM	310.0	CHEMBL5024	Homo sapiens	IC50	nM	310.0
	20639403	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	CC(C)Oc1cc(N2[C@@H](C)COC[C@H]2C)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4639008	=	IC50	nM	413.0	CHEMBL5024	Homo sapiens	IC50	nM	413.0
	20639404	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	CC(C)Oc1cc(N2[C@H](C)COC[C@H]2C)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4637335	=	IC50	nM	730.0	CHEMBL5024	Homo sapiens	IC50	nM	730.0
	20639405	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	CC(C)Oc1cc(N2C[C@@H]3C[C@H]2CO3)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4642004	=	IC50	nM	922.0	CHEMBL5024	Homo sapiens	IC50	nM	922.0
	20639406	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	CC(C)Oc1cc(N2CCOC[C@@H]2C)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4643415	=	IC50	nM	1000.0	CHEMBL5024	Homo sapiens	IC50	nM	1000.0
	20639407	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	CC(C)Oc1cc(N2CCO[C@H](C)C2)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4639601	=	IC50	nM	1500.0	CHEMBL5024	Homo sapiens	IC50	nM	1500.0
	20639408	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	CC(C)Oc1cc(N2CCOC3CC32)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4634446	=	IC50	nM	1510.0	CHEMBL5024	Homo sapiens	IC50	nM	1510.0
	20639409	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	CCC1COCCN1c1cc(OC(C)C)c2ccnc(-c3ccn[nH]3)c2n1		CHEMBL4633553	=	IC50	nM	1860.0	CHEMBL5024	Homo sapiens	IC50	nM	1860.0
	20639410	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	CC(C)Oc1cc(N2CCO[C@@H](C)C2)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4638419	=	IC50	nM	1970.0	CHEMBL5024	Homo sapiens	IC50	nM	1970.0
	20639411	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	CC(C)Oc1cc(N2CCOCC2C(F)(F)F)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4637275	=	IC50	nM	8610.0	CHEMBL5024	Homo sapiens	IC50	nM	8610.0
	20639412	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	CC(C)Oc1cc(N2C[C@H]3COC[C@H]3C2)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4633524	=	IC50	nM	9440.0	CHEMBL5024	Homo sapiens	IC50	nM	9440.0
	20639413	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	CC(C)Oc1cc(N2CC(F)(F)OC(F)(F)C2)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4643539	>	IC50	nM	20000.0	CHEMBL5024	Homo sapiens	IC50	nM	20000.0
	20639414	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	CC(C)Oc1cc(N2CCOCC2(C)C)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4646324	>	IC50	nM	20000.0	CHEMBL5024	Homo sapiens	IC50	nM	20000.0
	20639415	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	COC1(C)CN(c2cc(OC(C)C)c3ccnc(-c4ccn[nH]4)c3n2)C1		CHEMBL4646693	>	IC50	nM	20000.0	CHEMBL5024	Homo sapiens	IC50	nM	20000.0
	20639416	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	CC(C)Oc1cc(N2CCOCC2)nc2c(-c3ccc[nH]3)nccc12		CHEMBL4644965	=	IC50	nM	339.0	CHEMBL5024	Homo sapiens	IC50	nM	339.0
	20639417	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	CC(C)Oc1cc(N2CCOCC2)nc2c(-c3cc[nH]c3)nccc12		CHEMBL4634705	=	IC50	nM	589.0	CHEMBL5024	Homo sapiens	IC50	nM	589.0
	20639418	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	CC(C)Oc1cc(N2CCOCC2)nc2c(C(N)=O)nccc12		CHEMBL4646594	=	IC50	nM	3300.0	CHEMBL5024	Homo sapiens	IC50	nM	3300.0
	20639419	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	CC(C)Oc1cc(N2CCOCC2)nc2c(-c3cnc[nH]3)nccc12		CHEMBL4648541	=	IC50	nM	3400.0	CHEMBL5024	Homo sapiens	IC50	nM	3400.0
	20639420	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	CC(C)Oc1cc(N2CCOCC2)nc2c(-c3cn[nH]c3)nccc12		CHEMBL4649175	=	IC50	nM	3690.0	CHEMBL5024	Homo sapiens	IC50	nM	3690.0
	20639421	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	Cc1cn[nH]c1-c1nccc2c(OC(C)C)cc(N3CCOCC3)nc12		CHEMBL4649136	=	IC50	nM	5640.0	CHEMBL5024	Homo sapiens	IC50	nM	5640.0
	20639422	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	CC(C)Oc1cc(N2CCOCC2)nc2c(-c3ccnn3C)nccc12		CHEMBL4633576	=	IC50	nM	12500.0	CHEMBL5024	Homo sapiens	IC50	nM	12500.0
	20639423	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	Cc1cc(-c2nccc3c(OC(C)C)cc(N4CCOCC4)nc23)n[nH]1		CHEMBL4643596	=	IC50	nM	12700.0	CHEMBL5024	Homo sapiens	IC50	nM	12700.0
	20639424	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	COc1cccc(-c2nccc3c(OC(C)C)cc(N4CCOCC4)nc23)n1		CHEMBL4639778	=	IC50	nM	13200.0	CHEMBL5024	Homo sapiens	IC50	nM	13200.0
	20639425	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	CC(C)Oc1cc(N2CCOCC2)nc2c(-c3cccc(C(N)=O)c3)nccc12		CHEMBL4635292	=	IC50	nM	17200.0	CHEMBL5024	Homo sapiens	IC50	nM	17200.0
	20639426	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	CC(C)Oc1cc(N2CCOCC2)nc2c(-c3cccnc3)nccc12		CHEMBL4635622	=	IC50	nM	18100.0	CHEMBL5024	Homo sapiens	IC50	nM	18100.0
	20639427	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	CC(C)Oc1cc(N2CCOCC2)nc2c(-c3cc4ccccc4[nH]3)nccc12		CHEMBL4638863	>	IC50	nM	20000.0	CHEMBL5024	Homo sapiens	IC50	nM	20000.0
	20639428	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	CC(C)Oc1cc(N2CCOCC2)nc2c(-c3nnn[nH]3)nccc12		CHEMBL4648897	>	IC50	nM	20000.0	CHEMBL5024	Homo sapiens	IC50	nM	20000.0
	20639429	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	CC(C)Oc1cc(N2CCOCC2)nc2c(-c3ccc[nH]c3=O)nccc12		CHEMBL4644163	>	IC50	nM	20000.0	CHEMBL5024	Homo sapiens	IC50	nM	20000.0
	20639430	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	CC(C)Oc1cc(N2CCOCC2)nc2c(-c3cccc(=O)[nH]3)nccc12		CHEMBL4643584	>	IC50	nM	20000.0	CHEMBL5024	Homo sapiens	IC50	nM	20000.0
	20639431	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	CC(C)Oc1cc(N2CCOCC2)nc2c(C3CCNC3)nccc12		CHEMBL4644428	>	IC50	nM	20000.0	CHEMBL5024	Homo sapiens	IC50	nM	20000.0
	20639432	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	CNC(=O)c1nccc2c(OC(C)C)cc(N3CCOCC3)nc12		CHEMBL4633347	>	IC50	nM	20000.0	CHEMBL5024	Homo sapiens	IC50	nM	20000.0
	20639433	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	CC(C)Oc1cc(N2CCOCC2)nc2cnccc12		CHEMBL4641748	>	IC50	nM	20000.0	CHEMBL5024	Homo sapiens	IC50	nM	20000.0
	20639434	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	C[C@@H]1COCCN1c1cc(C(C)(O)C(C)(C)C)c2ccnc(-c3ccn[nH]3)c2n1		CHEMBL4635442	=	IC50	nM	2.0	CHEMBL5024	Homo sapiens	IC50	nM	2.0
	20639435	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	C[C@@H]1COCCN1c1cc(N2CCN(S(C)(=O)=O)CC2)c2ccnc(-c3ccn[nH]3)c2n1		CHEMBL4638048	=	IC50	nM	5.0	CHEMBL5024	Homo sapiens	IC50	nM	5.0
	20639436	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	C[C@@H]1COCCN1c1cc(-c2ccnn2C)c2ccnc(-c3ccn[nH]3)c2n1		CHEMBL4647810	=	IC50	nM	7.0	CHEMBL5024	Homo sapiens	IC50	nM	7.0
	20639437	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	C[C@@H]1COCCN1c1cc(-c2cccnc2F)c2ccnc(-c3ccn[nH]3)c2n1		CHEMBL4642221	=	IC50	nM	8.0	CHEMBL5024	Homo sapiens	IC50	nM	8.0
	20639438	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	C[C@@H]1COCCN1c1cc(N(C)c2ccc(F)cc2)c2ccnc(-c3ccn[nH]3)c2n1		CHEMBL4632518	=	IC50	nM	9.0	CHEMBL5024	Homo sapiens	IC50	nM	9.0
	20639439	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	Cc1nc(S(C)(=N)=O)ccc1-c1cc(N2CCOC[C@H]2C)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4637776	=	IC50	nM	10.0	CHEMBL5024	Homo sapiens	IC50	nM	10.0
	20639440	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	C[C@@H]1COCCN1c1cc(-c2cnc3n2CCC3)c2ccnc(-c3ccn[nH]3)c2n1		CHEMBL4633890	=	IC50	nM	10.0	CHEMBL5024	Homo sapiens	IC50	nM	10.0
	20639441	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	C[C@@H]1COCCN1c1cc(C2CCOCC2)c2ccnc(-c3ccn[nH]3)c2n1		CHEMBL4636395	=	IC50	nM	14.0	CHEMBL5024	Homo sapiens	IC50	nM	14.0
	20639442	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	C[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)c2ccnc(-c3ccn[nH]3)c2n1		CHEMBL4647939	=	IC50	nM	15.0	CHEMBL5024	Homo sapiens	IC50	nM	15.0
	20639443	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	CCS(=O)(CC)=Nc1cc(N2CCOC[C@H]2C)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4639847	=	IC50	nM	22.0	CHEMBL5024	Homo sapiens	IC50	nM	22.0
	20639444	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	C[C@@H]1COCCN1c1cc(C#Cc2cccnc2)c2ccnc(-c3ccn[nH]3)c2n1		CHEMBL4635106	=	IC50	nM	22.0	CHEMBL5024	Homo sapiens	IC50	nM	22.0
	20639445	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	Cc1nccn1-c1cc(N2CCOC[C@H]2C)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4649777	=	IC50	nM	25.0	CHEMBL5024	Homo sapiens	IC50	nM	25.0
	20639446	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	CCP(=O)(CC)c1cc(N2CCOC[C@H]2C)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4634477	=	IC50	nM	28.0	CHEMBL5024	Homo sapiens	IC50	nM	28.0
	20639447	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	CS(=O)(=O)c1ccc(-c2cc(N3CCOCC3)nc3c(-c4ccn[nH]4)nccc23)cc1		CHEMBL4640028	=	IC50	nM	59.0	CHEMBL5024	Homo sapiens	IC50	nM	59.0
	20639448	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	CC(C)Oc1cc(N2CCOCC2)nc2c(-c3ccn[nH]3)cccc12		CHEMBL4633003	=	IC50	nM	5050.0	CHEMBL5024	Homo sapiens	IC50	nM	5050.0
	20639449	CHEMBL4612706	Inhibition of 5'-TAMRA-labeled tracer 3',6'-bis(dimethylamino)-N-(4-{[2(1H-indol-4-yl)-6-(morpholin-4-yl)-pyrimidin-4-yl]amino}butyl)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-carboxamide binding to recombinant human full-length N-terminal Flag-tagged ATR expressed in HEK293-6E cells co-expressing human full-length STREP-tagged ATRIP preincubated for 10 mins followed by tracer addition and measured after 30 mins by TR-FRET assay	B	C[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-c2cccc3[nH]ccc23)n1		CHEMBL2325697	=	IC50	nM	3.0	CHEMBL5024	Homo sapiens	IC50	nM	3.0
	20639450	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	CC(C)Oc1cc(N2CCOCC2)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4641384	=	IC50	nM	424.0	CHEMBL5024	Homo sapiens	IC50	nM	424.0
	20639451	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	CC(C)Oc1cc(N2CCOC[C@H]2C)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4636667	=	IC50	nM	154.0	CHEMBL5024	Homo sapiens	IC50	nM	154.0
Not Determined	20639452	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	CC(C)Oc1cc(N2C3CCC2COC3)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4641978		IC50			CHEMBL5024	Homo sapiens	IC50		
Not Determined	20639453	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	CC(C)Oc1cc(N2[C@@H](C)COC[C@H]2C)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4639008		IC50			CHEMBL5024	Homo sapiens	IC50		
Not Determined	20639454	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	CC(C)Oc1cc(N2[C@H](C)COC[C@H]2C)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4637335		IC50			CHEMBL5024	Homo sapiens	IC50		
Not Determined	20639455	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	CC(C)Oc1cc(N2C[C@@H]3C[C@H]2CO3)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4642004		IC50			CHEMBL5024	Homo sapiens	IC50		
Not Determined	20639456	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	CC(C)Oc1cc(N2CCOC[C@@H]2C)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4643415		IC50			CHEMBL5024	Homo sapiens	IC50		
Not Determined	20639457	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	CC(C)Oc1cc(N2CCO[C@H](C)C2)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4639601		IC50			CHEMBL5024	Homo sapiens	IC50		
Not Determined	20639458	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	CC(C)Oc1cc(N2CCOC3CC32)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4634446		IC50			CHEMBL5024	Homo sapiens	IC50		
Not Determined	20639459	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	CCC1COCCN1c1cc(OC(C)C)c2ccnc(-c3ccn[nH]3)c2n1		CHEMBL4633553		IC50			CHEMBL5024	Homo sapiens	IC50		
Not Determined	20639460	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	CC(C)Oc1cc(N2CCO[C@@H](C)C2)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4638419		IC50			CHEMBL5024	Homo sapiens	IC50		
Not Determined	20639461	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	CC(C)Oc1cc(N2CCOCC2C(F)(F)F)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4637275		IC50			CHEMBL5024	Homo sapiens	IC50		
Not Determined	20639462	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	CC(C)Oc1cc(N2C[C@H]3COC[C@H]3C2)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4633524		IC50			CHEMBL5024	Homo sapiens	IC50		
Not Determined	20639463	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	CC(C)Oc1cc(N2CC(F)(F)OC(F)(F)C2)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4643539		IC50			CHEMBL5024	Homo sapiens	IC50		
Not Determined	20639464	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	CC(C)Oc1cc(N2CCOCC2(C)C)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4646324		IC50			CHEMBL5024	Homo sapiens	IC50		
Not Determined	20639465	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	COC1(C)CN(c2cc(OC(C)C)c3ccnc(-c4ccn[nH]4)c3n2)C1		CHEMBL4646693		IC50			CHEMBL5024	Homo sapiens	IC50		
	20639466	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	CC(C)Oc1cc(N2CCOCC2)nc2c(-c3ccc[nH]3)nccc12		CHEMBL4644965	>	IC50	nM	3000.0	CHEMBL5024	Homo sapiens	IC50	nM	3000.0
Not Determined	20639467	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	CC(C)Oc1cc(N2CCOCC2)nc2c(-c3cc[nH]c3)nccc12		CHEMBL4634705		IC50			CHEMBL5024	Homo sapiens	IC50		
Not Determined	20639468	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	CC(C)Oc1cc(N2CCOCC2)nc2c(C(N)=O)nccc12		CHEMBL4646594		IC50			CHEMBL5024	Homo sapiens	IC50		
Not Determined	20639469	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	CC(C)Oc1cc(N2CCOCC2)nc2c(-c3cnc[nH]3)nccc12		CHEMBL4648541		IC50			CHEMBL5024	Homo sapiens	IC50		
Not Determined	20639470	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	CC(C)Oc1cc(N2CCOCC2)nc2c(-c3cn[nH]c3)nccc12		CHEMBL4649175		IC50			CHEMBL5024	Homo sapiens	IC50		
Not Determined	20639471	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	Cc1cn[nH]c1-c1nccc2c(OC(C)C)cc(N3CCOCC3)nc12		CHEMBL4649136		IC50			CHEMBL5024	Homo sapiens	IC50		
Not Determined	20639472	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	CC(C)Oc1cc(N2CCOCC2)nc2c(-c3ccnn3C)nccc12		CHEMBL4633576		IC50			CHEMBL5024	Homo sapiens	IC50		
Not Determined	20639473	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	Cc1cc(-c2nccc3c(OC(C)C)cc(N4CCOCC4)nc23)n[nH]1		CHEMBL4643596		IC50			CHEMBL5024	Homo sapiens	IC50		
Not Determined	20639474	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	COc1cccc(-c2nccc3c(OC(C)C)cc(N4CCOCC4)nc23)n1		CHEMBL4639778		IC50			CHEMBL5024	Homo sapiens	IC50		
Not Determined	20639475	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	CC(C)Oc1cc(N2CCOCC2)nc2c(-c3cccc(C(N)=O)c3)nccc12		CHEMBL4635292		IC50			CHEMBL5024	Homo sapiens	IC50		
Not Determined	20639476	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	CC(C)Oc1cc(N2CCOCC2)nc2c(-c3cccnc3)nccc12		CHEMBL4635622		IC50			CHEMBL5024	Homo sapiens	IC50		
Not Determined	20639477	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	CC(C)Oc1cc(N2CCOCC2)nc2c(-c3cc4ccccc4[nH]3)nccc12		CHEMBL4638863		IC50			CHEMBL5024	Homo sapiens	IC50		
Not Determined	20639478	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	CC(C)Oc1cc(N2CCOCC2)nc2c(-c3nnn[nH]3)nccc12		CHEMBL4648897		IC50			CHEMBL5024	Homo sapiens	IC50		
Not Determined	20639479	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	CC(C)Oc1cc(N2CCOCC2)nc2c(-c3ccc[nH]c3=O)nccc12		CHEMBL4644163		IC50			CHEMBL5024	Homo sapiens	IC50		
Not Determined	20639480	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	CC(C)Oc1cc(N2CCOCC2)nc2c(-c3cccc(=O)[nH]3)nccc12		CHEMBL4643584		IC50			CHEMBL5024	Homo sapiens	IC50		
Not Determined	20639481	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	CC(C)Oc1cc(N2CCOCC2)nc2c(C3CCNC3)nccc12		CHEMBL4644428		IC50			CHEMBL5024	Homo sapiens	IC50		
Not Determined	20639482	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	CNC(=O)c1nccc2c(OC(C)C)cc(N3CCOCC3)nc12		CHEMBL4633347		IC50			CHEMBL5024	Homo sapiens	IC50		
Not Determined	20639483	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	CC(C)Oc1cc(N2CCOCC2)nc2cnccc12		CHEMBL4641748		IC50			CHEMBL5024	Homo sapiens	IC50		
	20639484	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	C[C@@H]1COCCN1c1cc(C(C)(O)C(C)(C)C)c2ccnc(-c3ccn[nH]3)c2n1		CHEMBL4635442	=	IC50	nM	34.0	CHEMBL5024	Homo sapiens	IC50	nM	34.0
	20639485	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	C[C@@H]1COCCN1c1cc(N2CCN(S(C)(=O)=O)CC2)c2ccnc(-c3ccn[nH]3)c2n1		CHEMBL4638048	=	IC50	nM	59.0	CHEMBL5024	Homo sapiens	IC50	nM	59.0
	20639486	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	C[C@@H]1COCCN1c1cc(-c2ccnn2C)c2ccnc(-c3ccn[nH]3)c2n1		CHEMBL4647810	=	IC50	nM	36.0	CHEMBL5024	Homo sapiens	IC50	nM	36.0
	20639487	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	C[C@@H]1COCCN1c1cc(-c2cccnc2F)c2ccnc(-c3ccn[nH]3)c2n1		CHEMBL4642221	=	IC50	nM	44.0	CHEMBL5024	Homo sapiens	IC50	nM	44.0
	20639488	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	C[C@@H]1COCCN1c1cc(N(C)c2ccc(F)cc2)c2ccnc(-c3ccn[nH]3)c2n1		CHEMBL4632518	=	IC50	nM	70.0	CHEMBL5024	Homo sapiens	IC50	nM	70.0
	20639489	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	Cc1nc(S(C)(=N)=O)ccc1-c1cc(N2CCOC[C@H]2C)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4637776	=	IC50	nM	266.0	CHEMBL5024	Homo sapiens	IC50	nM	266.0
	20639490	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	C[C@@H]1COCCN1c1cc(-c2cnc3n2CCC3)c2ccnc(-c3ccn[nH]3)c2n1		CHEMBL4633890	=	IC50	nM	82.0	CHEMBL5024	Homo sapiens	IC50	nM	82.0
	20639491	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	C[C@@H]1COCCN1c1cc(C2CCOCC2)c2ccnc(-c3ccn[nH]3)c2n1		CHEMBL4636395	=	IC50	nM	66.0	CHEMBL5024	Homo sapiens	IC50	nM	66.0
	20639492	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	C[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)c2ccnc(-c3ccn[nH]3)c2n1		CHEMBL4647939	=	IC50	nM	86.0	CHEMBL5024	Homo sapiens	IC50	nM	86.0
	20639493	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	CCS(=O)(CC)=Nc1cc(N2CCOC[C@H]2C)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4639847	=	IC50	nM	30.0	CHEMBL5024	Homo sapiens	IC50	nM	30.0
	20639494	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	C[C@@H]1COCCN1c1cc(C#Cc2cccnc2)c2ccnc(-c3ccn[nH]3)c2n1		CHEMBL4635106	=	IC50	nM	227.0	CHEMBL5024	Homo sapiens	IC50	nM	227.0
	20639495	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	Cc1nccn1-c1cc(N2CCOC[C@H]2C)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4649777	=	IC50	nM	76.0	CHEMBL5024	Homo sapiens	IC50	nM	76.0
	20639496	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	CCP(=O)(CC)c1cc(N2CCOC[C@H]2C)nc2c(-c3ccn[nH]3)nccc12		CHEMBL4634477	=	IC50	nM	289.0	CHEMBL5024	Homo sapiens	IC50	nM	289.0
	20639497	CHEMBL4612707	Inhibition of ATR in human HT-29 cells assessed as reduction in histone H2AX phosphorylation measured after 30 mins by immunofluorescence cytometric assay	B	CS(=O)(=O)c1ccc(-c2cc(N3CCOCC3)nc3c(-c4ccn[nH]4)nccc23)cc1		CHEMBL4640028	=	IC50	nM	380.0	CHEMBL5024	Homo sapiens	IC50	nM	380.0
Active	20639601	CHEMBL4612751	In vivo inhibition of ATR in human SUDHL8 cells harboring ATM K1964E mutant xenografted CB-17 mouse assessed as reduction in ATR phosphorylation at 50 mg/kg, po bid dosed every 3 days followed by 4 days interval	F	C[C@@H]1COCCN1c1cc(-c2ccnn2C)c2ccnc(-c3ccn[nH]3)c2n1		CHEMBL4647810		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
Active	20639602	CHEMBL4612752	In vivo inhibition of ATR in human SUDHL8 cells harboring ATM K1964E mutant xenografted CB-17 mouse assessed as change in pH2AX level at 50 mg/kg, po bid dosed every 3 days followed by 4 days interval	F	C[C@@H]1COCCN1c1cc(-c2ccnn2C)c2ccnc(-c3ccn[nH]3)c2n1		CHEMBL4647810		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
Not Active	22407730	CHEMBL4670828	Inhibition of ATR in human HCT116 cells assessed as decrease in Chk1 phosphorylation at Ser317 residue by measuring decrease in foci formation at 50 nM treated for 1 hr prior to UV-irradiation exposure and measured after 1 hr by Immunofluorescence analysis	B	Nc1cnc(-c2ccc3ncc4ccc(=O)n(-c5cccc(C(F)(F)F)c5)c4c3c2)cn1		CHEMBL4789044		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
Active	22407731	CHEMBL4670828	Inhibition of ATR in human HCT116 cells assessed as decrease in Chk1 phosphorylation at Ser317 residue by measuring decrease in foci formation at 50 nM treated for 1 hr prior to UV-irradiation exposure and measured after 1 hr by Immunofluorescence analysis	B	Nc1ccc(-c2ccc3ncc4ccc(=O)n(-c5cccc(C(F)(F)F)c5)c4c3c2)cn1		CHEMBL1765602		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
Active	22407732	CHEMBL4670828	Inhibition of ATR in human HCT116 cells assessed as decrease in Chk1 phosphorylation at Ser317 residue by measuring decrease in foci formation at 50 nM treated for 1 hr prior to UV-irradiation exposure and measured after 1 hr by Immunofluorescence analysis	B	O=c1ccc2cnc3ccc(-c4ccc(N5CCNCC5)nc4)cc3c2n1-c1cccc(C(F)(F)F)c1		CHEMBL4786681		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
Active	22407743	CHEMBL4670832	Inhibition of ATR in human HCT116 cells assessed as decrease in Chk1 phosphorylation at Ser317 residue at 250 nM treated for 1 hr prior to UV-irradiation exposure and measured after 1 hr by Immunoblot analysis	B	O=c1ccc2cnc3ccc(-c4ccc(N5CCOCC5)nc4)cc3c2n1-c1cccc(C(F)(F)F)c1		CHEMBL4447635		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
	22407744	CHEMBL4670832	Inhibition of ATR in human HCT116 cells assessed as decrease in Chk1 phosphorylation at Ser317 residue at 250 nM treated for 1 hr prior to UV-irradiation exposure and measured after 1 hr by Immunoblot analysis	B	O=c1ccc2cnc3ccc(-c4ccc(N5CCNCC5)nc4)cc3c2n1-c1cccc(C(F)(F)F)c1		CHEMBL4786681	=	Inhibition	%	100.0	CHEMBL5024	Homo sapiens	INH	%	100.0
Active	22407745	CHEMBL4670832	Inhibition of ATR in human HCT116 cells assessed as decrease in Chk1 phosphorylation at Ser317 residue at 250 nM treated for 1 hr prior to UV-irradiation exposure and measured after 1 hr by Immunoblot analysis	B	Nc1cnc(-c2ccc3ncc4ccc(=O)n(-c5cccc(C(F)(F)F)c5)c4c3c2)cn1		CHEMBL4789044		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
Active	22407746	CHEMBL4670832	Inhibition of ATR in human HCT116 cells assessed as decrease in Chk1 phosphorylation at Ser317 residue at 250 nM treated for 1 hr prior to UV-irradiation exposure and measured after 1 hr by Immunoblot analysis	B	CS(=O)(=O)Nc1ccc(-c2ccc3ncc4ccc(=O)n(-c5cccc(C(F)(F)F)c5)c4c3c2)cn1		CHEMBL4786064		Inhibition	%		CHEMBL5024	Homo sapiens	INH		
	22456820	CHEMBL4682232	Inhibition of ATR in human HeLa cells incubated for 4 hrs	B	C[C@H]1CN(CC(=O)Nc2ccc3c(c2)Cc2cccc(-c4cc(=O)cc(N5CCOCC5)o4)c2S3)C[C@@H](C)O1		CHEMBL2140173	=	IC50	nM	21000.0	CHEMBL5024	Homo sapiens	IC50	uM	21.0
	22456821	CHEMBL4682232	Inhibition of ATR in human HeLa cells incubated for 4 hrs	B	COc1ccc2c(c1)Cc1cccc(-c3cc(=O)cc(N4CCOCC4)o3)c1S2		CHEMBL4792737	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	22456822	CHEMBL4682232	Inhibition of ATR in human HeLa cells incubated for 4 hrs	B	C[C@H]1CN(C[C@@H](C)Oc2ccc3c(c2)Cc2cccc(-c4cc(=O)cc(N5CCOCC5)o4)c2S3)C[C@@H](C)O1		CHEMBL4794132	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
Not Determined	22456823	CHEMBL4682232	Inhibition of ATR in human HeLa cells incubated for 4 hrs	B	C[C@H](CN1CCOCC1)Oc1ccc2c(c1)Cc1cccc(-c3cc(=O)cc(N4CCOCC4)o3)c1S2		CHEMBL4745255		IC50			CHEMBL5024	Homo sapiens	IC50		
	22456824	CHEMBL4682232	Inhibition of ATR in human HeLa cells incubated for 4 hrs	B	O=c1cc(-c2cccc3c2Sc2ccc(O[C@@H]4CCN(CC(F)F)C4)cc2C3)oc(N2CCOCC2)c1		CHEMBL4783168	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	22456825	CHEMBL4682232	Inhibition of ATR in human HeLa cells incubated for 4 hrs	B	COC[C@@H](C)Oc1ccc2c(c1)Cc1cccc(-c3cc(=O)cc(N4CCOCC4)o3)c1S2		CHEMBL4752634	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	22456826	CHEMBL4682232	Inhibition of ATR in human HeLa cells incubated for 4 hrs	B	O=c1cc(-c2cccc3c2Sc2ccc(OC4COC4)cc2C3)oc(N2CCOCC2)c1		CHEMBL4760480	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	22990659	CHEMBL4775105	Inhibition of ATR (unknown origin)	B	CC(C)n1c(=O)n(C)c2cnc3cc(F)c(-c4ccc(OCCCN5CCCCC5)nc4)cc3c21		CHEMBL4594429	>=	IC50	nM	1000.0	CHEMBL5024	Homo sapiens	IC50	uM	1.0
	22990660	CHEMBL4775105	Inhibition of ATR (unknown origin)	B	Nc1nn2cc(F)cnc2c1C(=O)Nc1cncc(F)c1N1CCC(C(=O)N2CCN(C3COC3)CC2)CC1		CHEMBL4650286	<=	Ki	nM	0.15	CHEMBL5024	Homo sapiens	Ki	pM	150.0
	23120181	CHEMBL4804344	Inhibition of ATR in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4855542	=	IC50	nM	-16100.0	CHEMBL5024	Homo sapiens	IC50	uM	-16.1
	23120182	CHEMBL4804344	Inhibition of ATR in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1	Outside typical range	CHEMBL4860979	=	IC50	nM	-37500.0	CHEMBL5024	Homo sapiens	IC50	uM	-37.5
	23120183	CHEMBL4804344	Inhibition of ATR in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	17100.0	CHEMBL5024	Homo sapiens	IC50	uM	17.1
	23120184	CHEMBL4804344	Inhibition of ATR in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	15000.0	CHEMBL5024	Homo sapiens	IC50	uM	15.0
	23120185	CHEMBL4804344	Inhibition of ATR in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	28100.0	CHEMBL5024	Homo sapiens	IC50	uM	28.1
	23120186	CHEMBL4804344	Inhibition of ATR in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	IC50	nM	37500.0	CHEMBL5024	Homo sapiens	IC50	uM	37.5
	23121226	CHEMBL4804526	Inhibition of ATR in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL5024	Homo sapiens	INH	%	0.0
	23121227	CHEMBL4804526	Inhibition of ATR in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL5024	Homo sapiens	INH	%	0.0
	23121228	CHEMBL4804526	Inhibition of ATR in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL5024	Homo sapiens	INH	%	0.0
	23121229	CHEMBL4804526	Inhibition of ATR in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL5024	Homo sapiens	INH	%	0.0
	23121230	CHEMBL4804526	Inhibition of ATR in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	0.0	CHEMBL5024	Homo sapiens	INH	%	0.0
	23216411	CHEMBL4823708	Inhibition of ATR in human HT-29 cells assessed as reduction in CHK1 phosphorylation incubated for 4 hrs	B	O=c1cc(N2CCOCC2)cc(N2CCCCC[C@@H]2Cc2ccccc2)[nH]1		CHEMBL4872830	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	23216412	CHEMBL4823708	Inhibition of ATR in human HT-29 cells assessed as reduction in CHK1 phosphorylation incubated for 4 hrs	B	O=c1cc(N2CCOCC2)cc(N2C[C@H]3C[C@H]3[C@@H]2Cc2ccccc2)[nH]1		CHEMBL4874640	>	IC50	nM	30000.0	CHEMBL5024	Homo sapiens	IC50	uM	30.0
	23216413	CHEMBL4823708	Inhibition of ATR in human HT-29 cells assessed as reduction in CHK1 phosphorylation incubated for 4 hrs	B	C[C@@H]1CN(c2cc(N3C[C@@H]4C[C@@H]4[C@@H]3Cc3ccccc3)[nH]c(=O)c2)CCO1		CHEMBL4856420	=	IC50	nM	13000.0	CHEMBL5024	Homo sapiens	IC50	uM	13.0
	23216414	CHEMBL4823708	Inhibition of ATR in human HT-29 cells assessed as reduction in CHK1 phosphorylation incubated for 4 hrs	B	C[C@@H]1CCN(c2nc(N3CCOCC3)cc(=O)[nH]2)[C@H]1Cc1ccccc1		CHEMBL4852400	=	IC50	nM	5500.0	CHEMBL5024	Homo sapiens	IC50	uM	5.5
	23216415	CHEMBL4823708	Inhibition of ATR in human HT-29 cells assessed as reduction in CHK1 phosphorylation incubated for 4 hrs	B	O=c1cc(N2CCOCC2)cc(N2CCCC[C@@H]2Cc2ccccc2)[nH]1		CHEMBL4846084	=	IC50	nM	8000.0	CHEMBL5024	Homo sapiens	IC50	uM	8.0
	23290583	CHEMBL4839392	Binding affinity to ATR (unknown origin)	B	FC(F)c1cncc(-c2ccc3ncc4nnc(C5=CCCOCC5)n4c3c2)c1		CHEMBL4851439	=	IC50	nM	394.0	CHEMBL5024	Homo sapiens	IC50	nM	394.0
